Escolar Documentos
Profissional Documentos
Cultura Documentos
Registry Report
2007
Malaysia Cancer Statistics Data and Figure
Content
PREFACE
ACKNOWLEDGEMENTS
LIST OF TABLES
LIST OF FIGURES
12
LIST OF APPENDICES
14
1.0
INTRODUCTION
16
2.0
BACKGROUND
16
2.1
Geography
16
2.2
Population
16
2.3
Health Status
19
3.0
OBJECTIVE OF NCR
19
4.0
METHODS
19
4.1
19
4.2
Source of data
20
4.3
20
4.4
Numerator figures
20
4.5
Reference population
20
4.6
21
4.7
Multiple primaries
21
4.8
Staging
21
4.9
Quality control
21
4.10
21
4.10.1
21
4.10.2
21
4.10.3
21
4.10.4
22
4.10.5
22
4.10.6
22
4.10.7
22
5.0
6.0
REPORT SUMMARY
5.1
23
5.2
23
5.3
Staging
23
24
6.1
24
6.2
Age variations
27
6.3
Cancer in children
28
29
6.4.1
29
6.4.1.1
29
6.4.1.2
30
6.4.1.3
32
6.4
7.0
8.0
23
34
7.1
Female Breast
34
7.2
Colorectal
36
7.3
Lung
38
7.4
Nasopharynx
40
7.5
Cervix Uteri
42
7.6
Lymphoma
44
7.7
Leukaemia
46
7.8
Ovary
48
7.9
Stomach
49
7.10
Liver
51
7.11
Prostate
53
7.12
Oral
54
56
56
8.1.1
56
8.1.2
Selangor
58
8.1.3
Perak
60
8.1.4
Pahang
62
8.1.5
Kelantan
64
8.1.6
Penang
66
8.1.7
Johor
68
8.1.8
Kedah
70
8.1.9
Terengganu
72
8.1.10
Malacca
74
8.1.11
Sabah
76
8.1.12
Sarawak
78
8.1.13
Negeri Sembilan
80
8.1.14
Perlis
82
Preface
his is the National Cancer Registry (NCR) second report since it was handed over to Public Health Programme from
the Department of Radiotherapy and Oncology, Kuala Lumpur Hospital in 2006, and the first NCR report produced
using the CanReg system. Prior to this, the CanReg system which was produced by the International Agency for
Cancer Research was being used only by the Regional Cancer Registries, namely, the Penang, Kelantan, Pahang, Johor,
Sabah and Sarawak Cancer Registries.
Cancer is a chronic disease, hence, the retrieval of cancer information is a complex process. The information on new cancer
cases comes from voluntary notifications as well as from active finding done by all State Cancer Registries.
In contrast with the previous National Cancer Registry reports, this report provides information not only on cancer
occurrence in Peninsular Malaysia, but cancer occurrence in the whole country which include Peninsular Malaysia, Sabah
and Sarawak.
All care has been taken in the production of this report. The data were deemed to be accurate at the time of analysis and
publication, however, it may be subject to slight changes over time as further notification received. We believe that there
are cancer cases diagnosed in 2007 which have not yet been notified to the cancer registry, and this might have contributed
to the lower incidence rate in this cancer report compared to the previous reports.
The collection on the information of the 2007 new cancer cases was started in January 2007 when new cancer registries
were being established at states other than Penang, Kelantan, Pahang, Johor, Sabah and Sarawak. These new cancer
registries are the Cancer Registry of Federal Territory Kuala Lumpur & Putrajaya, Selangor Cancer Registry, Perak Cancer
Registry, Negeri Sembilan Cancer Registry, Malacca Cancer Registry, Terengganu Cancer Registry, Kedah Cancer Registry
and Perlis Cancer Registry. The Cancer Registry of the Federal Territory of Labuan has only been established in 2009.
For this 2007 data report, the percentage of ill defined (other and unspecified) cases was 2.6% and the
histological/morphological verification was 92.5%. We are aware that the Death Certificate Only notification (DCO) is an
important criteria for quality control, however, it is still a challenge for us as not all the State Cancer Registries have the
capacity to carry out DCO yet. We hope to be able to show improvement on this in the next report.
As of this point, most of the previously established Regional Cancer Registries had produced their cancer reports. Penang
and Sarawak Cancer Registries had each published two (2) five-year cancer reports namely the 1994-1998 and 1999-2003
for Penang; and 1996-2000 and 2001-2005 for Sarawak. The Kelantan and Pahang Cancer Registries had produced their
first five-year report, that is, the 1999-2003 report, while Sabah had produced the 2001-2005 report.
Much time and effort has been put into the process of collecting data and ensuring its accuracy, its completeness and its
good quality by the State Cancer Registries as well as the National Cancer Registry and also into the preparing of this report.
It is hoped that the information derived from this NCR 2007 report can be used as reference in the planning and evaluation
of Cancer Control Programme in Malaysia.
Acknowledgements
The National Cancer Registry (NCR) under the Non-Communicable Disease Section, Disease Control Division, Ministry of
Health, Malaysia would like to express its gratitude to all individual and organisation who have directly or indirectly
contributed to the National Cancer Registry and made this National Cancer Registry Report, Malaysia Cancer Statistics, Data
and Figure 2007 possible.
11.
12.
13.
The Honorable Minister of Health Malaysia, Y.B. Dato Sri Liow Tiong Lai.
Director General of Health Malaysia, Tan Sri Dato Seri Dr. Hj. Mohd Ismail Merican.
Deputy Director General of Health Malaysia (Public Health), Dato Dr. Hasan Bin Abdul Rahman.
Deputy Director General of Health Malaysia (Medical), Datuk Dr. Noor Hisham Bin Abdullah.
Deputy Director General of Health Malaysia (Research & Technical Support), Dato Dr. Maimunah Binti A. Hamid.
Deputy Director, Health Informatics Centre, Planning and Development Division, Ministry of Health, Malaysia.
State Directors and Deputy State Directors for their commitment and continuous support.
All State Epidemiologists (NCD) for their commitment and support.
Head of Oncology Department, Hospital Kuala Lumpur, Dr. Gerard Lim Chin Chye for his continuous support.
Oncologists, pathologists, other discipline specialists, palliative care professionals, and all other members of the medical
profession from various government, universities, non-government and private centers, upon whose commitment, hard
work, and timely data submission to State Cancer Registries, that this report ultimately depended on.
Director of National Registration Department for assistance and support.
Medical record departments of all hospitals.
All others whom had contributed directly and indirectly that made this report possible.
We would like to express our appreciation to the State Cancer Registries listed below for their
hard work and continuous data contribution to the National Cancer Registry.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
Dr. Noorhashimah Binti Abdullah, Kelantan State Health Department, for sharing her SHIbzz Tools to help produce
incidence summary tables faster and easier.
Nor Asikin Abd. Kadir, National Cancer Society, Penang Branch for her time and support.
2.
3.
4.
5.
2.
3.
4.
5.
6.
7.
8.
List of Tables
Table 1
17
Table 2
18
Table 3
18
Table 4
19
Table 5
Percentage of stage III and IV for selected cancer sites, Malaysia 2007
23
Table 6
24
Table 7
Number of new cancer cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
24
Table 8
24
Table 9
25
Table 10
26
Table 11
28
Table 12
28
Table 13
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay male
29
Table 14
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay female
30
Table 15
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese male
30
Table 16
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese female
31
Table 17
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian male
32
Table 18
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian female
33
Table 19
Female Breast, number of new cases, percentage, crude rate (CR), age-standardised rate (ASR)
and Cumulative Risk (CumR), Malaysia 2007
34
Table 20
Female Breast. number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative
rate (CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
34
Table 21
Colorectal. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
36
Table 22
Colorectal. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
36
Table 23
Lung. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
38
Table 24
Lung. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate (CR74)
and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
38
Table 25
Nasopharynx. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
40
Table 26
Nasopharynx. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative
rate (CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
40
Table 27
Cervix Uteri. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR), Malaysia 2007
42
Table 28
Cervix Uteri. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups, Malaysia 2007
42
Table 29
Lymphoma. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
44
Table 30
Lymphoma. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
44
Table 31
Leukaemia. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
46
Table 32
Leukaemia. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
46
Table 33
Ovary. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR), Malaysia 2007
48
Table 34
Ovary. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
48
Table 35
Stomach. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
49
Table 36
Stomach. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
49
Table 37
Liver. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
51
Table 38
Liver. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
51
Table 39
Prostate. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
53
Table 40
Prostate. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups, Malaysia 2007
53
Table 41
Oral. Number of new cases, percentage, crude rate (CR) and age-standardised rate (ASR),
Malaysia 2007
54
Table 42
Oral. Number of new cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Malaysia 2007
54
Table 43
Oral. Number of new cases, crude rate (CR) and age-standardised rate (ASR) by site and sex,
Malaysia 2007
54
Table 44
56
Table 45
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Federal Territory of Kuala Lumpur 2007
56
Table 46
Five most common cancers, male, Federal Territory of Kuala Lumpur 2007
56
Table 47
Five most common cancers, female, Federal Territory of Kuala Lumpur 2007
56
Table 48
58
Table 49
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups, Selangor 2007
58
Table 50
58
Table 51
58
Table 52
60
Table 53
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Perak 2007
60
Table 54
60
Table 55
60
Table 56
62
Table 57
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Pahang 2007
62
Table 58
62
Table 59
62
Table 60
64
Table 61
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Kelantan 2007
64
Table 62
64
Table 63
64
Table 64
66
Table 65
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Penang 2007
66
Table 66
66
Table 67
66
Table 68
68
Table 69
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Johor 2007
68
Table 70
68
Table 71
68
Table 72
70
Table 73
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Kedah, 2007
70
Table 74
70
Table 75
70
Table 76
72
Table 77
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex,Terengganu 2007
72
Table 78
72
Table 79
72
Table 80
74
Table 81
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Malacca, 2007
74
Table 82
74
10
Table 83
74
Table 84
76
Table 85
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Sabah 2007
76
Table 86
76
Table 87
76
Table 88
78
Table 89
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Sarawak 2007
78
Table 90
78
Table 91
78
Table 92
80
Table 93
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Negeri Sembilan, 2007
80
Table 94
80
Table 95
80
Table 96
82
Table 97
82
Table 98
82
11
List of Figures
Figure 1
Map of Malaysia
16
Figure 2
17
Figure 3
18
Figure 4
25
Figure 5
25
Figure 6
26
Figure 7
Average age-specific incidence rate, all residence, by all sites and sex, Malaysia 2007
27
Figure 8
Average age-specific incidence rate for ten most frequent sites, males, Malaysia 2007
27
Figure 9
Average age-specific incidence rate for ten most frequent sites, females, Malaysia 2007
27
Figure 10
28
Figure 11
28
Figure 12
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay male
29
Figure 13
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay female
30
Figure 14
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese male
31
Figure 15
Ten most frequent cancers in females by major ethnic groups, Malaysia 2007: Chinese female
31
Figure 16
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian male
32
Figure 17
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian female
33
Figure 18
Female Breast. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
34
Figure 19
35
Figure 20
Colorectal. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
36
Figure 21
37
Figure 22
Lung. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
39
Figure 23
39
Figure 24
Nasopharynx. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
41
Figure 25
41
Figure 26
Cervix Uteri. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
42
Figure 27
43
Figure 28
Lymphoma. Age-specific Cancer Incidence Rate per 100,000 population by sex, Malaysia 2007
44
Figure 29
45
Figure 30
Leukaemia. Age specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
46
Figure 31
47
Figure 32
Ovary. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
48
Figure 33
48
Figure 34
Stomach. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
49
Figure 35
50
Figure 36
Liver. Age specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
51
12
Figure 37
52
Figure 38
53
Figure 39
53
Figure 40
Oral. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
55
Figure 41
55
Figure 42
Five most common cancers, male, Federal Territory of Kuala Lumpur 2007
57
Figure 43
Five most common cancers, female, Federal Territory of Kuala Lumpur 2007
57
Figure 44
59
Figure 45
59
Figure 46
61
Figure 47
61
Figure 48
63
Figure 49
63
Figure 50
65
Figure 51
65
Figure 52
67
Figure 53
67
Figure 54
69
Figure 55
69
Figure 56
71
Figure 57
71
Figure 57
73
Figure 58
73
Figure 60
75
Figure 61
75
Figure 62
77
Figure 63
77
Figure 64
79
Figure 65
79
Figure 66
81
Figure 67
81
Figure 68
83
Figure 69
83
13
List of Appendices
Appendix 1
Population by sex, ethnic group and age, Malaysia, 2007 (source: Statistic Department)
84
Appendix 2
85
Appendix 3
86
Appendix 4
87
Appendix 5
88
Appendix 6
89
Appendix 7
90
Appendix 8
91
Appendix 9
92
Appendix 10
93
Appendix 11
94
Appendix 12
95
Appendix 13
96
Appendix 14
97
Appendix 15
98
Appendix 16
99
Appendix 17
100
Appendix 18
101
Appendix 19
102
Appendix 20
103
Appendix 21
104
Appendix 22
105
Appendix 23
106
Appendix 24
107
Appendix 25
108
Appendix 26
109
Appendix 27
Morphology of the cancer cases reported and registered at NCR, Malaysia 2007
110
14
National Cancer
Registry Report
2007
Malaysia Cancer Statistics Data and Figure
1.0 INTRODUCTION
Cancer is one of the common caused of death in Malaysia. The data from this report aims to provide an epidemiological
profile of cancer, cancer burden, and high risk group of specific cancer in Malaysia which is very important in the Cancer
Control Programme.
2.0 BACKGROUND
2.1
Geography
Malaysia covers and area of about 329,961 square kilometers, consisting of Peninsular Malaysia and East Malaysia
(Sabah, Sarawak and Federal Territory of Labuan). It is separated by the South East China Sea and has its frontier
with Thailand, Singapore, Indonesia and Brunei.
Peninsular Malaysia covers the area of 35,965 square kilometers and consists of the following states: Selangor Darul
Ehsan, Perak Darul Ridzuan, Kedah Darul Aman, Kelantan Darul Naim, Perlis, Penang, Negeri Terengganu Darul
Iman, Pahang Darul Makmur, Johor Darul Takzim, Malacca, Negeri Sembilan Darul Khusus and Federal Teritory of
Kuala Lumpur and Putrajaya.
2.2
Population
The estimated Malaysian population in 2007 was 25.3 millions. The population pyramid and its distribution of ethnic,
gender and age is as shown in Figure 2 and table 3 respectively. Overall, there were about 50.6 % male and 49.4%
female (Table 1) in the country. The major ethnic contribution was Malay (54.5%), followed by Chinese (24.9%),
Indian (7.5%) and others (13.1%), (Table 1 and Figure 3). In addition there were about more than 900,000 noncitizens in Malaysia (Table 2).
16
71.2
99.9
75-79
84.0
101.5
70-74
318.2
328.1
55-59
449.4
464.9
50-54
596.3
612.6
45-49
698.6
706.1
40-44
786.9
778.7
35-39
831.4
817.9
30-34
863.9
848.9
25-29
996.7
1,003.7
20-24
1,151.1
1,189.5
15-19
5-9
242.3
231.2
60-64
10-14
174.4
148.4
65-69
Age group
Female
1,215.6
1,278.1
1,261.5
1,341.8
1,326.6
1,403.9
0-4
1,378.5
1,463.9
2,000.000
1,500.000
1,000.000
500.000
0.000
500.000
1,000.000
1,500.000
2,000.000
Ethnicity
Malay
Chinese
Indian
Others
Total
13,773.1
6,287.9
1,883.9
326.1
25,265.8
54.5
24.9
7.5
13.1
100.0
Sex
Male
Female
Total
12773.0
12,492.8
25,265.8
50.6
49.4
100.0
17
13.1%
24.9%
54.5%
Malay
Chinese
Indian
Others
Number
25,265.8
907.8
27,173.6
93.0
7.0
100.0
Table 3: Age, sex and major ethnic distribution of Malaysian population 2007
Age group,
years
0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75+
Total
Malay
Indian
Male
Female
Male
Female
Male
Female
905.1
830.4
783.7
739.2
673.4
542.7
434.8
412.1
389.0
345.4
293.6
217.5
148.7
102.2
64.0
66.5
6,948.4
637,400
846.5
782.5
738.2
706.5
657.1
544.1
448.3
424.6
398.0
347.7
292.3
215.7
148.6
111.4
84.7
6,824.8
271.1
283.6
273.2
267.3
262.8
245.7
231.9
231.7
228.0
220.1
202.6
163.5
123.0
88.7
57.6
58.6
3,209.4
248.6
264.6
251.1
247.8
248.3
235.0
224.3
226.3
223.3
211.5
191.7
152.4
114.5
89.0
65.1
85.0
3,078.5
91.6
94.6
89.8
87.9
86.3
78.4
71.6
69.1
65.1
60.1
52.0
36.4
22.7
15.2
9.4
9,6
939.7
88.2
91.3
86.5
83.9
82.7
78.5
74.0
71.2
66.8
61.8
54.0
38.0
24.1
18.1
13.1
12.1
944.1
18
Chinese
All groups
Male
Female
1,463.9 1,378.5
1,403.9 1,326.6
1,341.8 1,261.5
1,278.1 1,215.6
1,189.5 1,151.1
1,003.7
996.7
848.9
863.9
817.9
831.4
778.7
786.9
706.1
698.6
612.6
596.3
464.9
449.4
328.1
318.2
231.2
242.3
174.4
148.4
155.2
201.4
12,773.0 12,492.8
2.3
Health Status
In 2007, cancer was the third common cause of death in Ministry of Health Malaysia Hospitals after Heart Diseases
& Diseases of Pulmonary Circulation and Septicaemia (Table 4).
Table 4: 10 Principle Cause of Deaths in Ministry of Health Malaysia (MOH) Hospitals, 2007
Diseases
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Percentage (%)
16.49
13.38
11.28
8.50
7.43
5.20
4.86
4.11
4.09
2.55
100.0
Source: Health Informatic Centre, Planning and Development Division, Ministry of Health, Malaysia
3.0
To determine the disease burden attributable to cancer by quantifying the magnitude of cancer morbidity, its
geographic and temporal trends in Malaysia.
To identify the subgroups in population at high risk of cancer to whom specific cancer prevention programme should
be targeted.
To enable evaluation on the effectiveness of the existing cancer control programmes.
To stimulate and facilitate research on cancer.
by ensuring:
1.
2.
3.
4.0 METHODS
All cancer data collected by State Cancer Registries using CanReg system were compiled and merged using
CanReg4 system at the National Cancer Registry (NCR).
4.1
19
vii.
viii.
ix.
x.
xi.
xii.
xiii.
xiv.
xv.
4.2
Source of data
As cancer is a non-notifiable disease, case registration is based primarily on voluntary notifications. The registry
seek to obtain basic epidemiological and clinical data on all cases of cancer diagnosed in Malaysia from 1st January
until 31st December 2007, regardless of citizenship, place of stay and basis of diagnosis. The registry received
notification from all sections of the medical profession in the whole country using a standardised format. However,
the analysis of data is confined only to Malaysian residents.
Malaysian residents are defined as Malaysian citizens as well as permanent residents living in Malaysia at the time
of diagnosis.
Active case finding and routine checks are done by the State Cancer Registries at the government and private
hospital discharges as well as pathology, heamatology and oncology record listings from the government hospital
to ensure completeness of the data. Any cancer cases picked up from pathology, heamatology, oncology are then
checked against previously registered cases. For the cases that are yet to be notified, reminders will be sent to the
hospital/head of department for more information. Additional missing data for these cases also were sought by
registry staff by searching the relevant hospital records and discharge list.
Multiple sources of data assist in optimising completeness but it can create the problem of multiple notification of
a patient. This issue has been addressed by cross checking names and Identity Card numbers (I/C) through
CanReg4 software. Identification card number is personal to each Malaysian citizen and permanent residents.
4.3
4.4
Numerator figures
Invasive cancer cases registered in Malaysian residents, diagnosed in 2007 were counted as Malaysian incidence
cases.
4.5
Reference population
The World Standard Population (modified by Doll et al., 1966) applied in this report is widely used in the published
volumes of the Cancer Incidence in Five Continents. This will facilitate comparison of cancer statistics between
different registries that use the same reference population.
20
4.6
4.7
Multiple primaries
Registration of multiple primary cancers is in accordance with the IARC criteria, as specified in the Manual for
Cancer Registry Personnel, IARC Technical Report No. 10, 1995 (Esteban et al., 1995).
4.8
Staging
The stage of cancer at the time of diagnosis is reported based on information provided by the notifying clinicians.
A scale from I to IV was used for reporting clinical stage. While definitive criteria were not provided, clinicians would
have been guided by TNM criteria.
4.9
Quality control
In order to ascertain high coverage and accuracy of data, all State Cancer Registries performed several quality
control checks. These include sourcing out missed cases, identifying multiple notifications and inaccurate
information.
Quality of data can be measured indirectly using percentages of morphologically verified cases (MV%) and death
certificate only cases (DCO%).
21
It is calculated by summing the products of the age-specific rates applied to the world standard
population; the calculated incidence rate is then called the World Standardised incidence rate. It is also
expressed per 100,000.
ASR = (ARi x Pi.std) / total world standard population
ARi - Age specific rate in the ith age class
Pi.std - The number in the ith age class of world standard population
22
5.2
5.3
Staging
Staging was reported for 8,869 from 18,219 (48.7%) new cases reported and registered at NCR. Of these, 17.0%
were reported as stage I, 25.3% as stage II, 25.0% as stage III and 32.7% as stage IV. Therefore, at diagnosis, of
those staged, 57.6% were already at advance stages of cancer.
Similar results were seen for several cancers where it can be easily detected and screening programmes are
available as shown in Table 5
Table 5: Percentage of stage III and IV for selected cancer sites, Malaysia 2007
ICD 10
C00
C01-C02
C03-C06
C11
C18-C21
C50
C53
Sites
Lip
Tongue
Mouth
Nasopharynx
Colorectal
Breast
Cervix Uteri
Stage IV (%)
30.8
40.4
55.9
32.3
31.7
17.7
18.7
23
No.
CR
ASR
CR74
CumR
8123
10096
18219
44.6
55.4
100
63.6
80.9
85.1
94.4
10.1
10.5
9.6
9.9
Table 7: Number of new cancer cases, crude rate (CR), age-standardised rate (ASR), cumulative
rate (CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
MALE
FEMALE
Ethnic
No.
CR
ASR
CR74
CumR
NO.
CR
ASR
CR74
CumR
Malay
Chinese
Indian
3093
3650
462
44.5
113.8
49.2
66.9
111.9
68.2
7.7
13.4
7.9
7.4
12.5
7.6
4238
3990
825
62.1
129.7
87.5
79.0
115.0
99.9
8.6
13.0
11.2
8.2
12.2
10.6
24
SITES
Breast
Colorectal
Trachea, Bronchus, Lung
Nasopharynx
Cervix Uteri
Lymphoma
Leukaemia
Ovary
Stomach
Liver
NO
3292
2246
1865
940
847
776
741
656
630
605
18.1
12.3
10.2
5.2
4.6
4.3
4.1
3.6
3.5
3.3
Breast
12.3
Colorectal
10.2
5.2
Cervix Uteri
4.6
4.3
Lymphoma
4.1
leukaemia
Ovary
3.6
Stomach
3.5
Liver
3.3
0
10
15
20
SITES
C33-C34
C18-C20
C11
C61
C81-C85,C96
C22
C91-C95
C16
C70-C72
C67
NO
CR
ASR
1320
1185
685
502
448
443
419
351
259
258
16.3
14.6
8.4
6.2
5.5
5.5
5.2
4.3
3.2
3.2
10.3
9.7
5.4
3.9
3.5
3.5
3.3
2.7
2.0
2.0
14.8
13.4
6.4
6.2
4.2
4.7
3.5
3.9
2.3
2.9
Colorectal
Nasopharynx
8.4
6.2
Prostate
Liver
5.5
Lymphoma
5.5
leukaemia
5.2
4.3
Stomach
Bladder
3.2
3.2
0
6
8
10
Percentage of all cancers
12
14
16
18
25
SITES
Breast
Colorectal
Cervix Uteri
Ovary
Trachea, Bronchus, Lung
Corpus Uteri
Lymphoma
Leukaemia
Thyroid
Stomach
C50
C56 C18-C20
C53
C56
C73 C33-C34
C54
C81-C85,C96
C91-C95
C73
C16
NO
CR
ASR
3242
1011
847
656
545
414
328
322
305
279
32.1
10.0
8.4
6.5
5.4
4.1
3.2
3.2
3.0
2.8
26.0
8.1
6.8
5.3
4.4
3.3
2.6
2.6
2.4
2.2
29.1
10.2
7.8
5.9
5.6
3.9
3.0
2.7
2.7
2.8
Breast
Colorectal
10
8.4
Cervix Uteri
6.5
Ovary
5.4
4.1
Corpus Uteri
leukaemia
3.2
3.2
Lymphoma
Thyroid
2.8
Stomach
0
10
15
26
20
25
30
35
Age variations
Cancer occurs at all ages and increases with age. The incidence rate in males exceeded the incidence rate in females
after the age of 60 years (Figure 7).
Figure 7: Average age-specific incidence rate, all residence, by all sites and sex, Malaysia 2007
600
500
400
300
200
Male
100
Female
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
Figure 8: Average age-specific incidence rate for ten most frequent sites, males, Malaysia 2007
160
Trachea, Bronchus, Lung
140
Colorectal
Nasopharynx
120
Prostate
Lymphoma
100
Liver
Leukaemia
80
Stomach
Brain, Nervous system
Bladder
60
40
20
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
Figure 9: Average age-specific incidence rate for ten most frequent sites, females, Malaysia 2007
120
100
Breast
Colorectal
Cervix Uteri
80
Incidence per 100,000
6.2
Ovary
Trachea, Bronchus, Lung
Corpus Uteri
Lymphoma
60
Leukaemia
Thyroid
Stomach
40
20
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
27
6.3
Cancer in children
There were 319 male and 220 female cancer cases in children diagnosed in 2007 and registered at NCR. The most
frequent cancer in children (0-14 years old) was leukaemia.
Table 11: Five most frequent cancers in children, male, Malaysia 2007
SITES
ICD-10
C91-C95
C70-C72
C81-C85, C96
C40-C41
C69
Leukaemia
Brain, Nervous system
Lymphoma
Bone
Eye
NO
153
48
29
19
12
48.0
15.0
9.1
6.0
3.8
Figure 10: Five most frequent cancers in children, male, Malaysia 2007
48
Leukaemia
15
Lymphoma
9.1
Bone
3.8
Eye
0
10
20
30
40
50
60
Table 12: Five most frequent cancers in children, female, Malaysia 2007
ICD-10
SITES
Leukaemia
Brain, Nervous system
Lymphoma
Ovary
Bone
C91-C95
C70-C72
C81-C85, C96
C56
C40-C41
NO
98
43
15
13
12
44.5
19.5
6.8
5.9
5.5
Figure 11: Five most frequent cancers in children, female, Malaysia 2007
44.5
Leukaemia
19.5
Lymphoma
6.8
Ovary
5.9
Bone
5.5
28
10
20
30
Percentage of all Paediatric cancers (0 - 14 y.o)
40
50
6.4
Table 13: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay male
MALE
ICD-10
SITES
C33-C34
C18-21
C91-C95
C81-C85,C96
C61
C11
C22
C70-C72
C67
C44
NO
CR
ASR
501
445
241
221
176
152
152
137
124
83
16.2
14.4
7.8
7.1
5.7
4.9
4.9
4.4
4.0
2.7
7.2
6.4
3.5
3.2
2.5
2.2
2.2
2.0
1.8
1.2
11.8
10.1
3.8
4.3
4.9
3.0
3.4
2.3
3.1
1.9
Figure 12: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay male
Trachea, Bronchus, Lung
16.2
Colorectal
14.4
Leukaemia
7.8
Lymphoma
7.1
Prostate
5.7
Liver
4.9
Nasopharynx
4.9
4.4
4
Bladder
Other Skin
2.7
0
10
12
14
16
18
29
Table 14: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay female
MALAY FEMALE
ICD-10
SITES
Breast
Colorectal
Ovary
Cervix Uteri
Trachea, Bronchus, Lung
Corpus Uteri
Leukaemia
Lymphoma
Thyroid
Brain, Nervous system
C50
C18-C21
C56
C53
C33-C34
C54
C91-C95
C81-C85,C96
C73
C70-C72
NO
CR
ASR
1432
360
336
282
201
195
184
172
169
128
33.8
8.5
7.9
6.7
4.7
4.6
4.3
4.0
4.0
3.0
21
5.3
4.9
4.1
2.9
2.9
2.7
2.5
2.5
1.9
25.4
7.5
6.0
5.3
4.4
3.7
3.0
3.0
3.0
2.1
Figure 13: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay female
Breast
33.8
Colorectal
8.5
Ovary
7.9
Cervix Uteri
6.7
4.7
Corpus Uteri
4.6
Leukaemia
4.3
Thyroid
Lymphoma
3
0
10
15
20
25
30
35
40
Table 15: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese male
CHINESE MALE
ICD-10
C33-C34
C18-C21
C11
C61
C22
C16
C81-C85,C96
C44
C91-C95
C32
30
SITES
Trachea, Bronchus, Lung
Colorectal
Nasopharynx
Prostate
Liver
Stomach
Lymphoma
Other Skin
Leukaemia
Larynx
NO
CR
ASR
652
631
389
264
215
179
136
125
103
87
17.9
17.3
10.7
7.2
5.9
4.9
3.7
3.4
2.8
2.4
20.3
19.7
12.1
8.2
6.7
5.6
4.2
3.9
3.2
2.7
20.5
19.4
10.9
8.7
6.4
5.6
4.1
4.0
3.3
2.7
Figure 14: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese male
Trachea, Bronchus, Lung
17.9
Colorectal
17.3
Nasopharynx
10.7
Prostate
7.2
Liver
5.9
Stomach
4.9
Lymphoma
3.7
Other Skin
3.4
Leukaemia
2.8
Larynx
2.4
0
10
12
14
16
18
20
Table 16: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese female
CHINESE FEMALE
ICD-10
SITES
C50
C18-C21
C53
C33-C34
C56
C54
C16
C11
C44
C73
Breast
Colorectal
Cervix Uteri
Trachea, Bronchus, Lung
Ovary
Corpus Uteri
Stomach
Nasopharynx
Other Skin
Thyroid
NO
CR
ASR
1343
510
330
273
201
160
138
123
79
76
33.7
12.9
8.3
6.8
5.0
4.0
3.5
3.1
2.0
1.9
43.6
16.6
10.7
8.9
6.5
5.2
4.5
4.0
2.6
2.5
38.1
14.6
9.5
8.0
5.8
4.5
4.0
3.5
2.2
2.2
Figure 15: Ten most frequent cancers in females by major ethnic groups, Malaysia 2007:
Chinese female
Breast
Colorectal
Cervix Uteri
Trachea, Bronchus, Lung
Ovary
Corpus Uteri
Stomach
Nasopharynx
Other Skin
Thyroid
0
10
15
20
25
30
35
40
31
Table 17: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian male
INDIAN MALE
ICD-10
SITES
C18-C21
C33-C34
C61
C16
C91-C95
C81-C85,C96
C67
C03-C06
C32
C01-C02
Colorectal
Trachea, Bronchus, Lung
Prostate
Stomach
Leukaemia
Lymphoma
Bladder
Mouth
Larynx
Tongue
NO
CR
ASR
65
46
31
30
29
25
21
21
16
15
14.1
10.0
6.7
6.5
6.3
5.4
4.5
4.5
3.5
3.2
6.9
4.9
3.3
3.2
3.1
2.7
2.2
2.2
1.7
1.6
10.2
7.2
5.8
4.8
3.4
3.1
3.5
3.6
2.6
2.0
Figure 16: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian male
Colorectal
14.1
10
Prostate
6.7
Stomach
6.5
Leukaemia
6.3
Lymphoma
5.4
Mouth
4.5
Bladder
4.5
Larynx
3.5
Tongue
3.2
0
10
32
12
14
16
Table 18: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian female
INDIAN FEMALE
ICD-10
SITES
Breast
Cervix Uteri
Colorectal
Mouth
Ovary
Corpus Uteri
Leukaemia
Oesophagus
Stomach
Tongue
C50
C53
C18-C21
C03-C06
C56
C54
C91-C95
C15
C16
C01-C02
NO
CR
ASR
297
85
53
49
48
34
28
28
26
20
36.0
10.3
6.5
5.9
5.8
4.1
3.4
3.4
3.2
2.4
31.5
9.0
5.6
5.3
5.1
3.6
3.0
3.0
2.8
2.1
33.7
10.3
6.9
7.4
5.2
4.1
2.9
3.7
3.4
2.6
Figure 17: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian female
Breast
36
Cervix Uteri
10.3
Colorectal
6.5
Mouth
5.9
Ovary
5.8
Corpus Uteri
4.1
Oesophagus
3.4
Leukaemia
3.4
Stomach
3.2
Tongue
2.4
0
10
15
20
25
30
35
40
33
Table 19: Female Breast, number of new cases, percentage, crude rate (CR),
age-standardised rate (ASR) and Cumulative Risk (CumR), Malaysia 2007
SEX
NO.
CR
ASR
CR74
CumR
Female
3,242
100
26.0
29.1
3.1
3.1
Table 20: Female Breast. number of new cases, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups and
sex, Malaysia 2007
ETHNIC GROUP
Malay
Chinese
Indian
NO.
CR
ASR
CR74
CumR
1432
1343
297
21.0
43.6
31.5
25.4
38.1
33.7
2.6
4.2
3.7
2.6
4.1
3.6
Figure 18: Female Breast. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
120
100
7.1
80
60
40
20
0-
5-
10-
15-
20-
25-
30-
35-
34
40-
45-
50-
55-
60-
65-
70-
75+
stage 3
24%
stage 4
18%
stage 2
37%
stage 1
21%
35
Table 21: Colorectal. Number of new cases, percentage, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
Sex
Male
Female
Both
No.
CR
ASR
CR74
CumR
1,235
1,011
2,246
55.0
45.0
100
9.7
8.1
13.4
10.2
1.6
1.2
1,6
1.2
Table 22: Colorectal. Number of new cases, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups and sex,
Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
445
631
65
6.4
19.7
6.9
10.1
19.4
10.2
Female
CR74 CumR
1.2
2.4
1.2
1.2
2.4
1.2
No.
CR
ASR
360
510
53
5.3
16.6
5.6
7.6
14.6
6.9
CR74 CumR
0.9
1.8
0.8
0.9
1.8
0.8
Figure 20: Colorectal. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
140
120
100
7.2
80
60
40
Male
20
Female
0-
5-
10-
15-
20-
25-
30-
35-
40-
36
45-
50-
55-
60-
65-
70-
75+
stage 4
32%
stage 1
9%
stage 2
28%
37
7.3
Table 23: Lung. Number of new cases, percentage, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
Sex
No.
CR
ASR
CR74
CumR
Male
Female
Both
1,320
545
1,865
70.8
29.2
100
10.3
4.4
14.7
5.6
1.9
0.7
1.9
0.7
Table 24: Lung. Number of new cases, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups and sex,
Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
38
No.
CR
ASR
501
652
46
7.2
20.3
4.9
11.8
20.5
7.2
Female
CR74 CumR
1.5
2.6
0.8
1.5
2.6
0.8
No.
CR
ASR
201
273
15
2.9
8.9
1.6
4.4
8.0
2.0
CR74 CumR
0.6
1.0
0.3
0.6
1.0
0.3
Figure 22: Lung. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
160
140
120
100
Male
80
Female
60
40
20
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
39
7.4
Table 25: Nasopharynx. Number of new cases, percentage, crude rate (CR), age-standardised
rate (ASR), cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
Sex
No.
CR
ASR
CR74
CumR
Male
Female
Both
685
255
900
72.9
27.1
100
5.4
2.0
6.4
2.3
0.7
0.2
0.7
0.2
Table 26: Nasopharynx. Number of new cases, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups and
sex, Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
40
No.
CR
ASR
152
389
9
2.2
12.1
1.0
3.0
10.9
1.1
Female
CR74 CumR
0.3
1.2
0.1
0.3
1.2
0.1
No.
CR
ASR
70
123
6
1.0
4
0.6
1.3
3.5
0.9
CR74 CumR
0.1
0.4
0.1
0.1
0.4
0.1
Figure 24: Nasopharynx. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
35
Male
30
Female
25
20
15
10
5
0
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
75+
stage 4
32%
stage 2
23%
stage 3
34%
41
Table 27: Cervix Uteri. Number of new cases, percentage, crude rate (CR), age-standardised
rate (ASR), cumulative rate (CR74) and cumulative risk (CumR), Malaysia 2007
Sex
No.
CR
ASR
CR74
CumR
Female
847
100
6.8
7.8
0.9
0.9
Table 28: Cervix Uteri. Number of new cases, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups,
Malaysia 2007
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
CR74
CumR
282
330
85
4.1
10.7
9.0
5.3
9.5
10.3
0.6
1.1
1.1
0.6
1.1
1.1
Figure 26: Cervix Uteri. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
35
7.5
30
25
20
15
10
5
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
42
50-
55-
60-
65-
70-
75+
Figure 27: Cervix Uteri, stage at diagnosis, all residence, Malaysia 2007
stage 4
19%
stage 3
26%
stage 1
21%
stage 2
34%
43
Table 29: Lymphoma. Number of new cases, percentage, crude rate (CR), age-standardised
rate (ASR), cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
Sex
No.
Male
Female
Both
448
328
776
CR
57.7
42.3
100
3.5
2.6
ASR
CR74
CumR
4.2
3.0
0.4
0.3
0.4
0.3
Table 30: Lymphoma. Number of new cases, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups and sex,
Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
221
136
25
3.2
4.2
2.7
4.3
4.1
3.1
Female
CR74 CumR
0.4
0.4
0.3
0.4
0.4
0.3
No.
CR
ASR
172
101
13
2.5
3.3
1.4
3.0
3.0
1.7
CR74 CumR
0.3
0.3
0.2
0.3
0.3
0.2
Figure 28: Lymphoma. Age-specific Cancer Incidence Rate per 100,000 population by sex,
Malaysia 2007
25
20
7.6
15
10
Male
Female
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
44
50-
55-
60-
65-
70-
75+
stage 4
28%
stage 1
11%
stage 2
34%
stage 3
23%
45
Table 31: Leukaemia. Number of new cases, percentage, crude rate (CR), age-standardised
rate (ASR), cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
Sex
No.
Male
Female
Both
419
322
741
CR
56.5
43.5
100
3.3
2.6
ASR
CR74
CumR
3.5
2.7
0.3
0.2
0.3
0.2
Table 32: Leukaemia. Number of new cases, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups and sex,
Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
241
103
29
3.4
3.2
3.1
3.9
3.2
3.4
Female
CR74 CumR
0.3
0.3
0.3
0.3
0.3
0.3
No.
CR
ASR
184
63
28
2.7
2.0
2.9
2.9
2.0
2.9
CR74 CumR
0.3
0.2
0.2
0.3
0.2
0.2
Figure 30: Leukaemia. Age specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
10
9
8
7.7
Male
Female
5
4
3
2
1
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
46
50-
55-
60-
65-
70-
75+
stage 3
17%
stage 2
35%
47
Table 33: Ovary. Number of new cases, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR), Malaysia 2007
Sex
No.
CR
ASR
CR74
CumR
Female
847
100
6.8
7.8
0.9
0.9
Table 34: Ovary. Number of new cases, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups and sex,
Malaysia 2007
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
CR74
CumR
336
201
48
4.9
6.5
5.1
6.0
5.8
5.2
0.6
0.6
0.5
0.6
0.6
0.5
Figure 32: Ovary. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
25
20
7.8
15
10
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
stage 4
21%
stage 2
15%
stage 3
31%
48
65-
70-
75+
Table 35: Stomach. Number of new cases, percentage, crude rate (CR), age-standardised
rate (ASR), cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
Sex
No.
Male
Female
Both
351
279
630
CR
55.7
54.3
100
2.7
2.2
ASR
CR74
CumR
3.9
2.8
0.5
0.3
0.5
0.3
Table 36: Stomach Cancer. Number of new cases, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups and
sex, Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
152
215
15
2.2
6.7
1.6
3.4
6.4
2.2
Female
CR74 CumR
0.4
0.8
0.2
0.4
0.8
0.2
No.
CR
ASR
69
69
7
1.0
2.2
0.7
1.4
2.0
0.9
CR74 CumR
0.2
0.3
0.1
0.2
0.2
0.1
Figure 34: Stomach. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
45
40
7.9
35
30
25
20
male
15
female
10
5
0
0-
10-
20-
30-
40-
50-
60-
70-
49
stage 1
8.5%
stage 4
48.7%
stage 2
18.1%
stage 3
24.7%
50
Table 37: Liver. Number of new cases, percentage, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
Sex
No.
Male
Female
Both
443
162
605
CR
73.2
22.8
100
ASR
CR74
CumR
4.7
1.6
0.6
0.2
0.6
0.2
3.5
1.3
Table 38: Liver. Number of new cases, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups and sex,
Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
152
215
15
2.2
6.7
1.6
3.4
6.4
2.2
Female
CR74 CumR
0.4
0.8
0.2
0.4
0.8
0.2
No.
CR
ASR
69
69
7
1.0
2.2
0.7
1.4
2.0
0.9
CR74 CumR
0.2
0.2
0.1
0.2
0.2
0.1
Figure 36: Liver. Age specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
35
30
25
Male
20
Female
15
10
5
0
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
75+
51
stage 2
12%
stage 3
19%
52
stage 4
62%
Table 39: Prostate. Number of new cases, percentage, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR), Malaysia 2007
Sex
No.
Male
502
CR
100
ASR
3.9
6.2
CR74
CumR
0.8
0.8
Table 40: Prostate. Number of new cases, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups, Malaysia 2007
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
CR74
CumR
176
264
31
2.5
8.2
3.3
4.9
8.7
5.8
0.7
1.1
0.5
0.7
1.1
0.5
Figure 38: Prostate. Age-specific Cancer Incidence per 100,000 population, Malaysia 2007
100
90
80
70
60
50
40
30
20
10
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
stage 4
39.1%
stage 2
27.3%
stage 3
20.3%
53
Table 41: Oral. Number of new cases, percentage, crude rate (CR) and age-standardised
rate (ASR), by sex, Malaysia 2007
SEX
Male
Female
Both
NO.
CR
ASR
171
182
353
48.4
51.6
100
1.3
1.5
1.8
1.8
Table 42: Oral. Number of new cases, crude rate (CR) and age-standardised rate (ASR), by
major ethnic groups and sex, Malaysia 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
52
62
36
0.8
1.9
3.8
1.1
1.8
3.8
57
32
70
0.9
1.1
7.4
1.2
0.8
10.2
Table 43: Oral. Number of new cases, crude rate (CR) and age-standardised rate (ASR),
by site and sex, Malaysia 2007
MALE
FEMALE
SITES
Lip
Tongue
Mouth
All
54
NO.
CR
ASR
NO.
CR
ASR
9
93
69
171
0.1
0.7
0.5
0.1
1.0
0.7
8
78
96
182
0.1
0.6
0.8
0.1
0.7
1.0
Figure 40: Oral. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia
2007
20
18
16
14
12
10
Male
Female
6
4
2
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
Stage 2
23.3%
Stage 4
44.6%
Stage 1
12.1%
55
NO.
CR
ASR
550
749
1,299
42.3
57.7
100.0
72.6
99.3
98.8
119.4
Table 45: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups and sex, Federal Territory of Kuala Lumpur 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
181
320
45
54.3
98.1
54.4
100.2
103.1
69.9
236
439
68
73
139.9
83.5
109.8
132.5
86.4
Table 46: Five most common cancers, male, Federal Territory of Kuala Lumpur 2007
MALE
ICD-10
C33-C34
C18-C21
C11
C81-C85,C96
C70-C72
SITES
Trachea, Bronchus, Lung
Colorectal
Nasopharynx
Lymphoma
Brain, Nervous system
NO
CR
ASR
94
82
45
37
33
17.0
14.8
8.2
6.7
6.0
6.3
5.5
3.0
2.5
2.2
19.2
15.8
6.8
5.5
4.4
Table 47: Five most common cancers, female, Federal Territory of Kuala Lumpur 2007
FEMALE
ICD-10
C50
C18-C21
C53
C33-C34
C56
56
SITES
Breast
Colorectal
Cervix Uteri
Trachea, Bronchus, Lung
Ovary
NO
CR
ASR
292
61
54
46
33
38.9
8.2
7.2
6.1
4.4
38.6
8.1
7.1
6.1
4.4
42.6
10.9
9.0
8.3
5.4
Figure 42: Five most common cancers, male, Federal Territory of Kuala Lumpur 2007
Trachea, Bronchus, Lung
17
Colorectal
14.8
Nasopharynx
8.2
Lymphoma
6.7
6
0
10
15
20
25
Figure 43: Five most common cancers, female, Federal Territory of Kuala Lumpur 2007
Breast
38.9
Colorectal
8.2
Cervix Uteri
7.2
6.1
Ovary
4.4
10
15
20
25
30
35
40
45
57
8.1.2
SELANGOR
NO.
CR
ASR
775
1326
2101
36.9
63.1
100.0
32.4
57.9
48.5
74.5
Table 49: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups, Selangor 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
309
353
100
23.9
50.1
30.3
42.0
57.6
38.8
570
534
205
46.2
80.6
62.6
69.6
78.1
74.9
SITES
Colorectal
Trachea, Bronchus, Lung
Nasopharynx
Lymphoma
Brain, Nervous system
NO
CR
ASR
117
114
71
54
49
15.1
14.7
9.2
7.0
6.3
4.9
4.8
3.0
2.3
2.1
7.7
8.2
3.4
2.9
2.5
58
SITES
Breast
Colorectal
Cervix Uteri
Ovary
Corpus Uteri
NO
CR
ASR
541
108
93
92
55
40.8
8.2
7.0
6.9
4.1
23.6
4.7
4.1
4.0
2.4
14.9
7.3
5.7
4.9
4.7
15.1
14.7
Nasopharynx
9.2
Lymphoma
6.3
10
15
20
25
Breast
8.2
Colorectal
Cervix Uteri
Ovary
6.9
Corpus Uteri
4.1
0
10
15
20
25
30
35
40
45
59
8.1.3
PERAK
NO.
CR
ASR
711
870
1581
45.0
55.0
100.0
63.3
77.2
69
75.8
Table 53: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups and sex, Perak 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
198
444
67
31.1
128.8
48.1
4.9
12.0
7.3
311
423
128
48.7
125.3
87.0
6.1
92.9
89.1
SITES
Trachea, Bronchus, Lung
Colorectal
Nasopharynx
Prostate
Other Skin
NO
CR
ASR
153
85
74
59
36
21.5
11.9
10.4
8.3
5.1
13.6
7.6
6.6
5.3
3.2
15.1
8.3
7.0
5.9
3.6
60
SITES
Breast
Colorectal
Cervix Uteri
Ovary
Trachea, Bronchus, Lung
NO
CR
ASR
346
82
61
59
36
39.8
9.4
7.0
6.8
4.1
30.7
7.3
5.4
5.2
3.2
30.3
7.0
5.3
5.2
3.2
11.9
10.4
Nasopharynx
8.3
Prostate
Other Skin
5.1
5
10
15
20
25
Breast
9.4
Colorectal
Cervix Uteri
Ovary
6.8
4.1
0
10
15
20
25
30
35
40
45
61
8.1.4
PAHANG
NO.
CR
ASR
407
478
885
46.0
54.0
100.0
56.8
69.5
75
84.8
Table 57: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups and sex, Pahang 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
226
163
13
43.5
133.6
37.4
61.6
117.6
66.1
293
151
29
58.3
133.7
87.1
76.1
112.4
104.0
SITES
Colorectal
Trachea, Bronchus, Lung
Nasopharnyx
Leukaemia
Lymphoma
NO
CR
ASR
68
56
40
23
22
16.7
13.7
9.8
5.6
5.4
9.4
7.8
5.6
3.2
3.1
12.2
10.8
6.6
3.6
3
62
SITES
Breast
Cervix Uteri
Colorectal
Ovary
Trachea, Bronchus, Lung
NO
CR
ASR
133
49
48
27
23
27.8
10.3
10.0
5.6
4.8
19.3
7.1
7.0
3.9
3.3
22
8.6
9.4
4.8
4.6
16.7
13.7
9.8
Nasopharnyx
Leukemia
5.6
Lymphoma
5.4
5
10
15
20
25
27.8
Cervix Uteri
10.3
10
Colorectal
5.6
Ovary
4.8
10
15
20
25
30
63
8.1.5
KELANTAN
NO.
CR
ASR
432
428
860
50.2
49.8
100.0
56.4
56.2
77.6
71
Table 61: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups and sex, Kelantan 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
403
25
0
56.4
91.6
0
78.2
85.9
0
391
31
1
54.3
121.6
0
69.5
102.2
0
SITES
Trachea, Bronchus, Lung
Colorectal
Leukaemia
Lymphoma
Liver
NO
CR
ASR
73
71
39
36
32
16.90
16.44
9.03
8.33
7.41
9.5
9.3
5.1
4.7
4.2
13.7
13.1
5.6
6.0
6.1
64
SITES
Breast
Colorectal
Ovary
Thyroid
Cervix Uteri
NO
CR
ASR
102
49
40
31
24
23.8
11.5
9.4
7.2
5.6
13.4
6.4
5.3
4.1
3.2
17.1
8.3
6.6
5.1
4.1
16.9
Colorectal
16.44
Leukaemia
9.03
8.33
Lymphoma
7.41
Liver
0
10
15
20
25
23.8
11.5
Colorectal
Ovary
9.4
7.2
Thyroid
5.6
Cervix Uteri
0
10
15
20
25
65
8.1.6
PENANG
NO.
CR
ASR
904
1059
1963
46.1
53.9
100.0
127.5
147.8
154.1
150
Table 65: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups and sex, Penang 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
202
625
69
64.6
194.8
94.3
104.0
181.4
138.7
246
696
109
77.1
218.2
144.2
100.3
175.3
165.5
SITES
Colorectal
Lung
Prostate
Nasopharynx
Stomach
NO
CR
ASR
147
142
77
56
49
16.3
15.7
8.5
6.2
5.4
20.7
20.0
10.9
7.9
6.9
25.6
24.3
15.0
8.3
8.5
66
SITES
Breast
Colorectal
Cervix Uteri
Lung
Ovary
NO
CR
ASR
333
127
99
65
62
31.4
12.0
9.3
6.1
5.9
46.5
17.7
13.8
9.1
8.7
46.7
18.3
13.4
9.3
8.5
Colorectal
16.3
15.7
Lung
8.5
Prostate
6.2
Nasopharynx
5.4
Stomach
5
10
15
20
Breast
31.4
Colorectal
12
9.3
Cervix Uteri
Lung
6.1
Ovary
5.9
0
10
15
20
25
30
35
67
8.1.7
JOHOR
NO.
CR
ASR
1586
1775
3361
47.2
52.8
100.0
110.4
120.5
179.1
150.3
Table 69: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups and sex, Johor 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
712
782
76
82.6
150.5
69.5
142.8
175.6
127.6
887
749
130
105.2
151
124.8
140.1
158.3
190.4
SITES
Trachea, Bronchus, Lung
Colorectal
Prostate
Nasopharynx
Leukaemia
NO
CR
ASR
282
270
126
99
97
17.8
17.0
7.9
6.2
6.0
19.6
18.8
8.8
6.9
6.7
31.9
32.2
15.8
11.6
9.2
68
SITES
Breast
Colorectal
Trachea, Bronchus, Lung
Cervix Uteri
Ovary
NO
CR
ASR
608
204
109
105
96
34.3
11.5
6.1
5.9
5.4
41.3
13.8
7.4
7.1
6.5
46.5
19.7
10.2
9.1
7.4
Colorectal
17
Prostate
7.9
6.2
Nasopharynx
6
Leukaemia
0
10
15
20
Breast
34.3
11.5
Colorectal
6.1
Cervix Uteri
5.9
5.4
Ovary
0
10
15
20
25
30
35
40
69
8.1.8
KEDAH
NO.
CR
ASR
420
589
1009
41.6
58.4
100.0
45.1
62.8
57.2
69.7
Table 73: Number of new cancer cases, crude rate (CR) and age-standardised rate
(ASR) by major ethnic groups and sex, Kedah, 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
210
163
42
29.2
121.9
67.0
37.7
115.0
111.2
312
210
64
42.9
164.0
97.3
48.9
140.1
121.6
SITES
Trachea, Bronchus, Lung
Colorectal
Prostate
Leukaemia
Lymphoma
NO
CR
ASR
60
57
41
27
26
14.3
13.6
9.8
6.4
6.2
6.4
6.1
4.4
3.0
2.8
8.6
8.0
6.3
2.9
3.2
70
SITES
Breast
Colorectal
Trachea, Bronchus, Lung
Cervix Uteri
Ovary
NO
CR
ASR
608
204
109
105
96
34.3
11.5
6.1
5.9
5.4
41.3
13.8
7.4
7.1
6.5
4.7
2.0
1.3
1.0
0.8
13.6
Colorectal
Prostate
9.8
6.4
Leukaemia
6.2
Lymphoma
5
10
15
20
Breast
Colorectal
9.8
Cervix Uteri
9.7
5.6
Ovary
0
10
15
20
25
30
35
71
8.1.9
TERENGGANU
NO.
CR
ASR
240
391
631
38.0
62.0
100.0
45.7
77.2
67.9
96.1
Table 77: Number of new cancer cases, crude rate (CR) and ag standardised rate (ASR)
by major ethnic groups and sex,Terengganu 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
243
14
0
47.5
105.3
0
71.2
88.0
0
387
19
1
78.0
145.0
0
98.7
116.1
0
SITES
Trachea,Bronchus,Lung
Colorectal
Leukaemia
Liver
Prostate
NO
CR
ASR
42
38
18
17
13
16.3
14.8
7.0
6.6
5.1
7.7
7.0
3.2
3.2
2.5
12.2
11.4
3.2
5.1
4.6
72
SITES
Breast
Ovary
Corpus Uteri
Cervix Uteri
Colorectal
NO
CR
ASR
107
41
37
29
26
26.3
10.1
9.1
7.1
6.3
20.9
8.1
7.3
5.5
4.8
25.5
9.6
9.0
7.0
6.8
Colorectal
Leukaemia
Liver
6.6
5.1
Prostate
5
10
15
20
Breast
26.3
Ovary
10.1
9.1
Corpus Uteri
7.1
Cervix Uteri
Colorectal
6.3
0
10
15
20
25
30
73
8.1.10 MALACCA
NO.
CR
ASR
322
389
711
45.3
54.7
100.0
91.2
110.0
113.3
117.8
Table 81: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups and sex, Malacca, 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
147
155
18
64.8
158.4
86.2
95.3
138.6
123.2
195
167
22
85.9
173.2
94.5
103.0
139.6
110.7
SITES
Trachea, Bronchus, Lung
Colorectal
Leukaemia
Liver
Lymphoma
NO
CR
ASR
60
58
24
21
17
24.4
23.6
9.8
8.5
6.9
16.8
16.5
6.9
6.0
4.9
21.9
20.9
7.4
7.5
5.6
74
SITES
Breast
Colorectal
Corpus Uteri
Cervix Uteri
Ovary
NO
CR
ASR
135
46
30
29
28
34.8
11.9
7.7
7.5
7.2
38.3
13.1
8.5
8.2
7.9
41.6
14.4
9.0
9.0
8.5
24.4
23.6
Colorectal
9.8
Leukemia
Liver
8.5
6.9
Lymphoma
0
10
15
20
25
30
Breast
34.8
Colorectal
11.9
Corpus Uteri
7.7
Cervix Uteri
7.5
Ovary
7.2
10
20
30
40
75
8.1.11 SABAH
NO.
CR
ASR
735
766
1501
49.0
51.0
100.0
72.1
70.8
104.9
101
Table 85: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups and sex, Sabah 2007
MALE
FEMALE
ETHNIC
Malay
Kadazan
Bajau
Murut
NO.
CR
ASR
NO.
CR
ASR
26
215
78
20
14.6
82.1
40.3
42.7
25.4
130.3
72.4
86.1
24
246
100
29
14.3
93.1
52.9
62.3
27.3
137.9
79.8
93.9
SITES
Trachea, Bronchus, Lung
Colorectal
Nasopharynx
Stomach
Liver
NO
CR
ASR
89
88
84
59
46
12.1
12.0
11.4
8.0
6.3
8.7
8.6
8.2
5.8
4.5
13.3
12.4
11.4
8.7
6.3
76
SITES
Breast
Cervix Uteri
Colorectal
Ovary
Trachea, Bronchus, Lung
NO
CR
ASR
147
82
80
58
46
19.2
10.7
10.4
7.6
6.0
13.6
7.6
7.4
5.4
4.3
17.0
10.0
11.7
6.7
8.1
12
Colorectal
Nasopharynx
11.4
Stomach
6.3
Liver
0
10
15
20
Breast
10.7
Cervix Uteri
Colorectal
10.4
7.6
Ovary
10
15
20
25
77
8.1.12 SARAWAK
NO.
CR
ASR
729
851
1580
46.1
53.9
100.0
59.8
73.1
86
90.4
Table 89: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups and sex, Sarawak 2007
MALE
FEMALE
ETHNIC
Bidayuh
Iban
Melanau
Malay
Chinese
NO.
CR
ASR
NO.
CR
ASR
93
177
19
111
282
96.1
50.9
28
41
93.3
143.3
69.5
38
68.9
115.4
84
214
33
184
278
88.3
62.9
50.5
70.4
93.5
111.4
71.9
83.6
96.4
103
SITES
Nasopharynx
Colorectal
Trachea, Bronchus, Lung
Liver
Stomach
NO
CR
ASR
115
103
97
55
48
15.8
14.2
13.3
07.5
06.6
9.4
8.4
7.9
4.5
3.9
10.7
13.2
12.7
6.6
6.4
78
SITES
Breast
Cervix Uteri
Colorectal
Ovary
Nasopharynx
NO
CR
ASR
190
126
86
51
49
22.3
14.8
10.0
6.0
5.8
16.3
10.8
7.4
4.4
4.2
18.8
12.2
10.8
5.0
4.5
Nasopharynx
Colorectal
14.2
13.3
Liver
7.5
Stomach
6.6
5
10
15
20
22.3
Cervix Uteri
14.8
Colorectal
10
6
Ovary
Nasopharynx
5.8
0
10
15
20
25
79
NO.
CR
ASR
277
350
627
44.2
55.8
100.0
55.1
73.7
68.9
78.8
Table 93: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups and sex, Negeri Sembilan, 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
126
168
0
48.6
133.1
0
61.9
119.9
0
178
151
4
69.6
128.2
5.4
75.6
111.3
7.7
Table 94: Five most common cancers, male, Negeri Sembilan 2007
MALE
ICD-10
C33-C34
C18-C21
C11
C61
C81-C85,C96
SITES
Trachea, Bronchus, Lung
Colorectal
Nasopharynx
Prostate
Lymphoma
NO
CR
ASR
54
51
30
21
17
19.5
18.4
10.8
7.6
6.2
10.1
6.0
4.2
3.4
2.8
14.3
13.2
6.6
6.2
3.6
Table 95: Five most common cancers, female, Negeri Sembilan 2007
FEMALE
ICD-10
C50
C18-C21
C56
C53
C54
80
SITES
Breast
Colorectal
Ovary
Cervix Uteri
Corpus Uteri
NO
CR
ASR
126
35
34
32
19
36
10
9.7
9.1
5.4
26.5
7.3
7.2
6.7
4.0
28.0
8.3
7.3
7.0
4.1
Figure 66: Five most common cancers, male, Negeri Sembilan 2007
Trachea, Bronchus, Lung
19.5
Colorectal
18.4
10.8
Nasopharynx
7.6
Prostate
6.2
Lymphoma
0
10
15
20
25
Figure 67: Five most common cancers, female, Negeri Sembilan 2007
Breast
36
Colorectal
10
Ovary
9.7
Cervix Uteri
9.1
Corpus Uteri
5.4
0
10
15
20
25
30
35
40
81
8.1.14 PERLIS
NO.
CR
ASR
32
75
107
30
70
100
31.5
64.4
38
66.6
SITES
Trachea, Bronchus, Lung
Nasopharynx
Bladder
Colorectal
Liver
NO
CR
ASR
5
4
3
2
2
15.6
12.5
9.4
6.2
6.2
4.9
3.9
2.9
2.0
2.0
0.5
0.6
0.2
0.2
0.3
82
SITES
Trachea, Bronchus, Lung
Cervix Uteri
Breast
Thyroid
Tongue
NO
CR
ASR
18
8
7
5
4
24.0
10.7
9.3
6.7
5.3
15.4
6.9
6.0
4.3
3.4
1.9
0.8
0.6
0.6
0.5
Nasopharynx
12.5
9.4
Bladder
Colorectal
6.2
Liver
6.2
5
10
15
20
24
10.7
Cervix Uteri
9.3
Breast
6.7
Thyroid
Tongue
5.3
0
10
15
20
25
30
83
Appendix 1: Population by sex, ethnic group and age, Malaysia, 2007 (source: Statistic Department)
Age Group
Total
Malay
Chinese
Indian
Others
0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80+
Total
2842.400
2730.500
2603.400
2493.700
2340.600
2000.400
1712.800
1649.300
1565.600
1404.700
1208.900
914.300
646.300
473.500
322.900
185.500
171.000
25,265.800
1751.700
1612.900
1521.900
1445.700
1330.500
1086.800
883.100
836.700
786.900
693.100
585.900
433.200
297.300
213.700
142.600
80.100
71.100
13,773.100
519.700
548.300
524.300
515.100
511.100
480.600
456.200
457.900
451.300
431.600
394.300
315.800
237.600
177.800
122.600
73.800
69.800
6,287.900
179.800
185.900
176.300
171.800
169.000
156.800
145.600
140.200
131.900
121.900
106.000
74.400
46.900
33.300
22.500
11.300
10.300
1,883.900
36.600
42.800
43.100
37.800
31.300
24.900
19.500
19.400
17.500
15.400
12.600
8.800
5.700
4.000
2.600
1.700
2.300
326.100
Male
0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80+
Total
1463.900
1403.900
1341.800
1278.100
1189.500
1003.700
848.900
817.900
778.700
706.100
612.600
464.900
328.100
231.200
148.400
84.000
71.200
12,773.000
905.100
830.400
783.700
739.200
673.400
542.700
434.800
412.100
389.000
345.400
293.600
217.500
148.700
102.200
64.000
36.000
30.500
6,948.400
271.100
283.600
273.200
267.300
262.800
245.700
231.900
231.700
228.000
220.100
202.600
163.500
123.000
88.700
57.600
32.800
25.800
3,209.400
91.600
94.600
89.800
87.900
86.300
78.400
71.600
69.100
65.100
60.100
52.000
36.400
22.700
15.200
9.400
5.000
4.600
939.700
19.200
22.200
22.200
18.900
15.500
11.800
8.700
9.100
8.400
8.000
7.100
4.800
3.000
2.200
1.400
0.900
1.500
1,64.900
Female
0-4
5-9
10-`4
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80+
Total
1378.500
1326.600
1261.500
1215.600
1151.100
996.700
863.900
831.400
786.900
698.600
596.300
449.400
318.200
242.300
174.400
101.500
99.900
12,492.800
846.500
782.500
738.200
706.500
657.100
544.100
448.300
424.600
398.000
347.700
292.300
215.700
148.600
111.400
78.600
44.000
40.700
6,824.800
248.600
264.600
251.100
247.800
248.300
235.000
224.300
226.300
223.300
211.500
191.700
152.400
114.500
89.000
65.100
41.000
44.000
3,078.500
88.200
91.300
86.500
83.900
82.700
78.500
74.000
71.200
66.800
61.800
54.000
38.000
24.100
18.100
13.100
6.400
5.700
944.100
17.400
20.600
20.900
19.000
15.800
13.000
10.800
10.300
9.200
7.300
5.500
4.000
2.700
1.800
1.200
0.800
0.800
161.100
84
(ICD-10)
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18-C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81-C85;C96
C90
C91-C95
Sites
Lip
Tongue
Mouth
Salivary Glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx Unspec
Oesophagus
Stomach
Small Intestine
Colorectal
Liver
Gallbladder
Pancreas
Nose, Sinuses
Larynx
Trachea, Bronchus, Lung
Other Thoracic Organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi Sarcoma
Connective Soft Tissue
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus Unspec
Ovary
Other Female Genital
Placenta
Penis
Prostate
Testis
Other Male Genital
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary Organs
Eye
Brain, Nervous System
Thyroid
Adrenal Gland
Other Endocrine
Lymphoma
Multiple Myeloma
Leukaemia
Others
ALL SITES
Number
with
Total
recorded
Stage
17
171
165
143
38
28
940
49
13
206
630
43
2246
605
101
284
79
183
1865
52
173
61
402
5
2
148
3292
21
31
847
414
85
656
3
7
23
502
74
4
201
11
3
331
12
37
471
434
21
53
776
107
741
413
18219
13
99
93
14
26
18
468
15
7
99
259
19
1105
202
19
135
40
108
1083
21
75
20
117
2
1
117
2114
7
14
519
243
33
426
2
1
4
271
44
4
106
9
3
137
7
10
160
139
5
14
235
18
103
66
8869
Stage
%
II
III
IV
76.4
57.0
56.0
16.5
68.4
64.3
49.8
30.6
53.9
48.1
39.7
44.2
49.2
33.4
18.8
47.5
50.6
59.0
58.1
40.4
43.4
33
29.1
20
50
79.1
65.2
33.3
45.2
61.3
58.7
38.3
64.9
66.7
14.3
17.4
44.8
59.5
100
52.7
81.8
100
41.39
58.3
27
34
32
23.8
26.4
30.3
16.8
13.9
19.7
48.7
6
10
10
3
2
1
53
1
1
7
22
3
98
14
2
6
12
27
39
3
11
2
50
0
0
50
447
0
2
109
109
12
140
1
1
1
36
20
2
15
3
1
35
0
4
27
44
2
3
35
1
15
13
1511
46.2
10.1
10.8
21.4
7.7
5.6
11.3
6.7
14.3
7.1
8.5
15.8
8.9
6.9
10.5
4.4
30
25.0
3.6
14.3
14.7
10
42.7
0
0
42.7
21.1
0
14.3
21
44.9
36.4
32.9
50
100
25.0
13.3
45.5
50
14
33.3
33
25.5
0
40
16.9
31.3
40
21.4
14.9
5.6
14.6
33.3
17
2
25
13
5
4
3
108
3
2
19
47
4
305
25
3
19
10
25
86
3
23
3
23
0
0
23
782
3
4
180
54
5
64
1
0
0
74
11
1
19
1
0
44
4
1
37
30
0
5
80
4
37
22
2246
15.4
25.3
14.0
35.7
15.4
16.7
23.1
20.0
28.6
19.2
18.1
21.1
27.6
12.4
15.8
14.1
25
23.1
7.9
14.3
30.7
15
19.7
0
0
19.7
37
43
28.6
34.7
22.2
15.2
15
50
0
0.0
27.3
25
25
18
11.1
0
32.1
57.1
10
23.1
22
0
35.7
34.0
22.2
35.9
33.3
25.3
1
24
18
3
6
5
156
5
2
26
64
3
352
38
3
20
4
31
301
10
6
8
24
1
0
24
510
2
2
133
48
9
133
0
0
0
55
1
0
20
0
2
29
0
0
34
15
1
3
55
3
17
9
2216
7.7
24.2
19.4
21.4
23.1
27.8
33.3
33.3
28.6
26.3
24.7
15.8
31.8
18.8
15.8
14.8
10.0
28.7
27.8
47.6
8.0
40
20.5
50
0
20.5
24.2
28.5
14.3
25.6
19.8
27.3
31.2
0
0
0.0
20.3
2.3
0
19
0
67
21.1
0
0
21.3
10.7
20
21.4
23.4
16.6
16.5
13.6
25
4
40
52
3
14
9
151
6
2
47
126
9
350
125
11
90
14
25
657
5
35
7
20
1
1
20
375
2
6
97
32
7
89
0
0
3
106
12
1
52
5
0
29
3
5
62
50
2
3
65
10
34
22
2896
30.8
40.4
55.9
21.4
53.9
50.0
32.3
40.0
28.6
47.5
48.7
47.4
31.7
61.9
57.9
66.7
35.0
23.1
60.7
23.8
46.7
35
17.1
50
100
17.1
17.7
28.5
42.9
18.7
13.2
21.2
20.9
0
0
75.0
39.1
27.3
25
49
55.6
0
21.1
42.9
50
38.8
36
40
21.4
27.7
55.5
33
33.3
32.7
85
86
Total
Trachea, Bronchus, Lung
Colorectal
Nasopharynx
Prostate
Lymphoma
Liver
Leukaemia
Stomach
Brain, Nervous system
Bladder
Other Skin
Larynx
Pancreas
Kidney
Thyroid
Oesophagus
Bone
Tongue
Connective, Soft tissue
Testis
Mouth
Multiple Myeloma
Gallbladder etc.
Nose, sinuses etc.
Breast
Salivary glands
Other Endocrine
Hypopharynx
Melanoma of Skin
Small intestine
Other Thoracic organs
Penis
Other Oropharynx
Tonsil
Eye
Adrenal gland
Pharynx unspec.
Lip
Renal Pelvis
Other Urinary organs
Mesothelioma
Other male genital
Kaposi sarcoma
Ureter
Immunoproliferative dis.
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
1320
1235
685
502
448
443
419
351
259
258
236
164
151
141
129
125
97
93
76
74
69
60
52
51
50
47
37
36
34
27
27
23
22
20
20
13
10
9
9
8
5
4
2
2
1
279
8123
16.3%
15.3%
8.4%
6.2%
5.5%
5.5%
5.1%
4.3%
3.2%
3.2%
2.9%
2.0%
0.2%
1.7%
1.6%
1.5%
1.2%
1.1%
0.9%
0.9%
0.8%
0.7%
0.6%
0.6%
0.6%
0.6%
0.5%
0.4%
0.4%
0.3%
0.3%
0.3%
0.3%
0.2%
0.2%
0.2%
0.1%
0.1%
0.1%
0.1%
0.4%
0.0%
0.0%
0.0%
0.0%
3.4%
100.0%
10.3
9.7
5.4
3.9
3.5
3.5
3.3
2.7
2.0
2.0
1.8
1.3
1.2
1.1
1.0
1.0
0.8
0.7
0.6
0.6
0.5
0.5
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
2.2
63.6
1.9
1.6
0.7
0.8
0.4
0.6
0.3
0.5
0.2
0.4
0.3
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
10.1
14.7
13.4
6.4
6.2
4.2
4.7
3.5
3.9
2.3
2.9
2.6
1.9
1.6
1.4
1.3
1.4
0.8
1.0
0.7
0.6
0.7
0.6
0.6
0.5
0.5
0.5
0.3
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
3.0
85.1
13.9
12.6
5.9
5.7
3.8
4.2
3.2
3.5
2.0
2.6
2.3
1.6
1.4
1.2
1.0
1.2
0.7
0.8
0.5
0.4
0.6
0.5
0.4
0.4
0.3
0.3
0.2
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.6
83.1
15.6
14.2
6.9
6.8
4.6
5.1
3.9
4.3
2.6
3.3
3.0
2.1
1.9
1.7
1.5
1.7
1.0
1.2
0.9
0.7
0.9
0.8
0.7
0.6
0.6
0.6
0.4
0.6
0.5
0.4
0.4
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.0
0.1
0.0
3.3
86.9
CumR
1.9
1.6
0.7
0.8
0.4
0.6
0.3
0.5
0.2
0.4
0.3
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
9.6
Total
Breast
Colorectal
Cervix Uteri
Ovary
Trachea, Bronchus, Lung
Corpus Uteri
Lymphoma
Leukaemia
Thyroid
Stomach
Nasopharynx
Brain, Nervous system
Other Skin
Liver
Pancreas
Mouth
Uterus unspec.
Oesophagus
Tongue
Bone
Bladder
Connective, Soft tissue
Kidney
Gallbladder etc.
Multiple Myeloma
Salivary glands
Vagina
Nose, sinuses etc.
Melanoma of Skin
Other Thoracic organs
Vulva
Larynx
Tonsil
Eye
Small intestine
Other Endocrine
Hypopharynx
Lip
Adrenal gland
Placenta
Other Oropharynx
Other Urinary organs
Pharynx unspec.
Other Female Genital
Renal Pelvis
Ureter
Mesothelioma
Kaposi sarcoma
Immunoproliferative dis.
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
3242
1011
847
656
545
414
328
322
305
279
255
212
166
162
133
96
85
81
78
76
73
72
60
49
47
38
31
28
27
25
21
19
18
17
16
16
13
8
8
7
6
4
3
3
2
1
0
0
0
191
10096
32.1
10.0
8.4
6.5
5.4
4.1
3.3
3.2
3.0
2.8
2.5
2.1
1.6
1.6
1.3
1.0
0.8
0.8
0.8
0.8
0.7
0.7
0.6
0.5
0.5
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.9
100
26.0
8.1
6.8
5.3
4.4
3.3
2.6
2.6
2.4
2.2
2.0
1.7
1.3
1.3
1.1
0.8
0.7
0.6
0.6
0.6
0.6
0.6
0.5
0.4
0.4
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.5
80.9
3.1
1.2
0.9
0.6
0.7
0.4
0.3
0.2
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
10.5
29.1
10.2
7.8
5.9
5.6
3.9
3.0
2.7
2.7
2.8
2.3
1.9
1.7
1.6
1.4
1.0
0.7
0.8
0.7
0.6
0.8
0.7
0.6
0.5
0.5
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.9
94.4
28.1
9.5
7.3
5.4
5.2
3.5
2.7
2.4
2.4
2.5
2.0
1.6
1.4
1.4
1.1
0.8
0.6
0.7
0.6
0.5
0.6
0.5
0.4
0.4
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6
92.5
CumR
30.1
10.8
8.4
6.3
6.1
4.2
3.3
3.0
3.0
3.2
2.6
2.1
1.9
1.9
1.6
1.2
0.9
1.0
0.9
0.8
0.9
0.8
0.7
0.7
0.6
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
2.1
96.2
3.1
1.2
0.9
0.6
0.7
0.4
0.3
0.2
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
9.9
87
Appendix 5: Incidence Summary Table, All Residence, Malay Male, Malaysia 2007
2007 Malay Male
Age Group
C33-C34
C18-21
C91-C95
C81-C85,C96
C61
C11
C22
C70-C72
C67
C44
C73
C16
C32
C25
C40-C41
C64
C47;C49
C62
C90
C15
C01-C02
C75
C23-C24
C07-C08
C30-C31
C50
C03-C06
C69
C37-C38
C43
C17
C74
C14
C00
C12-C13
C09
C10
C45
C60
C63
C65
C88
C46
C66
C68
Other
All
88
Total
Trachea, Bronchus, Lung
Colorectal
Leukaemia
Lymphoma
Prostate
Nasopharynx
Liver
Brain, Nervous system
Bladder
Other Skin
Thyroid
Stomach
Larynx
Pancreas
Bone
Kidney
Connective, Soft tissue
Testis
Multiple Myeloma
Oesophagus
Tongue
Other Endocrine
Gallbladder etc.
Salivary glands
Nose, sinuses etc.
Breast
Mouth
Eye
Other Thoracic organs
Melanoma of Skin
Small intestine
Adrenal gland
Pharynx unspec.
Lip
Hypopharynx
Tonsil
Other Oropharynx
Mesothelioma
Penis
Other male genital
Renal Pelvis
Immunoproliferative dis.
Kaposi sarcoma
Ureter
Other Urinary organs
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
501
445
241
221
176
152
152
137
124
83
69
65
51
50
48
45
43
41
40
36
27
27
25
23
23
23
21
14
12
11
9
6
5
4
4
3
3
3
3
3
3
1
0
0
0
120
3093
16.2
14.4
7.8
7.1
5.7
4.9
4.9
4.4
4
2.7
2.2
2.1
1.6
1.6
1.6
1.5
1.4
1.3
1.3
1.2
0.9
0.9
0.8
0.7
0.7
0.7
0.7
0.5
0.4
0.4
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
3.9
100
7.2
6.4
3.5
3.2
2.5
2.2
2.2
2.0
1.8
1.2
1.0
0.9
0.7
0.7
0.7
0.6
0.6
0.6
0.6
0.5
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.7
44.5
1.5
1.2
0.3
0.4
0.7
0.3
0.4
0.2
0.4
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
7.7
11.8
10.1
3.8
4.3
4.9
3.0
3.4
2.3
3.1
1.9
1.5
1.5
1.2
1.2
0.8
1.0
0.8
0.6
0.9
0.9
0.5
0.4
0.6
0.5
0.5
0.4
0.5
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
2.6
66.9
10.8
9.2
3.3
3.7
4.2
2.5
2.8
1.9
2.6
1.4
1.1
1.1
0.9
0.8
0.6
0.7
0.6
0.4
0.6
0.6
0.3
0.3
0.4
0.3
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.1
64.4
12.9
11.1
4.3
4.9
5.7
3.5
4.0
2.8
3.7
2.3
1.8
1.9
1.6
1.5
1.0
1.4
1.1
0.8
1.1
1.2
0.8
0.6
0.9
0.7
0.7
0.6
0.7
0.4
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.0
0.0
0.0
3.1
69.3
CumR
1.5
1.2
0.3
0.4
0.7
0.3
0.4
0.2
0.4
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
7.4
Appendix 6: Incidence Summary Table, All Residence, Malays Female, Malaysia 2007
2007 Malay Female
Age Group
C50
C18-C21
C56
C53
C33-C34
C54
C91-C95
C81-C85,C96
C73
C70-C72
C11
C22
C16
C44
C25
C55
C40-C41
C01-C02
C47;C49
C90
C15
C64
C67
C03-C06
C23-C24
C07-C08
C43
C30-C31
C52
C69
C75
C32
C58
C09
C37-C38
C00
C74
C12-C13
C17
C51
C57
C10
C14
C65
C68
Other
All
Total
Breast
Colorectal
Ovary
Cervix Uteri
Trachea, Bronchus, Lung
Corpus Uteri
Leukaemia
Lymphoma
Thyroid
Brain, Nervous system
Nasopharynx
Liver
Stomach
Other Skin
Pancreas
Uterus unspec.
Bone
Tongue
Connective, Soft tissue
Multiple Myeloma
Oesophagus
Kidney
Bladder
Mouth
Gallbladder etc.
Salivary glands
Melanoma of Skin
Nose, sinuses etc.
Vagina
Eye
Other Endocrine
Larynx
Placenta
Tonsil
Other Thoracic organs
Lip
Adrenal gland
Hypopharynx
Small intestine
Vulva
Other Female Genital
Other Oropharynx
Pharynx unspec.
Renal Pelvis
Other Urinary organs
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
1432
360
336
282
201
195
184
172
169
128
70
69
55
53
47
47
39
35
35
35
27
25
20
18
18
17
14
12
10
10
9
7
6
5
5
4
4
3
3
3
2
1
1
1
1
68
4238
33.8
8.5
7.9
6.7
4.7
4.6
4.3
4
4
3
1.7
1.6
1.3
1.3
1.1
1.1
0.9
0.8
0.8
0.8
0.6
0.6
0.5
0.4
0.4
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
1.6
100
21.0
5.3
4.9
4.1
2.9
2.9
2.7
2.5
2.5
1.9
1.0
1.0
0.8
0.8
0.7
0.7
0.6
0.5
0.5
0.5
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.0
62.1
2.6
0.9
0.6
0.6
0.6
0.4
0.3
0.3
0.3
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
8.6
25.4
7.5
6.0
5.3
4.4
3.7
3.0
3.0
3.0
2.1
1.3
1.4
1.1
1.1
1.0
0.8
0.6
0.7
0.6
0.7
0.6
0.5
0.4
0.4
0.4
0.3
0.3
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
1.4
79.0
24.1
6.7
5.4
4.7
3.8
3.1
2.5
2.6
2.5
1.7
1.0
1.1
0.8
0.8
0.7
0.6
0.4
0.5
0.4
0.5
0.4
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1
76.5
CumR
26.8
8.3
6.7
5.9
5.0
4.2
3.4
3.5
3.5
2.5
1.6
1.8
1.5
1.4
1.3
1.1
0.8
0.9
0.8
0.9
0.9
0.7
0.6
0.6
0.6
0.5
0.4
0.3
0.3
0.3
0.2
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
1.7
81.4
2.6
0.9
0.6
0.6
0.6
0.4
0.3
0.3
0.3
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
8.2
89
Appendix 7: Incidence Summary Table, All Residence, Chinese Male, Malaysia 2007
2007 Chinese Male
Age Group
C33-C34
C18-C21
C11
C61
C22
C16
C81-C85,C96
C44
Other
C91-C95
C32
C64
C67
C70-C72
C25
C15
C01-C02
C73
C40-C41
C50
C62
C30-C31
C23-C24
C07-C08
C47;C49
C03-C06
C17
C12-C13
C90
C43
C37-C38
C68
C75
C60
C65
C09
C10
C00
C69
C14
C45
C46
C66
C63
C74
C88
Other
All
90
Total
Trachea, Bronchus, Lung
Colorectal
Nasopharynx
Prostate
Liver
Stomach
Lymphoma
Other Skin
Other & unspecified
Leukaemia
Larynx
Kidney
Bladder
Brain, Nervous system
Pancreas
Oesophagus
Tongue
Thyroid
Bone
Breast
Testis
Nose, sinuses etc.
Gallbladder etc.
Salivary glands
Connective, Soft tissue
Mouth
Small intestine
Hypopharynx
Multiple Myeloma
Melanoma of Skin
Other Thoracic organs
Other Urinary organs
Other Endocrine
Penis
Renal Pelvis
Tonsil
Other Oropharynx
Lip
Eye
Pharynx unspec.
Mesothelioma
Kaposi sarcoma
Ureter
Other male genital
Adrenal gland
Immunoproliferative dis.
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
652
631
389
264
215
179
136
125
111
103
87
86
85
84
78
64
41
33
27
23
22
21
20
20
19
17
15
15
13
10
9
8
7
7
6
6
5
4
3
2
2
2
2
1
1
0
111
3650
17.9
17.3
10.7
7.2
5.9
4.9
3.7
3.4
3
2.8
2.4
2.4
2.3
2.3
2.1
1.8
1.1
0.9
0.7
0.6
0.6
0.6
0.5
0.5
0.5
0.5
0.4
0.4
0.4
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
3
100
20.3
19.7
12.1
8.2
6.7
5.6
4.2
3.9
3.5
3.2
2.7
2.7
2.6
2.6
2.4
2
1.3
1
0.8
0.7
0.7
0.7
0.6
0.6
0.6
0.5
0.5
0.5
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
3.5
113.8
2.6
2.4
1.2
1.1
0.8
0.7
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
13.4
20.5
19.4
10.9
8.7
6.4
5.6
4.1
4
3.4
3.3
2.7
2.5
2.7
2.5
2.4
2
1.2
0.9
0.8
0.7
0.6
0.6
0.6
0.6
0.6
0.5
0.4
0.5
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
3.4
111.9
18.9
17.8
9.8
7.6
5.6
4.8
3.4
3.3
2.8
2.6
2.1
2
2.1
2
1.9
1.5
0.9
0.6
0.5
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
2.8
108.2
22.1
20.9
12
9.7
7.3
6.4
4.8
4.7
4.1
3.9
3.3
3
3.3
3
2.9
2.5
1.6
1.3
1.2
0.9
0.9
0.9
0.9
0.8
0.8
0.7
0.7
0.7
0.6
0.5
0.5
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.2
0.1
0.1
0
4.1
115.5
CumR
2.6
2.4
1.2
1.1
0.8
0.7
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
12.5
Appendix 8: Incidence Summary Table, All Residence, Chinese Female, Malaysia 2007
2007 Chinese Female
Age Group
C50
C18-C21
C53
C33-C34
C56
C54
C16
C11
C81-C85,C96
C44
C73
C22
C25
C91-C95
C70-C72
C67
C64
C55
C40-C41
C47;C49
C23-C24
C15
C03-C06
C01-C02
C30-C31
C07-C08
C43
C37-C38
C52
C51
C17
C90
C32
C09
C12-C13
C68
C74
C75
C00
C10
C69
C57
C65
C66
C14
C45
C46
C58
C88
Other
All
Total
Breast
Colorectal
Cervix Uteri
Trachea, Bronchus, Lung
Ovary
Corpus Uteri
Stomach
Nasopharynx
Lymphoma
Other Skin
Thyroid
Liver
Pancreas
Leukaemia
Brain, Nervous system
Bladder
Kidney
Uterus unspec.
Bone
Connective, Soft tissue
Gallbladder etc.
Oesophagus
Mouth
Tongue
Nose, sinuses etc.
Salivary glands
Melanoma of Skin
Other Thoracic organs
Vagina
Vulva
Small intestine
Multiple Myeloma
Larynx
Tonsil
Hypopharynx
Other Urinary organs
Adrenal gland
Other Endocrine
Lip
Other Oropharynx
Eye
Other Female Genital
Renal Pelvis
Ureter
Pharynx unspec.
Mesothelioma
Kaposi sarcoma
Placenta
Immunoproliferative dis.
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
1343
510
330
273
201
160
138
123
101
79
76
69
65
63
58
41
28
26
23
22
21
18
15
15
13
12
11
10
10
9
9
8
6
5
3
3
3
3
2
2
2
1
1
1
0
0
0
0
0
78
3990
33.7
12.9
8.3
6.8
5
4
3.5
3.1
2.5
2
1.9
1.7
1.6
1.6
1.5
1
0.7
0.7
0.6
0.6
0.5
0.5
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
2
100
43.6
16.6
10.7
8.9
6.5
5.2
4.5
4
3.3
2.6
2.5
2.2
2.1
2
1.9
1.3
0.9
0.8
0.7
0.7
0.7
0.6
0.5
0.5
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
2.5
129.7
4.2
1.8
1.1
1
0.6
0.5
0.5
0.4
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.2
13
38.1
14.6
9.5
8
5.8
4.5
4
3.5
3
2.2
2.2
2
1.9
2
1.9
1.2
0.8
0.7
0.7
0.7
0.6
0.5
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0
0.1
0.1
0
0
0
0
0
0
0
0
2.3
115
36
13.3
8.5
7
5
3.8
3.3
2.9
2.4
1.7
1.7
1.6
1.5
1.5
1.4
0.8
0.5
0.4
0.4
0.4
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.7
111.3
CumR
40.1
15.9
10.5
8.9
6.7
5.3
4.6
4.1
3.6
2.7
2.8
2.5
2.4
2.5
2.3
1.5
1.1
1
0.9
0.9
0.9
0.7
0.6
0.6
0.6
0.5
0.5
0.4
0.5
0.4
0.4
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0
0
0
0
0
2.8
118.5
4.1
1.8
1.1
1
0.6
0.5
0.5
0.4
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.2
12.2
91
Appendix 9: Incidence Summary Table, All Residence, Indian Male, Malaysia 2007
2007 Indian Male
Age Group
C18-C21
C33-C34
C61
C16
C91-C95
C81-C85,C96
C70-C72
C03-C06
C67
C15
C32
C01-C02
C22
C10
C40-C41
C09
C11
C12-C13
C44
C73
C25
C62
C64
C60
C30-C31
C07-C08
C23-C24
C14
C43
C75
C17
C37-C38
C50
C00
C45
C46
C47;C49
C63
C65
C66
C68
C69
C74
C88
C90
Other
All
92
Total
Colorectal
Trachea, Bronchus, Lung
Prostate
Stomach
Leukaemia
Lymphoma
Brain, Nervous system
Mouth
Bladder
Oesophagus
Larynx
Tongue
Liver
Other Oropharynx
Bone
Tonsil
Nasopharynx
Hypopharynx
Other Skin
Thyroid
Pancreas
Testis
Kidney
Penis
Nose, sinuses etc.
Salivary glands
Gallbladder etc.
Pharynx unspec.
Melanoma of Skin
Other Endocrine
Small intestine
Other Thoracic organs
Breast
Lip
Mesothelioma
Kaposi sarcoma
Connective, Soft tissue
Other male genital
Renal Pelvis
Ureter
Other Urinary organs
Eye
Adrenal gland
Immunoproliferative dis.
Multiple Myeloma
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
65
46
31
30
29
25
22
21
21
17
16
15
15
12
10
9
9
8
7
7
6
5
5
4
3
3
2
2
2
2
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
10
462
14.1
10
6.7
6.5
6.3
5.4
4.8
4.5
4.5
3.7
3.5
3.2
3.2
2.6
2.2
1.9
1.9
1.7
1.5
1.5
1.3
1.1
1.1
0.9
0.6
0.6
0.4
0.4
0.4
0.4
0.2
0.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
2.2
100
6.9
4.9
3.3
3.2
3.1
2.7
2.3
2.2
2.2
1.8
1.7
1.6
1.6
1.3
1.1
1
1
0.9
0.7
0.7
0.6
0.5
0.5
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
1.1
49.2
1.2
0.8
0.5
0.6
0.3
0.3
0.3
0.4
0.4
0.4
0.3
0.2
0.2
0.3
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
7.9
10.2
7.2
5.8
4.8
3.4
3.1
2.5
3.6
3.5
2.8
2.6
2
2.2
1.8
1.1
1.4
1.1
1.1
0.8
0.9
0.9
0.6
0.7
0.6
0.3
0.4
0.3
0.4
0.3
0.2
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
1.5
68.2
7.6
5
3.7
3
2.1
1.8
1.4
2
1.9
1.4
1.3
0.9
1
0.7
0.4
0.4
0.3
0.3
0.2
0.2
0.1
0
0
0
0
-0.1
-0.1
-0.2
-0.2
-0.1
-0.1
-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0.5
61.6
12.8
9.4
7.9
6.6
4.7
4.3
3.7
5.1
5.1
4.1
3.9
3.1
3.3
2.9
1.7
2.3
1.9
1.9
1.4
1.7
1.6
1.2
1.3
1.2
0.7
0.8
0.7
1
0.8
0.5
0.3
0.3
0.3
0
0
0
0
0
0
0
0
0
0
0
0
2.5
74.7
CumR
1.2
0.8
0.5
0.6
0.3
0.3
0.3
0.4
0.4
0.4
0.3
0.2
0.2
0.3
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
7.6
Appendix 10: Incidence Summary Table, All Residence, Indian Female, Malaysia 2007
2007 Indian Female
Age Group
C50
C53
C18-C21
C03-C06
C56
C54
C15
C91-C95
C16
C01-C02
C33-C34
C70-C72
C81-C85,C96
C73
C25
C22
C11
C52
C23-C24
C32
C44
C09
C40-C41
C47;C49
C67
C75
C12-C13
C30-C31
C51
C10
C14
C37-C38
C55
C64
C90
C00
C07-C08
C43
C69
C17
C45
C46
C57
C58
C65
C66
C68
C74
C88
Other
All
Total
Breast
Cervix Uteri
Colorectal
Mouth
Ovary
Corpus Uteri
Oesophagus
Leukaemia
Stomach
Tongue
Trachea, Bronchus, Lung
Brain, Nervous system
Lymphoma
Thyroid
Pancreas
Liver
Nasopharynx
Vagina
Gallbladder etc.
Larynx
Other Skin
Tonsil
Bone
Connective, Soft tissue
Bladder
Other Endocrine
Hypopharynx
Nose, sinuses etc.
Vulva
Other Oropharynx
Pharynx unspec.
Other Thoracic organs
Uterus unspec.
Kidney
Multiple Myeloma
Lip
Salivary glands
Melanoma of Skin
Eye
Small intestine
Mesothelioma
Kaposi sarcoma
Other Female Genital
Placenta
Renal Pelvis
Ureter
Other Urinary organs
Adrenal gland
Immunoproliferative dis.
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
297
85
53
49
48
34
28
28
26
20
15
13
13
11
8
7
6
6
5
5
5
4
4
4
4
4
3
3
3
2
2
2
2
2
2
1
1
1
1
0
0
0
0
0
0
0
0
0
0
18
825
36
10.3
6.5
5.9
5.8
4.1
3.4
3.4
3.2
2.4
1.8
1.6
1.6
1.3
1
0.8
0.7
0.7
0.6
0.6
0.6
0.5
0.5
0.5
0.5
0.5
0.4
0.4
0.4
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
2.2
100
31.5
9
5.6
5.2
5.1
3.6
3
3
2.8
2.1
1.6
1.4
1.4
1.2
0.8
0.7
0.6
0.6
0.5
0.5
0.5
0.4
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
1.9
87.5
3.7
1.1
0.8
1
0.5
0.4
0.5
0.2
0.4
0.3
0.3
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0.1
0
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
11.2
33.7
10.3
6.9
7.4
5.2
4.1
3.7
2.9
3.4
2.6
2
1.4
1.7
1.2
1
0.9
0.9
0.8
0.7
0.7
0.8
0.5
0.4
0.5
0.6
0.5
0.3
0.4
0.4
0.3
0.3
0.2
0.3
0.2
0.2
0.2
0.1
0.2
0.1
0
0
0
0
0
0
0
0
0
0
2.2
99.9
29.7
8
5
5.3
3.7
2.6
2.3
1.8
2.1
1.4
0.9
0.6
0.7
0.4
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0
0
0
0
0
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.2
-0.1
-0.2
-0.1
0
0
0
0
0
0
0
0
0
0
1.1
92.8
CumR
37.6
12.6
8.9
9.5
6.7
5.5
5.1
4
4.8
3.8
3
2.2
2.6
1.9
1.7
1.6
1.5
1.4
1.4
1.3
1.4
0.9
0.8
1
1.3
0.9
0.7
0.9
0.8
0.8
0.6
0.6
0.7
0.5
0.5
0.5
0.3
0.5
0.3
0
0
0
0
0
0
0
0
0
0
3.2
106.9
3.6
1.1
0.8
1
0.5
0.4
0.5
0.2
0.4
0.3
0.3
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0.1
0
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
10.6
93
94
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
9
93
69
47
20
22
685
36
10
125
351
27
589
631
15
443
52
151
51
164
1320
27
97
34
236
5
2
76
50
23
502
74
4
141
9
2
258
8
20
259
129
13
37
38
410
1
60
130
223
66
279
8123
7887
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
-4
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
3
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
5
0
3
1
0
0
0
11
19
0
6
0
0
6
0
0
35
24
16
3
135
135
0-
0
0
0
0
0
0
2
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
3
0
0
0
0
0
0
2
0
1
0
0
0
0
1
19
1
1
1
1
8
0
0
17
11
12
1
84
81
5-
-9
-14
0
0
1
0
0
0
4
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
17
0
1
0
0
2
0
0
0
2
0
0
0
0
0
0
0
10
3
0
3
3
11
0
1
15
17
6
2
100
99
10-19
0
1
0
0
0
0
11
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
14
2
2
0
0
4
0
0
0
7
1
0
0
0
1
0
0
7
5
0
5
5
16
0
0
8
7
4
6
108
106
15-24
0
2
0
1
0
1
6
0
0
0
0
1
2
2
1
1
0
1
0
0
3
2
10
2
2
0
0
5
1
0
0
15
0
0
0
0
0
0
0
9
4
0
3
5
21
0
0
11
26
0
2
139
137
20-29
0
1
1
2
0
0
21
0
0
0
3
1
3
5
0
3
0
0
1
0
9
2
7
0
5
0
0
5
0
0
0
11
1
0
0
0
2
0
0
9
5
1
1
1
21
0
0
4
17
4
6
152
147
25-34
0
6
1
4
1
0
37
0
0
1
6
1
6
16
0
12
0
2
0
1
17
0
2
0
5
0
0
6
4
1
0
6
0
2
0
0
3
0
1
16
5
0
2
2
15
0
0
3
6
0
7
197
192
30-39
0
4
2
3
0
0
53
0
1
1
12
1
15
16
0
7
0
2
5
2
22
2
2
3
10
0
0
4
3
1
0
6
0
7
0
0
4
0
0
20
9
0
3
2
20
0
2
3
17
3
9
276
266
35-44
1
3
4
3
0
2
65
0
0
1
14
2
32
29
1
22
4
6
4
5
42
1
4
1
8
0
2
7
6
3
2
7
0
9
0
0
9
0
1
20
7
1
3
5
28
0
4
6
12
3
12
401
393
40-
-49
2
10
12
4
4
0
109
3
0
9
27
3
41
53
1
44
5
13
7
10
84
3
5
1
13
0
0
5
10
2
6
2
0
14
1
0
19
1
2
18
15
0
2
2
38
0
6
4
11
3
23
647
634
45-54
0
15
7
7
3
1
104
2
1
7
28
2
69
62
3
55
5
18
8
16
139
4
4
6
23
1
0
9
9
2
21
7
0
25
1
0
20
0
0
24
12
0
4
4
27
0
8
5
19
5
22
814
791
50-59
0
7
6
5
1
4
87
2
1
20
43
6
85
87
1
76
10
17
6
24
173
1
9
4
16
0
0
4
4
6
35
1
0
20
1
0
31
0
0
30
16
0
4
4
55
0
13
9
13
1
41
979
963
55-64
0
14
7
8
4
3
75
7
4
18
37
4
71
111
2
68
3
35
9
19
193
4
7
3
26
0
0
8
4
2
72
0
0
28
0
0
34
3
0
12
13
2
2
0
45
0
9
1
17
2
36
1022
996
60-69
1
16
11
3
1
1
72
9
1
21
62
4
86
105
2
61
10
30
7
32
220
4
3
5
34
1
0
12
4
3
105
2
1
13
3
1
38
2
0
14
20
1
2
1
46
0
9
4
9
1
43
1136
1102
65-
Appendix 11: Number of new cancer cases, All Residence, Male, Malaysia 2007
-74
2
6
5
4
4
6
22
6
1
22
55
2
81
58
3
44
9
5
2
28
204
1
5
3
38
1
0
2
2
0
120
1
0
10
2
1
47
0
0
20
7
1
2
1
20
0
3
4
10
0
31
901
863
70-
3
8
12
3
2
3
17
6
0
25
64
0
97
86
1
47
6
21
2
27
213
3
6
4
50
2
0
2
3
3
141
0
1
9
0
0
50
2
4
12
7
0
0
2
33
1
5
1
7
6
35
1032
982
75+
0.10%
1.10%
0.80%
0.60%
0.20%
0.30%
8.40%
0.40%
0.10%
1.50%
4.30%
0.30%
7.30%
7.80%
0.20%
5.50%
0.60%
1.90%
0.60%
2.00%
16.30%
0.30%
1.20%
0.40%
2.90%
0.10%
0.00%
0.90%
0.60%
0.30%
6.20%
0.90%
0.00%
1.70%
0.10%
0.00%
3.20%
0.10%
0.20%
3.20%
1.60%
0.20%
0.50%
0.50%
5.00%
0.00%
0.70%
1.60%
2.70%
0.80%
3.40%
100.00%
97.10%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Other Female Genital
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
8
78
96
38
18
6
255
13
3
81
279
16
555
433
23
162
49
133
28
19
545
25
76
27
166
0
0
72
3242
21
31
847
414
85
656
3
7
60
2
1
73
4
17
212
305
8
16
29
299
0
47
91
178
53
191
10096
9930
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
1
0
2
0
0
0
0
3
0
0
0
0
0
0
1
0
0
6
0
0
0
0
5
12
0
2
0
0
2
0
0
24
11
15
2
88
88
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
3
0
0
0
0
2
0
0
0
0
0
0
2
0
0
1
0
0
0
0
0
19
0
0
0
0
7
0
0
14
3
4
3
59
59
5-
-9
-14
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
7
0
1
0
0
2
1
0
0
0
0
0
10
0
0
1
0
0
0
0
1
12
0
1
0
0
6
0
0
11
8
8
2
73
72
10-19
0
0
0
1
0
0
6
0
0
0
4
0
1
2
0
0
0
1
0
0
0
0
16
1
3
0
0
7
6
0
0
0
1
0
21
0
0
1
0
0
0
0
2
13
12
0
1
6
12
0
0
8
9
3
3
140
137
15-24
0
0
2
4
0
0
14
0
0
0
0
2
3
3
1
1
0
1
2
0
3
0
4
0
5
0
0
1
18
0
0
2
0
2
22
0
0
2
0
0
1
0
0
11
15
0
0
7
17
0
0
3
12
2
5
165
160
20-29
0
1
2
1
0
0
9
0
0
0
5
0
7
4
0
2
0
2
0
0
6
0
1
0
3
0
0
3
57
0
0
12
6
3
27
0
0
0
1
0
0
0
1
10
33
0
0
8
16
0
0
3
7
2
5
237
234
25-34
0
5
3
1
0
0
18
0
1
0
6
0
9
9
0
3
1
2
1
0
5
2
3
0
2
0
0
3
138
0
0
27
15
2
21
1
0
2
0
0
0
0
2
9
19
1
0
0
15
0
0
2
13
1
3
345
343
30-39
0
2
2
2
0
0
19
0
0
1
9
0
19
9
1
6
0
2
5
0
12
0
1
1
3
0
0
4
246
2
2
82
23
5
36
0
2
3
0
0
2
0
1
16
32
0
2
1
12
0
1
2
13
3
2
586
583
35-44
0
6
3
3
1
0
33
0
0
4
14
1
31
27
0
6
1
5
1
0
23
2
6
6
7
0
0
9
432
0
4
110
39
11
74
0
1
1
0
0
4
0
0
17
31
0
3
2
20
0
5
5
14
4
15
981
974
40-
-49
0
6
0
3
1
1
30
2
1
1
18
1
42
37
2
18
1
11
2
3
50
3
8
1
10
0
0
8
664
3
3
119
58
17
110
1
2
4
0
0
3
0
0
15
40
0
2
0
24
0
2
5
16
2
18
1368
1358
45-54
1
13
8
5
2
0
36
2
0
10
22
4
52
43
2
8
5
15
3
1
58
2
5
0
8
0
0
4
540
1
3
111
71
18
117
0
1
5
0
0
5
1
0
22
34
2
3
1
32
0
10
4
17
2
20
1329
1321
50-59
1
11
7
7
5
0
32
1
0
13
25
2
79
51
6
28
7
17
4
3
58
4
5
4
16
0
0
7
451
2
5
122
81
12
68
0
0
8
0
0
7
0
1
9
30
0
3
2
24
0
10
1
27
1
28
1285
1269
55-64
1
10
14
1
2
1
24
3
1
15
29
0
57
45
2
29
12
26
1
0
86
3
2
3
14
0
0
5
272
2
1
82
49
6
51
1
1
6
0
0
12
3
1
17
21
1
2
0
28
0
6
4
11
2
22
987
973
60-69
0
6
17
0
1
1
19
0
0
12
49
1
76
66
1
18
5
20
3
3
89
2
6
4
22
0
0
10
199
2
5
73
27
1
52
0
0
4
0
1
11
0
2
17
20
0
0
1
31
0
5
1
7
3
25
918
896
65-
Appendix 12: Number of new cancer cases, All Residence, Female, Malaysia 2007
-74
1
6
16
4
2
2
9
3
0
8
37
1
81
61
2
17
8
14
3
6
79
1
2
3
22
0
0
3
110
2
3
52
20
3
25
0
0
8
0
0
10
0
1
9
12
0
0
0
25
0
5
2
5
1
13
697
675
70-
3
12
22
6
4
1
6
2
0
17
61
4
97
76
6
24
9
17
3
3
75
5
5
4
50
0
0
1
108
7
5
55
24
5
19
0
0
8
1
0
18
0
0
4
6
1
0
1
28
0
3
2
5
0
25
838
788
75+
0.10%
0.80%
1.00%
0.40%
0.20%
0.10%
2.50%
0.10%
0.00%
0.80%
2.80%
0.20%
5.50%
4.30%
0.20%
1.60%
0.50%
1.30%
0.30%
0.20%
5.40%
0.20%
0.80%
0.30%
1.60%
0.00%
0.00%
0.70%
32.10%
0.20%
0.30%
8.40%
4.10%
0.80%
6.50%
0.00%
0.10%
0.60%
0.00%
0.00%
0.70%
0.00%
0.20%
2.10%
3.00%
0.10%
0.20%
0.30%
3.00%
0.00%
0.50%
0.90%
1.80%
0.50%
1.90%
100.00%
98.40%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
95
96
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
9
93
69
47
20
22
685
36
10
125
351
27
589
631
15
443
52
151
51
164
1320
27
97
34
236
5
2
76
50
23
502
74
4
141
9
2
258
8
20
259
129
13
37
38
410
1
60
130
223
66
279
8123
7887
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0.2
0
0.1
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0.3
0
0.2
0.1
0
0
0
0.8
1.3
0
0.4
0
0
0.4
0
0
2.4
1.6
1.1
0.2
9
9
0-
-4
0
0
0
0
0
0
0.1
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0.2
0
0
0
0
0
0
0.1
0
0.1
0
0
0
0
0.1
1.4
0.1
0.1
0.1
0.1
0.6
0
0
1.2
0.8
0.9
0.1
6
6
5-
-9
-14
0
0
0.1
0
0
0
0.3
0
0
0
0
0
0.1
0.1
0
0
0
0
0
0
0
0
1.3
0
0.1
0
0
0.1
0
0
0
0.1
0
0
0
0
0
0
0
0.7
0.2
0
0.2
0.2
0.8
0
0.1
1.1
1.3
0.4
0.1
7
7
10-19
0
0.1
0
0
0
0
0.9
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0
1.1
0.2
0.2
0
0
0.3
0
0
0
0.5
0.1
0
0
0
0.1
0
0
0.5
0.4
0
0.4
0.4
1.3
0
0
0.6
0.5
0.3
0.5
8
8
15-24
0
0.2
0
0.1
0
0.1
0.5
0
0
0
0
0.1
0.2
0.2
0.1
0.1
0
0.1
0
0
0.3
0.2
0.8
0.2
0.2
0
0
0.4
0.1
0
0
1.3
0
0
0
0
0
0
0
0.8
0.3
0
0.3
0.4
1.8
0
0
0.9
2.2
0
0.2
12
12
20-29
0
0.1
0.1
0.2
0
0
2.1
0
0
0
0.3
0.1
0.3
0.5
0
0.3
0
0
0.1
0
0.9
0.2
0.7
0
0.5
0
0
0.5
0
0
0
1.1
0.1
0
0
0
0.2
0
0
0.9
0.5
0.1
0.1
0.1
2.1
0
0
0.4
1.7
0.4
0.6
15
15
25-34
0
0.7
0.1
0.5
0.1
0
4.4
0
0
0.1
0.7
0.1
0.7
1.9
0
1.4
0
0.2
0
0.1
2
0
0.2
0
0.6
0
0
0.7
0.5
0.1
0
0.7
0
0.2
0
0
0.4
0
0.1
1.9
0.6
0
0.2
0.2
1.8
0
0
0.4
0.7
0
0.8
23
23
30-39
0
0.5
0.2
0.4
0
0
6.5
0
0.1
0.1
1.5
0.1
1.8
2
0
0.9
0
0.2
0.6
0.2
2.7
0.2
0.2
0.4
1.2
0
0
0.5
0.4
0.1
0
0.7
0
0.9
0
0
0.5
0
0
2.4
1.1
0
0.4
0.2
2.4
0
0.2
0.4
2.1
0.4
1.1
34
33
35-44
0.1
0.4
0.5
0.4
0
0.3
8.4
0
0
0.1
1.8
0.3
4.1
3.7
0.1
2.8
0.5
0.8
0.5
0.6
5.4
0.1
0.5
0.1
1
0
0.3
0.9
0.8
0.4
0.3
0.9
0
1.2
0
0
1.2
0
0.1
2.6
0.9
0.1
0.4
0.6
3.6
0
0.5
0.8
1.5
0.4
1.5
52
51
40-
-49
0.3
1.4
1.7
0.6
0.6
0
15.4
0.4
0
1.3
3.8
0.4
5.8
7.5
0.1
6.2
0.7
1.8
1
1.4
11.9
0.4
0.7
0.1
1.8
0
0
0.7
1.4
0.3
0.9
0.3
0
2
0.1
0
2.7
0.1
0.3
2.6
2.1
0
0.3
0.3
5.4
0
0.9
0.6
1.6
0.4
3.3
92
90
45-54
0
2.5
1.1
1.1
0.5
0.2
17
0.3
0.2
1.1
4.6
0.3
11.3
10.1
0.5
9
0.8
2.9
1.3
2.6
22.7
0.7
0.7
1
3.8
0.2
0
1.5
1.5
0.3
3.4
1.1
0
4.1
0.2
0
3.3
0
0
3.9
2
0
0.7
0.7
4.4
0
1.3
0.8
3.1
0.8
3.6
133
129
50-59
0
1.5
1.3
1.1
0.2
0.9
18.7
0.4
0.2
4.3
9.3
1.3
18.3
18.7
0.2
16.4
2.2
3.7
1.3
5.2
37.2
0.2
1.9
0.9
3.4
0
0
0.9
0.9
1.3
7.5
0.2
0
4.3
0.2
0
6.7
0
0
6.5
3.4
0
0.9
0.9
11.8
0
2.8
1.9
2.8
0.2
8.8
211
207
55-64
0
4.3
2.1
2.4
1.2
0.9
22.9
2.1
1.2
5.5
11.3
1.2
21.7
33.9
0.6
20.7
0.9
10.7
2.7
5.8
58.9
1.2
2.1
0.9
7.9
0
0
2.4
1.2
0.6
22
0
0
8.5
0
0
10.4
0.9
0
3.7
4
0.6
0.6
0
13.7
0
2.7
0.3
5.2
0.6
11
312
304
60-
-69
0.4
6.9
4.8
1.3
0.4
0.4
31.2
3.9
0.4
9.1
26.8
1.7
37.2
45.4
0.9
26.4
4.3
13
3
13.9
95.2
1.7
1.3
2.2
14.7
0.4
0
5.2
1.7
1.3
45.4
0.9
0.4
5.6
1.3
0.4
16.4
0.9
0
6.1
8.7
0.4
0.9
0.4
19.9
0
3.9
1.7
3.9
0.4
18.6
492
477
65-74
1.3
4
3.4
2.7
2.7
4
14.8
4
0.7
14.8
37.1
1.3
54.6
39.1
2
29.7
6.1
3.4
1.3
18.9
137.6
0.7
3.4
2
25.6
0.7
0
1.3
1.3
0
80.9
0.7
0
6.7
1.3
0.7
31.7
0
0
13.5
4.7
0.7
1.3
0.7
13.5
0
2
2.7
6.7
0
20.9
608
582
70-
1.9
5.2
7.7
1.9
1.3
1.9
11
3.9
0
16.1
41.3
0
62.5
55.5
0.6
30.3
3.9
13.5
1.3
17.4
137.3
1.9
3.9
2.6
32.2
1.3
0
1.3
1.9
1.9
90.9
0
0.6
5.8
0
0
32.2
1.3
2.6
7.7
4.5
0
0
1.3
21.3
0.6
3.2
0.6
4.5
3.9
22.6
665
633
75+
0.1
0.7
0.5
0.4
0.2
0.2
5.4
0.3
0.1
1
2.7
0.2
4.6
4.9
0.1
3.5
0.4
1.2
0.4
1.3
10.3
0.2
0.8
0.3
1.8
0
0
0.6
0.4
0.2
3.9
0.6
0
1.1
0.1
0
2
0.1
0.2
2
1
0.1
0.3
0.3
3.2
0
0.5
1
1.7
0.5
2.2
63.6
61.8
Total
% of
0.1
1
0.7
0.5
0.2
0.2
6.4
0.4
0.1
1.4
3.9
0.3
6.4
6.8
0.2
4.7
0.6
1.6
0.5
1.9
14.8
0.3
0.8
0.3
2.6
0.1
0
0.7
0.5
0.2
6.2
0.6
0
1.4
0.1
0
2.9
0.1
0.2
2.3
1.3
0.1
0.3
0.3
3.9
0
0.6
1
1.9
0.6
3
85.1
82.4
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Other Female Genital
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
8
78
96
38
18
6
255
13
3
81
279
16
555
433
23
162
49
133
28
19
545
25
76
27
166
0
0
72
3242
21
31
847
414
85
656
3
7
60
2
1
73
4
17
212
305
8
16
29
299
0
47
91
178
53
191
10096
9930
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0
0.1
0
0.1
0
0
0
0
0.2
0
0
0
0
0
0
0.1
0
0
0.4
0
0
0
0
0.4
0.9
0
0.1
0
0
0.1
0
0
1.7
0.8
1.1
0.1
6
6
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.2
0
0
0
0
0.2
0
0
0
0
0
0
0.2
0
0
0.1
0
0
0
0
0
1.4
0
0
0
0
0.5
0
0
1.1
0.2
0.3
0.2
4
4
5-
-9
-14
0.1
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0.6
0
0.1
0
0
0.2
0.1
0
0
0
0
0
0.8
0
0
0.1
0
0
0
0
0.1
1
0
0.1
0
0
0.5
0
0
0.9
0.6
0.6
0.2
6
6
10-19
0
0
0
0.1
0
0
0.5
0
0
0
0.3
0
0.1
0.2
0
0
0
0.1
0
0
0
0
1.3
0.1
0.2
0
0
0.6
0.5
0
0
0
0.1
0
1.7
0
0
0.1
0
0
0
0
0.2
1.1
1
0
0.1
0.5
1
0
0
0.7
0.7
0.2
0.2
12
11
15-24
0
0
0.2
0.3
0
0
1.2
0
0
0
0
0.2
0.3
0.3
0.1
0.1
0
0.1
0.2
0
0.3
0
0.3
0
0.4
0
0
0.1
1.6
0
0
0.2
0
0.2
1.9
0
0
0.2
0
0
0.1
0
0
1
1.3
0
0
0.6
1.5
0
0
0.3
1
0.2
0.4
14
14
20-29
0
0.1
0.2
0.1
0
0
0.9
0
0
0
0.5
0
0.7
0.4
0
0.2
0
0.2
0
0
0.6
0
0.1
0
0.3
0
0
0.3
5.7
0
0
1.2
0.6
0.3
2.7
0
0
0
0.1
0
0
0
0.1
1
3.3
0
0
0.8
1.6
0
0
0.3
0.7
0.2
0.5
24
23
25-34
0
0.6
0.3
0.1
0
0
2.1
0
0.1
0
0.7
0
1
1
0
0.3
0.1
0.2
0.1
0
0.6
0.2
0.3
0
0.2
0
0
0.3
16
0
0
3.1
1.7
0.2
2.4
0.1
0
0.2
0
0
0
0
0.2
1
2.2
0.1
0
0
1.7
0
0
0.2
1.5
0.1
0.3
40
40
30-39
0
0.2
0.2
0.2
0
0
2.3
0
0
0.1
1.1
0
2.3
1.1
0.1
0.7
0
0.2
0.6
0
1.4
0
0.1
0.1
0.4
0
0
0.5
29.6
0.2
0.2
9.9
2.8
0.6
4.3
0
0.2
0.4
0
0
0.2
0
0.1
1.9
3.9
0
0.2
0.1
1.4
0
0.1
0.2
1.6
0.4
0.2
71
70
35-44
0
0.8
0.4
0.4
0.1
0
4.2
0
0
0.5
1.8
0.1
3.9
3.4
0
0.8
0.1
0.6
0.1
0
2.9
0.3
0.8
0.8
0.9
0
0
1.1
54.9
0
0.5
14
5
1.4
9.4
0
0.1
0.1
0
0
0.5
0
0
2.2
3.9
0
0.4
0.3
2.5
0
0.6
0.6
1.8
0.5
1.9
125
124
40-
-49
0
0.9
0
0.4
0.1
0.1
4.3
0.3
0.1
0.1
2.6
0.1
6
5.3
0.3
2.6
0.1
1.6
0.3
0.4
7.2
0.4
1.1
0.1
1.4
0
0
1.1
95.1
0.4
0.4
17
8.3
2.4
15.8
0.1
0.3
0.6
0
0
0.4
0
0
2.1
5.7
0
0.3
0
3.4
0
0.3
0.7
2.3
0.3
2.6
196
195
45-54
0.2
2.2
1.3
0.8
0.3
0
6
0.3
0
1.7
3.7
0.7
8.7
7.2
0.3
1.3
0.8
2.5
0.5
0.2
9.7
0.3
0.8
0
1.3
0
0
0.7
90.6
0.2
0.5
18.6
11.9
3
19.6
0
0.2
0.8
0
0
0.8
0.2
0
3.7
5.7
0.3
0.5
0.2
5.4
0
1.7
0.7
2.9
0.3
3.4
223
222
50-59
0.2
2.4
1.6
1.6
1.1
0
7.1
0.2
0
2.9
5.6
0.4
17.6
11.4
1.3
6.2
1.6
3.8
0.9
0.7
12.9
0.9
1.1
0.9
3.6
0
0
1.6
100.4
0.4
1.1
27.2
18
2.7
15.1
0
0
1.8
0
0
1.6
0
0.2
2
6.7
0
0.7
0.4
5.3
0
2.2
0.2
6
0.2
6.2
286
283
55-64
0.3
3.1
4.4
0.3
0.6
0.3
7.5
0.9
0.3
4.7
9.1
0
17.9
14.2
0.6
9.1
3.8
8.2
0.3
0
27
0.9
0.6
0.9
4.4
0
0
1.6
85.5
0.6
0.3
25.8
15.4
1.9
16
0.3
0.3
1.9
0
0
3.8
0.9
0.3
5.3
6.6
0.3
0.6
0
8.8
0
1.9
1.3
3.5
0.6
6.9
310
306
60-
-69
0
2.5
7
0
0.4
0.4
7.8
0
0
5
20.2
0.4
31.4
27.3
0.4
7.4
2.1
8.3
1.2
1.2
36.8
0.8
2.5
1.7
9.1
0
0
4.1
82.2
0.8
2.1
30.1
11.2
0.4
21.5
0
0
1.7
0
0.4
4.5
0
0.8
7
8.3
0
0
0.4
12.8
0
2.1
0.4
2.9
1.2
10.3
379
370
65-74
0.6
3.4
9.2
2.3
1.1
1.1
5.2
1.7
0
4.6
21.2
0.6
46.5
35
1.1
9.8
4.6
8
1.7
3.4
45.3
0.6
1.1
1.7
12.6
0
0
1.7
63.1
1.1
1.7
29.8
11.5
1.7
14.3
0
0
4.6
0
0
5.7
0
0.6
5.2
6.9
0
0
0
14.3
0
2.9
1.1
2.9
0.6
7.5
400
387
70-
1.5
6
10.9
3
2
0.5
3
1
0
8.4
30.3
2
48.2
37.8
3
11.9
4.5
8.4
1.5
1.5
37.3
2.5
2.5
2
24.8
0
0
0.5
53.7
3.5
2.5
27.3
11.9
2.5
9.4
0
0
4
0.5
0
8.9
0
0
2
3
0.5
0
0.5
13.9
0
1.5
1
2.5
0
12.4
416
392
75+
0.1
0.6
0.8
0.3
0.1
0
2
0.1
0
0.6
2.2
0.1
4.4
3.5
0.2
1.3
0.4
1.1
0.2
0.2
4.4
0.2
0.6
0.2
1.3
0
0
0.6
26
0.2
0.2
6.8
3.3
0.7
5.3
0
0.1
0.5
0
0
0.6
0
0.1
1.7
2.4
0.1
0.1
0.2
2.4
0
0.4
0.7
1.4
0.4
1.5
80.9
79.5
Total
% of
0.1
0.7
1
0.3
0.2
0.1
2.3
0.1
0
0.8
2.8
0.1
5.6
4.4
0.2
1.6
0.5
1.4
0.3
0.2
5.6
0.2
0.6
0.3
1.7
0
0
0.7
29.1
0.2
0.3
7.8
3.9
0.7
5.9
0
0.1
0.6
0
0
0.8
0
0.2
1.9
2.7
0.1
0.1
0.2
2.8
0
0.5
0.8
1.5
0.4
1.9
94.4
92.7
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
97
98
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
27
21
23
3
3
152
4
5
36
65
9
185
253
7
152
25
50
23
51
501
12
48
11
83
3
0
43
23
3
176
41
3
45
3
0
124
0
14
137
69
6
27
23
198
1
40
65
126
50
120
3093
3010
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
3
0
0
1
0
0
0
8
14
0
3
0
0
2
0
0
17
18
12
0
82
82
-4
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
0
0
0
0
0
0
1
0
0
0
0
0
0
1
13
0
0
1
0
4
0
0
8
8
11
1
53
51
5-
-9
-14
0
0
1
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
1
0
0
2
0
0
0
2
0
0
0
0
0
0
0
6
1
0
3
3
6
0
1
7
5
6
2
59
58
10-19
0
1
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
1
2
0
0
1
0
0
0
5
1
0
0
0
0
0
0
5
4
0
5
3
9
0
0
3
6
4
3
64
62
15-24
0
0
0
1
0
1
1
0
0
0
0
0
0
1
1
1
0
0
0
0
2
2
4
2
1
0
0
5
1
0
0
10
0
0
0
0
0
0
0
5
2
0
2
4
14
0
0
6
16
0
2
84
83
20-29
0
0
1
1
0
0
4
0
0
0
1
0
1
4
0
2
0
0
0
0
7
2
5
0
3
0
0
3
0
0
0
5
0
0
0
0
1
0
0
4
3
0
1
0
10
0
0
4
11
3
4
80
77
25-34
0
2
1
2
1
0
8
0
0
0
2
1
4
10
0
7
0
1
0
0
9
0
0
0
2
0
0
5
4
0
0
4
0
0
0
0
0
0
1
11
3
0
2
2
8
0
0
0
3
0
3
96
94
30-39
0
0
1
2
0
0
11
0
1
0
2
0
10
8
0
3
0
0
4
1
15
1
1
2
5
0
0
0
0
0
0
3
0
2
0
0
1
0
0
12
4
0
2
1
7
0
1
1
10
1
5
117
112
35-44
0
3
2
2
0
0
16
0
0
1
3
1
14
13
1
7
1
4
2
1
22
0
1
0
5
0
0
4
2
0
1
3
0
3
0
0
4
0
1
8
6
0
2
2
19
0
4
5
9
2
8
182
177
40-49
1
4
2
1
1
0
24
0
0
1
11
1
20
24
1
19
3
4
2
3
47
1
0
0
7
0
0
4
6
0
3
2
0
4
0
0
11
0
1
12
4
0
1
2
16
0
6
3
8
1
15
276
269
45-
-54
0
7
4
3
1
0
20
0
1
6
8
0
28
24
2
20
3
8
3
7
62
2
4
3
9
0
0
1
3
1
10
1
0
8
1
0
9
0
0
10
5
0
3
2
14
0
5
2
6
5
10
321
312
50-59
0
2
0
1
0
0
14
0
1
4
6
4
28
34
0
24
4
3
2
11
69
0
5
2
6
0
0
3
3
0
14
1
0
3
0
0
18
0
0
16
9
0
2
2
24
0
7
4
7
0
15
348
342
55-64
0
3
2
5
0
0
23
1
1
7
2
1
24
46
1
24
1
11
6
5
68
1
4
0
8
0
0
5
1
1
21
0
0
12
0
0
20
0
0
4
5
1
2
0
24
0
6
1
8
0
14
369
361
60-
Appendix 15: Number of new cancer cases, Malay Male, Malaysia 2007
-69
1
2
1
1
0
0
11
1
0
3
10
0
15
41
0
11
5
12
2
7
65
1
0
1
11
1
0
5
1
1
33
1
1
7
0
0
14
0
0
2
13
1
1
1
16
0
6
3
4
0
9
321
310
65-74
0
1
2
2
0
0
7
1
0
7
6
1
16
19
0
13
5
0
2
8
71
0
3
0
10
1
0
2
1
0
52
0
0
1
1
0
22
0
0
11
5
1
0
0
7
0
1
0
3
0
18
300
290
70-
2
2
4
2
0
1
6
1
0
7
14
0
25
29
1
20
3
6
0
8
64
2
2
0
11
1
0
2
1
0
42
0
1
5
0
0
24
0
2
4
5
0
0
1
18
1
3
1
4
5
11
341
330
75+
0.10%
0.90%
0.70%
0.70%
0.10%
0.10%
4.90%
0.10%
0.20%
1.20%
2.10%
0.30%
6.00%
8.20%
0.20%
4.90%
0.80%
1.60%
0.70%
1.60%
16.20%
0.40%
1.60%
0.40%
2.70%
0.10%
0.00%
1.40%
0.70%
0.10%
5.70%
1.30%
0.10%
1.50%
0.10%
0.00%
4.00%
0.00%
0.50%
4.40%
2.20%
0.20%
0.90%
0.70%
6.40%
0.00%
1.30%
2.10%
4.10%
1.60%
3.90%
100.00%
97.30%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Other Female Genital
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
35
18
17
5
1
70
3
1
27
55
3
174
178
8
69
18
47
12
7
201
5
39
14
53
0
0
35
1432
3
10
282
195
47
336
2
6
25
1
0
20
1
10
128
169
4
9
14
158
0
35
42
103
39
68
4238
4185
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
3
0
0
0
0
0
0
0
0
0
6
0
0
0
0
1
8
0
1
0
0
2
0
0
10
6
12
0
51
51
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
0
0
0
0
2
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
12
0
0
0
0
2
0
0
4
1
3
1
29
29
5-
-9
-14
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
4
0
0
0
0
1
1
0
0
0
0
0
7
0
0
1
0
0
0
0
1
10
0
0
0
0
4
0
0
6
5
8
1
51
51
10-19
0
0
0
1
0
0
4
0
0
0
3
0
0
1
0
0
0
0
0
0
0
0
10
0
3
0
0
4
6
0
0
0
1
0
13
0
0
0
0
0
0
0
1
8
6
0
0
3
6
0
0
8
6
1
1
86
83
15-24
0
0
0
1
0
0
3
0
0
0
0
0
3
2
0
0
0
1
1
0
3
0
4
0
1
0
0
1
12
0
0
0
0
1
12
0
0
1
0
0
0
0
0
6
10
0
0
4
13
0
0
2
9
2
3
95
94
20-29
0
1
0
1
0
0
2
0
0
0
0
0
3
2
0
1
0
0
0
0
0
0
1
0
2
0
0
1
38
0
0
3
2
2
18
0
0
0
1
0
0
0
1
6
19
0
0
3
12
0
0
0
4
2
3
128
126
25-34
0
4
2
1
0
0
3
0
1
0
1
0
5
6
0
2
0
1
0
0
4
1
2
0
1
0
0
2
72
0
0
9
11
1
12
1
0
1
0
0
0
0
2
6
8
0
0
0
11
0
0
0
6
0
2
178
177
30-39
0
1
0
1
0
0
5
0
0
1
2
0
7
4
1
3
0
2
4
0
6
0
1
0
1
0
0
1
140
1
0
25
10
4
19
0
2
1
0
0
1
0
1
13
21
0
1
0
4
0
1
1
8
3
0
296
295
35-44
0
2
0
1
0
0
8
0
0
0
6
1
14
13
0
2
0
4
0
0
7
0
3
5
5
0
0
7
232
0
3
45
25
6
32
0
1
0
0
0
2
0
0
9
14
0
3
1
13
0
5
4
6
1
4
484
479
40-49
0
5
0
1
0
0
7
0
0
0
6
0
17
15
1
10
1
4
0
1
22
0
3
1
3
0
0
2
322
0
1
40
29
9
56
0
1
1
0
0
2
0
0
9
24
0
2
0
18
0
2
0
12
2
8
637
634
45-
-54
0
3
2
2
0
0
8
1
0
4
5
1
25
22
0
5
3
2
1
0
26
0
2
0
2
0
0
4
220
0
2
41
37
10
64
0
1
4
0
0
3
0
0
14
18
1
1
1
18
0
7
3
7
1
5
576
574
50-59
1
4
1
2
1
0
14
0
0
2
7
0
25
21
1
17
2
6
3
0
23
0
2
1
6
0
0
1
174
0
2
51
35
8
37
0
0
2
0
0
3
0
0
4
14
0
2
2
14
0
7
0
17
0
8
520
514
55-64
0
4
1
0
0
0
7
0
0
5
4
0
24
18
2
8
4
12
0
0
27
0
1
1
6
0
0
0
94
0
1
27
22
2
21
1
1
2
0
0
2
1
1
8
13
1
0
0
9
0
3
1
7
2
9
352
346
60-69
0
4
4
0
0
0
6
0
0
5
13
1
12
28
0
9
2
6
1
2
36
2
1
3
6
0
0
4
64
0
1
16
9
1
23
0
0
2
0
0
3
0
1
6
14
0
0
0
11
0
4
1
4
2
10
317
311
65-
Appendix 16: Number of new cancer cases, Malay Female, Malaysia 2007
-74
1
1
3
1
1
0
1
0
0
4
3
0
24
19
0
6
2
4
0
2
28
1
1
1
6
0
0
1
31
1
0
13
8
2
13
0
0
2
0
0
2
0
1
6
7
0
0
0
11
0
3
1
1
0
5
217
211
70-
1
6
5
5
3
1
2
2
0
6
5
0
14
27
3
6
4
5
2
2
19
0
0
2
11
0
0
1
26
1
0
12
6
1
8
0
0
2
0
0
2
0
0
3
1
1
0
0
10
0
3
1
4
0
8
221
210
75+
0.10%
0.80%
0.40%
0.40%
0.10%
0.00%
1.70%
0.10%
0.00%
0.60%
1.30%
0.10%
4.10%
4.20%
0.20%
1.60%
0.40%
1.10%
0.30%
0.20%
4.70%
0.10%
0.90%
0.30%
1.30%
0.00%
0.00%
0.80%
33.80%
0.10%
0.20%
6.70%
4.60%
1.10%
7.90%
0.00%
0.10%
0.60%
0.00%
0.00%
0.50%
0.00%
0.20%
3.00%
4.00%
0.10%
0.20%
0.30%
3.70%
0.00%
0.80%
1.00%
2.40%
0.90%
1.60%
100.00%
98.70%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
99
100
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
27
21
23
3
3
152
4
5
36
65
9
185
253
7
152
25
50
23
51
501
12
48
11
83
3
0
43
23
3
176
41
3
45
3
0
124
0
14
137
69
6
27
23
198
1
40
65
126
50
120
3093
3010
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
3
0
0
1
0
0
0
8
14
0
3
0
0
2
0
0
17
18
12
0
82
82
-4
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
0
0
0
0
0
0
1
0
0
0
0
0
0
1
13
0
0
1
0
4
0
0
8
8
11
1
53
51
5-
-9
-14
0
0
1
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
1
0
0
2
0
0
0
2
0
0
0
0
0
0
0
6
1
0
3
3
6
0
1
7
5
6
2
59
58
10-19
0
1
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
1
2
0
0
1
0
0
0
5
1
0
0
0
0
0
0
5
4
0
5
3
9
0
0
3
6
4
3
64
62
15-24
0
0
0
1
0
1
1
0
0
0
0
0
0
1
1
1
0
0
0
0
2
2
4
2
1
0
0
5
1
0
0
10
0
0
0
0
0
0
0
5
2
0
2
4
14
0
0
6
16
0
2
84
83
20-29
0
0
1
1
0
0
4
0
0
0
1
0
1
4
0
2
0
0
0
0
7
2
5
0
3
0
0
3
0
0
0
5
0
0
0
0
1
0
0
4
3
0
1
0
10
0
0
4
11
3
4
80
77
25-34
0
2
1
2
1
0
8
0
0
0
2
1
4
10
0
7
0
1
0
0
9
0
0
0
2
0
0
5
4
0
0
4
0
0
0
0
0
0
1
11
3
0
2
2
8
0
0
0
3
0
3
96
94
30-39
0
0
1
2
0
0
11
0
1
0
2
0
10
8
0
3
0
0
4
1
15
1
1
2
5
0
0
0
0
0
0
3
0
2
0
0
1
0
0
12
4
0
2
1
7
0
1
1
10
1
5
117
112
35-44
0
3
2
2
0
0
16
0
0
1
3
1
14
13
1
7
1
4
2
1
22
0
1
0
5
0
0
4
2
0
1
3
0
3
0
0
4
0
1
8
6
0
2
2
19
0
4
5
9
2
8
182
177
40-49
1
4
2
1
1
0
24
0
0
1
11
1
20
24
1
19
3
4
2
3
47
1
0
0
7
0
0
4
6
0
3
2
0
4
0
0
11
0
1
12
4
0
1
2
16
0
6
3
8
1
15
276
269
45-
-54
0
7
4
3
1
0
20
0
1
6
8
0
28
24
2
20
3
8
3
7
62
2
4
3
9
0
0
1
3
1
10
1
0
8
1
0
9
0
0
10
5
0
3
2
14
0
5
2
6
5
10
321
312
50-59
0
2
0
1
0
0
14
0
1
4
6
4
28
34
0
24
4
3
2
11
69
0
5
2
6
0
0
3
3
0
14
1
0
3
0
0
18
0
0
16
9
0
2
2
24
0
7
4
7
0
15
348
342
55-64
0
3
2
5
0
0
23
1
1
7
2
1
24
46
1
24
1
11
6
5
68
1
4
0
8
0
0
5
1
1
21
0
0
12
0
0
20
0
0
4
5
1
2
0
24
0
6
1
8
0
14
369
361
60-
-69
1
2
1
1
0
0
11
1
0
3
10
0
15
41
0
11
5
12
2
7
65
1
0
1
11
1
0
5
1
1
33
1
1
7
0
0
14
0
0
2
13
1
1
1
16
0
6
3
4
0
9
321
310
65-74
0
1
2
2
0
0
7
1
0
7
6
1
16
19
0
13
5
0
2
8
71
0
3
0
10
1
0
2
1
0
52
0
0
1
1
0
22
0
0
11
5
1
0
0
7
0
1
0
3
0
18
300
290
70-
2
2
4
2
0
1
6
1
0
7
14
0
25
29
1
20
3
6
0
8
64
2
2
0
11
1
0
2
1
0
42
0
1
5
0
0
24
0
2
4
5
0
0
1
18
1
3
1
4
5
11
341
330
75+
0.10%
0.90%
0.70%
0.70%
0.10%
0.10%
4.90%
0.10%
0.20%
1.20%
2.10%
0.30%
6.00%
8.20%
0.20%
4.90%
0.80%
1.60%
0.70%
1.60%
16.20%
0.40%
1.60%
0.40%
2.70%
0.10%
0.00%
1.40%
0.70%
0.10%
5.70%
1.30%
0.10%
1.50%
0.10%
0.00%
4.00%
0.00%
0.50%
4.40%
2.20%
0.20%
0.90%
0.70%
6.40%
0.00%
1.30%
2.10%
4.10%
1.60%
3.90%
100.00%
97.30%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Other Female Genital
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
35
18
17
5
1
70
3
1
27
55
3
174
178
8
69
18
47
12
7
201
5
39
14
53
0
0
35
1432
3
10
282
195
47
336
2
6
25
1
0
20
1
10
128
169
4
9
14
158
0
35
42
103
39
68
4238
4185
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.2
0
0
0
0
0.4
0
0
0
0
0
0
0
0
0
0.7
0
0
0
0
0.1
0.9
0
0.1
0
0
0.2
0
0
1.2
0.7
1.4
0
6
6
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.3
0
0
0
0
0.3
0
0
0
0
0
0
0.1
0
0
0
0
0
0
0
0
1.5
0
0
0
0
0.3
0
0
0.5
0.1
0.4
0.1
4
4
5-
-9
-14
0.1
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0.5
0
0
0
0
0.1
0.1
0
0
0
0
0
0.9
0
0
0.1
0
0
0
0
0.1
1.4
0
0
0
0
0.5
0
0
0.8
0.7
1.1
0.1
7
7
10-19
0
0
0
0.1
0
0
0.6
0
0
0
0.4
0
0
0.1
0
0
0
0
0
0
0
0
1.4
0
0.4
0
0
0.6
0.8
0
0
0
0.1
0
1.8
0
0
0
0
0
0
0
0.1
1.1
0.8
0
0
0.4
0.8
0
0
1.1
0.8
0.1
0.1
12
12
15-24
0
0
0
0.2
0
0
0.5
0
0
0
0
0
0.5
0.3
0
0
0
0.2
0.2
0
0.5
0
0.6
0
0.2
0
0
0.2
1.8
0
0
0
0
0.2
1.8
0
0
0.2
0
0
0
0
0
0.9
1.5
0
0
0.6
2
0
0
0.3
1.4
0.3
0.5
14
14
20-29
0
0.2
0
0.2
0
0
0.4
0
0
0
0
0
0.6
0.4
0
0.2
0
0
0
0
0
0
0.2
0
0.4
0
0
0.2
7
0
0
0.6
0.4
0.4
3.3
0
0
0
0.2
0
0
0
0.2
1.1
3.5
0
0
0.6
2.2
0
0
0
0.7
0.4
0.6
24
23
25-34
0
0.9
0.4
0.2
0
0
0.7
0
0.2
0
0.2
0
1.1
1.3
0
0.4
0
0.2
0
0
0.9
0.2
0.4
0
0.2
0
0
0.4
16.1
0
0
2
2.5
0.2
2.7
0.2
0
0.2
0
0
0
0
0.4
1.3
1.8
0
0
0
2.5
0
0
0
1.3
0
0.4
40
40
30-39
0
0.2
0
0.2
0
0
1.2
0
0
0.2
0.5
0
1.6
0.9
0.2
0.7
0
0.5
0.9
0
1.4
0
0.2
0
0.2
0
0
0.2
33
0.2
0
5.9
2.4
0.9
4.5
0
0.5
0.2
0
0
0.2
0
0.2
3.1
4.9
0
0.2
0
0.9
0
0.2
0.2
1.9
0.7
0
70
70
35-44
0
0.5
0
0.3
0
0
2
0
0
0
1.5
0.3
3.5
3.3
0
0.5
0
1
0
0
1.8
0
0.8
1.3
1.3
0
0
1.8
58.3
0
0.8
11.3
6.3
1.5
8
0
0.3
0
0
0
0.5
0
0
2.3
3.5
0
0.8
0.3
3.3
0
1.3
1
1.5
0.3
1
122
120
40-49
0
1.4
0
0.3
0
0
2
0
0
0
1.7
0
4.9
4.3
0.3
2.9
0.3
1.2
0
0.3
6.3
0
0.9
0.3
0.9
0
0
0.6
92.7
0
0.3
11.5
8.3
2.6
16.1
0
0.3
0.3
0
0
0.6
0
0
2.6
6.9
0
0.6
0
5.2
0
0.6
0
3.5
0.6
2.3
183
182
45-
-54
0
1
0.7
0.7
0
0
2.7
0.3
0
1.4
1.7
0.3
8.6
7.5
0
1.7
1
0.7
0.3
0
8.9
0
0.7
0
0.7
0
0
1.4
75.3
0
0.7
14
12.7
3.4
21.9
0
0.3
1.4
0
0
1
0
0
4.8
6.2
0.3
0.3
0.3
6.2
0
2.4
1
2.4
0.3
1.7
197
197
50-59
0.5
1.9
0.5
0.9
0.5
0
6.5
0
0
0.9
3.2
0
11.6
9.7
0.5
7.9
0.9
2.8
1.4
0
10.7
0
0.9
0.5
2.8
0
0
0.5
80.7
0
0.9
23.7
16.2
3.7
17.2
0
0
0.9
0
0
1.4
0
0
1.9
6.5
0
0.9
0.9
6.5
0
3.2
0
7.9
0
3.7
241
238
55-64
0
2.7
0.7
0
0
0
4.7
0
0
3.4
2.7
0
16.2
12.1
1.3
5.4
2.7
8.1
0
0
18.2
0
0.7
0.7
4
0
0
0
63.3
0
0.7
18.2
14.8
1.3
14.1
0.7
0.7
1.3
0
0
1.3
0.7
0.7
5.4
8.8
0.7
0
0
6.1
0
2
0.7
4.7
1.3
6.1
237
233
60-
-69
0
3.6
3.6
0
0
0
5.4
0
0
4.5
11.7
0.9
10.8
25.2
0
8.1
1.8
5.4
0.9
1.8
32.3
1.8
0.9
2.7
5.4
0
0
3.6
57.5
0
0.9
14.4
8.1
0.9
20.7
0
0
1.8
0
0
2.7
0
0.9
5.4
12.6
0
0
0
9.9
0
3.6
0.9
3.6
1.8
9
285
279
65-74
1.3
1.3
3.8
1.3
1.3
0
1.3
0
0
5.1
3.8
0
30.6
24.2
0
7.6
2.5
5.1
0
2.5
35.6
1.3
1.3
1.3
7.6
0
0
1.3
39.5
1.3
0
16.6
10.2
2.5
16.6
0
0
2.5
0
0
2.5
0
1.3
7.6
8.9
0
0
0
14
0
3.8
1.3
1.3
0
6.4
276
269
70-
1.2
7.1
5.9
5.9
3.5
1.2
2.4
2.4
0
7.1
5.9
0
16.5
31.9
3.5
7.1
4.7
5.9
2.4
2.4
22.4
0
0
2.4
13
0
0
1.2
30.7
1.2
0
14.2
7.1
1.2
9.5
0
0
2.4
0
0
2.4
0
0
3.5
1.2
1.2
0
0
11.8
0
3.5
1.2
4.7
0
9.5
261
248
75+
0.1
0.5
0.3
0.2
0.1
0
1
0
0
0.4
0.8
0
2.6
2.6
0.1
1
0.3
0.7
0.2
0.1
2.9
0.1
0.6
0.2
0.8
0
0
0.5
21
0
0.1
4.1
2.9
0.7
4.9
0
0.1
0.4
0
0
0.3
0
0.1
1.9
2.5
0.1
0.1
0.2
2.3
0
0.5
0.6
1.5
0.6
1
62.1
61.4
Total
% of
0.1
0.7
0.4
0.3
0.1
0
1.3
0.1
0
0.6
1.1
0.1
3.6
3.8
0.2
1.4
0.4
1
0.2
0.2
4.4
0.1
0.6
0.3
1.1
0
0
0.6
25.5
0.1
0.2
5.3
3.7
0.8
6
0
0.1
0.5
0
0
0.4
0
0.2
2.1
3
0.1
0.1
0.2
2.8
0
0.7
0.6
1.7
0.6
1.4
79
77.9
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
101
102
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
41
17
20
6
5
389
15
2
64
179
15
337
287
7
215
20
78
21
87
652
9
27
10
125
2
2
19
23
7
264
22
1
86
6
2
85
8
3
84
33
1
7
9
127
0
13
34
59
10
111
3650
3525
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
0
0
0
0
1
3
0
0
0
0
1
0
0
8
1
3
2
23
23
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
1
0
1
0
0
0
0
0
2
1
1
0
1
0
0
0
1
2
1
0
13
12
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
3
0
0
7
7
0
0
24
24
10-19
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
1
0
0
0
2
0
0
0
1
0
0
0
0
1
0
0
1
0
0
0
1
2
0
0
2
1
0
2
19
19
15-24
0
1
0
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
3
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
2
2
0
1
0
4
0
0
2
2
0
0
22
21
20-29
0
0
0
1
0
0
7
0
0
0
1
1
0
1
0
0
0
0
0
0
2
0
1
0
2
0
0
1
0
0
0
5
1
0
0
0
1
0
0
2
0
0
0
1
7
0
0
0
3
1
1
39
37
25-34
0
4
0
1
0
0
20
0
0
1
2
0
2
2
0
3
0
0
0
1
5
0
2
0
2
0
0
1
0
0
0
2
0
2
0
0
3
0
0
5
2
0
0
0
3
0
0
3
3
0
2
71
69
30-39
0
1
0
0
0
0
30
0
0
1
4
1
4
5
0
4
0
2
0
1
3
0
1
0
4
0
0
1
3
0
0
3
0
5
0
0
1
0
0
3
3
0
0
1
7
0
1
1
5
0
3
98
94
35-44
1
0
1
1
0
0
35
0
0
0
7
1
13
9
0
12
2
2
2
4
13
1
0
1
1
0
2
2
3
0
0
3
0
4
0
0
3
0
0
6
1
0
0
3
6
0
0
1
1
1
3
145
144
40-49
1
3
5
3
0
0
60
0
0
3
10
2
15
19
0
18
1
6
4
7
27
0
2
1
5
0
0
1
2
0
2
0
0
9
1
0
4
1
0
3
6
0
0
0
12
0
0
0
2
1
5
241
236
45-
-54
0
5
1
3
1
0
69
2
0
1
10
1
32
29
1
23
1
5
5
4
60
1
0
2
10
1
0
4
6
1
7
4
0
13
0
0
5
0
0
12
4
0
1
1
8
0
2
0
9
0
9
353
343
50-59
0
3
3
4
1
0
60
0
0
13
24
2
50
46
1
40
4
11
2
11
72
1
3
1
5
0
0
1
1
2
19
0
0
17
1
0
8
0
0
13
4
0
2
0
21
0
4
4
5
1
16
476
471
55-64
0
8
2
2
0
1
39
4
2
7
22
2
42
54
1
30
1
20
3
9
97
2
1
0
17
0
0
1
3
1
41
0
0
15
0
0
11
3
0
7
3
0
0
0
13
0
1
0
5
0
11
481
464
60-
-69
0
9
2
2
1
0
45
3
0
12
31
4
63
48
2
42
5
15
3
22
132
2
2
3
20
0
0
5
2
1
65
1
0
5
3
1
11
2
0
9
6
0
1
0
21
0
3
1
5
1
28
639
619
65-74
2
4
0
2
3
2
12
2
0
12
33
1
57
29
2
23
3
4
0
13
112
1
2
0
22
0
0
0
1
0
56
0
0
9
1
1
17
0
0
6
0
0
2
1
7
0
1
4
6
0
11
464
442
70-
0
3
3
1
0
2
9
4
0
14
35
0
59
44
0
19
3
13
2
15
127
1
3
1
35
1
0
0
2
2
74
0
0
4
0
0
20
2
2
7
1
0
0
0
12
0
1
0
2
1
18
542
507
75+
0.10%
1.10%
0.50%
0.50%
0.20%
0.10%
10.70%
0.40%
0.10%
1.80%
4.90%
0.40%
9.20%
7.90%
0.20%
5.90%
0.50%
2.10%
0.60%
2.40%
17.90%
0.20%
0.70%
0.30%
3.40%
0.10%
0.10%
0.50%
0.60%
0.20%
7.20%
0.60%
0.00%
2.40%
0.20%
0.10%
2.30%
0.20%
0.10%
2.30%
0.90%
0.00%
0.20%
0.20%
3.50%
0.00%
0.40%
0.90%
1.60%
0.30%
3.00%
100.00%
96.60%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Other Female Genital
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
2
15
15
12
5
2
123
3
0
18
138
9
322
182
6
69
21
65
13
6
273
10
23
11
79
0
0
22
1343
9
10
330
160
26
201
1
0
28
1
1
41
3
2
58
76
3
3
8
93
0
8
21
35
7
78
3990
3911
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
3
0
1
0
0
0
0
0
4
2
0
2
16
16
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
0
0
0
0
2
0
0
3
0
0
0
11
11
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
1
0
0
1
0
0
1
2
0
1
9
8
10-19
0
0
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
1
1
0
0
0
1
0
0
0
0
0
0
6
0
0
0
0
0
0
0
0
3
5
0
1
1
5
0
0
0
0
1
1
29
29
15-24
0
0
1
1
0
0
4
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
3
0
0
0
2
0
0
1
0
0
2
0
0
0
0
0
0
0
0
3
2
0
0
2
2
0
0
1
2
0
1
29
26
20-29
0
0
0
0
0
0
5
0
0
0
2
0
3
1
0
0
0
2
0
0
4
0
0
0
0
0
0
2
14
0
0
4
2
0
4
0
0
0
0
0
0
0
0
1
12
0
0
2
3
0
0
1
2
0
1
65
65
25-34
0
0
0
0
0
0
8
0
0
0
1
0
4
1
0
1
0
1
1
0
1
0
1
0
1
0
0
1
46
0
0
7
2
0
6
0
0
1
0
0
0
0
0
0
5
0
0
0
0
0
0
1
2
0
0
91
90
30-39
0
1
1
1
0
0
7
0
0
0
4
0
11
1
0
2
0
0
1
0
6
0
0
1
2
0
0
1
81
0
0
24
8
0
11
0
0
1
0
0
1
0
0
3
3
0
1
0
7
0
0
1
3
0
1
184
182
35-44
0
1
0
1
0
0
19
0
0
0
5
0
12
9
0
2
1
1
1
0
13
0
1
1
1
0
0
2
137
0
0
29
8
1
22
0
0
1
0
0
2
0
0
5
9
0
0
1
4
0
0
1
2
3
6
301
300
40-49
0
0
0
1
0
0
15
0
0
1
8
1
18
14
0
6
0
4
2
2
21
1
4
0
5
0
0
2
245
2
0
51
21
8
36
1
0
2
0
0
1
0
0
3
8
0
0
0
3
0
0
4
1
0
5
496
491
45-
-54
1
4
2
1
2
0
21
1
0
2
7
3
20
15
1
2
1
8
2
1
25
2
2
0
4
0
0
0
230
0
1
34
25
8
35
0
0
1
0
0
2
1
0
6
6
1
0
0
10
0
1
0
6
0
8
502
498
50-59
0
2
1
3
1
0
17
0
0
3
11
2
44
17
1
7
3
9
1
0
27
3
3
3
5
0
0
5
215
0
1
45
35
2
21
0
0
4
0
0
3
0
0
5
12
0
0
0
5
0
2
0
4
1
15
538
533
55-64
0
0
1
0
1
0
10
2
0
2
17
0
27
21
0
14
5
11
1
0
44
2
1
1
6
0
0
3
133
1
0
36
19
4
20
0
0
4
0
0
5
2
0
8
3
0
1
0
12
0
2
3
3
0
9
434
428
60-
-69
0
1
1
0
1
0
8
0
0
2
17
0
56
29
1
7
2
13
2
1
40
0
3
1
13
0
0
3
115
1
2
38
16
0
19
0
0
2
0
1
8
0
1
7
5
0
0
1
12
0
1
0
2
1
7
440
427
65-74
0
3
2
3
0
2
4
0
0
0
26
0
50
35
1
9
4
7
1
2
41
0
1
2
11
0
0
2
60
1
3
31
9
0
11
0
0
6
0
0
7
0
0
3
3
0
0
0
11
0
2
1
3
1
6
364
353
70-
1
3
6
1
0
0
4
0
0
8
39
2
77
39
2
16
5
8
1
0
51
2
5
1
27
0
0
0
65
4
3
30
15
3
7
0
0
6
1
0
12
0
0
1
3
0
0
1
16
0
0
0
1
0
15
481
454
75+
0.10%
0.40%
0.40%
0.30%
0.10%
0.10%
3.10%
0.10%
0.00%
0.50%
3.50%
0.20%
8.10%
4.60%
0.20%
1.70%
0.50%
1.60%
0.30%
0.20%
6.80%
0.30%
0.60%
0.30%
2.00%
0.00%
0.00%
0.60%
33.70%
0.20%
0.30%
8.30%
4.00%
0.70%
5.00%
0.00%
0.00%
0.70%
0.00%
0.00%
1.00%
0.10%
0.10%
1.50%
1.90%
0.10%
0.10%
0.20%
2.30%
0.00%
0.20%
0.50%
0.90%
0.20%
2.00%
100.00%
98.00%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
103
104
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
41
17
20
6
5
389
15
2
64
179
15
337
287
7
215
20
78
21
87
652
9
27
10
125
2
2
19
23
7
264
22
1
86
6
2
85
8
3
84
33
1
7
9
127
0
13
34
59
10
111
3650
3525
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0.7
0
0
0
0
0.4
1.1
0
0
0
0
0.4
0
0
3
0.4
1.1
0.7
8
8
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0.4
0
0
0
0
0
0
0.4
0
0.4
0
0
0
0
0
0.7
0.4
0.4
0
0.4
0
0
0
0.4
0.7
0.4
0
5
4
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
1.1
0
0
2.6
2.6
0
0
9
9
10-19
0
0
0
0
0
0
0.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0.7
0.4
0
0
0
0.7
0
0
0
0.4
0
0
0
0
0.4
0
0
0.4
0
0
0
0.4
0.7
0
0
0.7
0.4
0
0.7
7
7
15-24
0
0.4
0
0
0
0
0.4
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0.4
0
1.1
0
0.4
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0
0.8
0.8
0
0.4
0
1.5
0
0
0.8
0.8
0
0
8
8
20-29
0
0
0
0.4
0
0
2.9
0
0
0
0.4
0.4
0
0.4
0
0
0
0
0
0
0.8
0
0.4
0
0.8
0
0
0.4
0
0
0
2
0.4
0
0
0
0.4
0
0
0.8
0
0
0
0.4
2.9
0
0
0
1.2
0.4
0.4
16
15
25-34
0
1.7
0
0.4
0
0
8.6
0
0
0.4
0.9
0
0.9
0.9
0
1.3
0
0
0
0.4
2.2
0
0.9
0
0.9
0
0
0.4
0
0
0
0.9
0
0.9
0
0
1.3
0
0
2.2
0.9
0
0
0
1.3
0
0
1.3
1.3
0
0.9
31
30
30-39
0
0.4
0
0
0
0
13
0
0
0.4
1.7
0.4
1.7
2.2
0
1.7
0
0.9
0
0.4
1.3
0
0.4
0
1.7
0
0
0.4
1.3
0
0
1.3
0
2.2
0
0
0.4
0
0
1.3
1.3
0
0
0.4
3
0
0.4
0.4
2.2
0
1.3
42
41
35-44
0.4
0
0.4
0.4
0
0
15.4
0
0
0
3.1
0.4
5.7
4
0
5.3
0.9
0.9
0.9
1.8
5.7
0.4
0
0.4
0.4
0
0.9
0.9
1.3
0
0
1.3
0
1.8
0
0
1.3
0
0
2.6
0.4
0
0
1.3
2.6
0
0
0.4
0.4
0.4
1.3
64
63
40-49
0.5
1.4
2.3
1.4
0
0
27.3
0
0
1.4
4.5
0.9
6.8
8.6
0
8.2
0.5
2.7
1.8
3.2
12.3
0
0.9
0.5
2.3
0
0
0.5
0.9
0
0.9
0
0
4.1
0.5
0
1.8
0.5
0
1.4
2.7
0
0
0
5.5
0
0
0
0.9
0.5
2.3
110
107
45-
-54
0
2.5
0.5
1.5
0.5
0
34.1
1
0
0.5
4.9
0.5
15.8
14.3
0.5
11.4
0.5
2.5
2.5
2
29.6
0.5
0
1
4.9
0.5
0
2
3
0.5
3.5
2
0
6.4
0
0
2.5
0
0
5.9
2
0
0.5
0.5
4
0
1
0
4.4
0
4.4
174
169
50-59
0
1.8
1.8
2.4
0.6
0
36.7
0
0
8
14.7
1.2
30.6
28.2
0.6
24.5
2.4
6.7
1.2
6.7
44.1
0.6
1.8
0.6
3.1
0
0
0.6
0.6
1.2
11.6
0
0
10.4
0.6
0
4.9
0
0
8
2.4
0
1.2
0
12.9
0
2.4
2.4
3.1
0.6
9.8
291
288
55-64
0
6.5
1.6
1.6
0
0.8
31.7
3.3
1.6
5.7
17.9
1.6
34.2
43.9
0.8
24.4
0.8
16.3
2.4
7.3
78.9
1.6
0.8
0
13.8
0
0
0.8
2.4
0.8
33.4
0
0
12.2
0
0
8.9
2.4
0
5.7
2.4
0
0
0
10.6
0
0.8
0
4.1
0
8.9
391
377
60-
-69
0
10.2
2.3
2.3
1.1
0
50.8
3.4
0
13.5
35
4.5
71.1
54.2
2.3
47.4
5.6
16.9
3.4
24.8
148.9
2.3
2.3
3.4
22.6
0
0
5.6
2.3
1.1
73.3
1.1
0
5.6
3.4
1.1
12.4
2.3
0
10.2
6.8
0
1.1
0
23.7
0
3.4
1.1
5.6
1.1
31.6
721
698
65-74
3.5
6.9
0
3.5
5.2
3.5
20.8
3.5
0
20.8
57.3
1.7
99
50.4
3.5
40
5.2
6.9
0
22.6
194.6
1.7
3.5
0
38.2
0
0
0
1.7
0
97.3
0
0
15.6
1.7
1.7
29.5
0
0
10.4
0
0
3.5
1.7
12.2
0
1.7
6.9
10.4
0
19.1
806
768
70-
0
5.1
5.1
1.7
0
3.4
15.4
6.8
0
23.9
59.8
0
100.8
75.1
0
32.4
5.1
22.2
3.4
25.6
216.9
1.7
5.1
1.7
59.8
1.7
0
0
3.4
3.4
126.4
0
0
6.8
0
0
34.2
3.4
3.4
12
1.7
0
0
0
20.5
0
1.7
0
3.4
1.7
30.7
926
866
75+
0.1
1.3
0.5
0.6
0.2
0.2
12.1
0.5
0.1
2
5.6
0.5
10.5
8.9
0.2
6.7
0.6
2.4
0.7
2.7
20.3
0.3
0.8
0.3
3.9
0.1
0.1
0.6
0.7
0.2
8.2
0.7
0
2.7
0.2
0.1
2.7
0.2
0.1
2.6
1
0
0.2
0.3
4
0
0.4
1.1
1.8
0.3
3.5
113.8
109.9
Total
% of
0.1
1.2
0.5
0.6
0.2
0.2
10.9
0.5
0.1
2
5.6
0.4
10.4
8.7
0.2
6.4
0.6
2.4
0.6
2.7
20.5
0.3
0.8
0.3
4
0.1
0.1
0.6
0.7
0.2
8.7
0.6
0
2.5
0.2
0.1
2.7
0.3
0.1
2.5
0.9
0
0.2
0.3
3.8
0
0.4
1.1
1.8
0.3
3.5
111.9
107.9
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Other Female Genital
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
2
15
15
12
5
2
123
3
0
18
138
9
322
182
6
69
21
65
13
6
273
10
23
11
79
0
0
22
1343
9
10
330
160
26
201
1
0
28
1
1
41
3
2
58
76
3
3
8
93
0
8
21
35
7
78
3990
3911
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0
0.4
1.2
0
0.4
0
0
0
0
0
1.6
0.8
0
0.8
6
6
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.9
0
0
0
0
0.8
0
0
1.1
0
0
0
4
4
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.8
0
0.4
0
0
0.4
0
0
0.4
0.8
0
0.4
4
3
10-19
0
0
0
0
0
0
0.4
0
0
0
0.4
0
0
0
0
0
0
0.4
0
0
0
0
0.4
0.4
0
0
0
0.4
0
0
0
0
0
0
2.4
0
0
0
0
0
0
0
0
1.2
2
0
0.4
0.4
2
0
0
0
0
0.4
0.4
12
12
15-24
0
0
0.4
0.4
0
0
1.6
0
0
0
0
0.4
0
0
0
0.4
0
0
0
0
0
0
0
0
1.2
0
0
0
0.8
0
0
0.4
0
0
0.8
0
0
0
0
0
0
0
0
1.2
0.8
0
0
0.8
0.8
0
0
0.4
0.8
0
0.4
12
10
20-29
0
0
0
0
0
0
2.1
0
0
0
0.9
0
1.3
0.4
0
0
0
0.9
0
0
1.7
0
0
0
0
0
0
0.9
6
0
0
1.7
0.9
0
1.7
0
0
0
0
0
0
0
0
0.4
5.1
0
0
0.9
1.3
0
0
0.4
0.9
0
0.4
28
28
25-34
0
0
0
0
0
0
3.6
0
0
0
0.4
0
1.8
0.4
0
0.4
0
0.4
0.4
0
0.4
0
0.4
0
0.4
0
0
0.4
20.5
0
0
3.1
0.9
0
2.7
0
0
0.4
0
0
0
0
0
0
2.2
0
0
0
0
0
0
0.4
0.9
0
0
41
40
30-39
0
0.4
0.4
0.4
0
0
3.1
0
0
0
1.8
0
4.9
0.4
0
0.9
0
0
0.4
0
2.7
0
0
0.4
0.9
0
0
0.4
35.8
0
0
10.6
3.5
0
4.9
0
0
0.4
0
0
0.4
0
0
1.3
1.3
0
0.4
0
3.1
0
0
0.4
1.3
0
0.4
81
80
35-44
0
0.4
0
0.4
0
0
8.5
0
0
0
2.2
0
5.4
4
0
0.9
0.4
0.4
0.4
0
5.8
0
0.4
0.4
0.4
0
0
0.9
61.4
0
0
13
3.6
0.4
9.9
0
0
0.4
0
0
0.9
0
0
2.2
4
0
0
0.4
1.8
0
0
0.4
0.9
1.3
2.7
135
134
40-49
0
0
0
0.5
0
0
7.1
0
0
0.5
3.8
0.5
8.5
6.6
0
2.8
0
1.9
0.9
0.9
9.9
0.5
1.9
0
2.4
0
0
0.9
115.9
0.9
0
24.1
9.9
3.8
17
0.5
0
0.9
0
0
0.5
0
0
1.4
3.8
0
0
0
1.4
0
0
1.9
0.5
0
2.4
235
232
45-
-54
0.5
2.1
1
0.5
1
0
11
0.5
0
1
3.7
1.6
10.4
7.8
0.5
1
0.5
4.2
1
0.5
13.1
1
1
0
2.1
0
0
0
120.1
0
0.5
17.7
13.1
4.2
18.3
0
0
0.5
0
0
1
0.5
0
3.1
3.1
0.5
0
0
5.2
0
0.5
0
3.1
0
4.2
262
260
50-59
0
1.3
0.7
2
0.7
0
11.2
0
0
2
7.2
1.3
28.9
11.2
0.7
4.6
2
5.9
0.7
0
17.7
2
2
2
3.3
0
0
3.3
141.2
0
0.7
29.5
23
1.3
13.8
0
0
2.6
0
0
2
0
0
3.3
7.9
0
0
0
3.3
0
1.3
0
2.6
0.7
9.8
353
350
55-64
0
0
0.9
0
0.9
0
8.7
1.7
0
1.7
14.9
0
23.6
18.4
0
12.2
4.4
9.6
0.9
0
38.5
1.7
0.9
0.9
5.2
0
0
2.6
116.2
0.9
0
31.5
16.6
3.5
17.5
0
0
3.5
0
0
4.4
1.7
0
7
2.6
0
0.9
0
10.5
0
1.7
2.6
2.6
0
7.9
379
374
60-
-69
0
1.1
1.1
0
1.1
0
9
0
0
2.2
19.1
0
63
32.6
1.1
7.9
2.2
14.6
2.2
1.1
45
0
3.4
1.1
14.6
0
0
3.4
129.3
1.1
2.2
42.7
18
0
21.4
0
0
2.2
0
1.1
9
0
1.1
7.9
5.6
0
0
1.1
13.5
0
1.1
0
2.2
1.1
7.9
495
480
65-74
0
4.6
3.1
4.6
0
3.1
6.1
0
0
0
40
0
76.9
53.8
1.5
13.8
6.1
10.8
1.5
3.1
63
0
1.5
3.1
16.9
0
0
3.1
92.2
1.5
4.6
47.7
13.8
0
16.9
0
0
9.2
0
0
10.8
0
0
4.6
4.6
0
0
0
16.9
0
3.1
1.5
4.6
1.5
9.2
560
543
70-
1.2
3.5
7.1
1.2
0
0
4.7
0
0
9.4
45.9
2.4
90.7
45.9
2.4
18.8
5.9
9.4
1.2
0
60
2.4
5.9
1.2
31.8
0
0
0
76.5
4.7
3.5
35.3
17.7
3.5
8.2
0
0
7.1
1.2
0
14.1
0
0
1.2
3.5
0
0
1.2
18.8
0
0
0
1.2
0
17.7
566
534
75+
0.1
0.5
0.5
0.4
0.2
0.1
4
0.1
0
0.6
4.5
0.3
10.5
5.9
0.2
2.2
0.7
2.1
0.4
0.2
8.9
0.3
0.7
0.4
2.6
0
0
0.7
43.7
0.3
0.3
10.7
5.2
0.8
6.5
0
0
0.9
0
0
1.3
0.1
0.1
1.9
2.5
0.1
0.1
0.3
3
0
0.3
0.7
1.1
0.2
2.5
129.7
127.1
Total
% of
0
0.4
0.4
0.3
0.1
0.1
3.5
0.1
0
0.5
4
0.2
9.2
5.3
0.2
2
0.6
1.9
0.4
0.2
8
0.3
0.7
0.3
2.2
0
0
0.7
38.1
0.3
0.3
9.5
4.6
0.7
5.8
0
0
0.8
0
0
1.2
0.1
0.1
1.9
2.2
0.1
0.1
0.3
2.8
0
0.2
0.7
1.1
0.2
2.3
115
112.7
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
105
106
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
0
15
21
3
9
12
9
8
2
17
30
1
30
34
1
15
2
6
3
16
46
1
10
2
7
0
0
0
1
4
31
5
0
5
0
0
21
0
0
22
7
0
2
1
24
0
0
9
16
4
10
462
455
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
1
0
5
5
-4
5-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
1
0
0
0
3
3
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
3
3
10-19
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
3
0
0
1
0
0
1
9
9
15-24
0
1
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
1
2
0
0
11
11
20-29
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
1
0
0
0
1
0
0
0
1
0
1
9
9
25-34
0
0
0
0
0
0
1
0
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
7
6
30-39
0
2
0
1
0
0
2
0
0
0
0
0
0
1
0
0
0
0
1
0
1
0
0
1
0
0
0
0
0
1
0
0
0
0
0
0
1
0
0
5
0
0
0
0
4
0
0
0
1
0
0
21
21
35-44
0
0
0
0
0
2
0
0
0
0
0
0
0
3
0
0
0
0
0
0
1
0
2
0
2
0
0
0
0
0
1
1
0
1
0
0
0
0
0
3
0
0
1
0
0
0
0
0
2
0
0
19
17
40-49
0
2
4
0
3
0
0
2
0
3
2
0
4
1
0
3
0
1
0
0
4
1
2
0
0
0
0
0
1
0
1
0
0
0
0
0
2
0
0
3
2
0
1
0
1
0
0
1
1
1
0
46
46
45-
-54
0
2
1
1
1
1
1
0
0
0
3
0
4
4
0
0
1
2
0
4
3
0
0
0
2
0
0
0
0
0
2
0
0
2
0
0
4
0
0
2
0
0
0
1
0
0
0
1
3
0
0
45
43
50-59
0
2
2
0
0
3
1
2
0
3
6
0
3
6
0
4
0
0
2
2
10
0
1
0
1
0
0
0
0
1
1
0
0
0
0
0
0
0
0
1
2
0
0
0
3
0
0
1
1
0
3
61
60
55-64
0
3
0
1
2
2
2
1
0
3
4
0
3
2
0
2
1
2
0
3
9
0
1
0
0
0
0
0
0
0
4
0
0
1
0
0
1
0
0
1
0
0
0
0
3
0
0
0
2
2
2
57
57
60-
Appendix 23: Number of new cancer cases, Indian Male, Malaysia 2007
-69
0
0
7
0
0
1
1
0
1
5
6
0
5
6
0
0
0
0
0
2
8
0
0
0
0
0
0
0
0
1
2
0
0
1
0
0
6
0
0
0
1
0
0
0
4
0
0
0
0
0
1
58
58
65-74
0
1
2
0
1
3
0
2
1
2
4
0
5
3
1
1
0
1
0
2
3
0
0
1
1
0
0
0
0
0
6
1
0
0
0
0
3
0
0
3
1
0
0
0
0
0
0
0
0
0
0
48
47
70-
0
2
5
0
2
0
0
0
0
1
4
0
4
7
0
3
0
0
0
3
7
0
0
0
0
0
0
0
0
1
14
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
1
0
2
60
60
75+
0.00%
3.20%
4.50%
0.60%
1.90%
2.60%
1.90%
1.70%
0.40%
3.70%
6.50%
0.20%
6.50%
7.40%
0.20%
3.20%
0.40%
1.30%
0.60%
3.50%
10.00%
0.20%
2.20%
0.40%
1.50%
0.00%
0.00%
0.00%
0.20%
0.90%
6.70%
1.10%
0.00%
1.10%
0.00%
0.00%
4.50%
0.00%
0.00%
4.80%
1.50%
0.00%
0.40%
0.20%
5.20%
0.00%
0.00%
1.90%
3.50%
0.90%
2.20%
100.00%
98.50%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Other Female Genital
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
1
20
49
1
4
2
6
3
2
28
26
0
22
26
5
7
5
8
3
5
15
2
4
1
5
0
0
4
297
3
6
85
34
2
48
0
0
2
0
0
4
0
1
13
11
0
4
3
10
0
2
6
17
5
18
825
820
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
2
0
3
3
-4
5-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
2
1
1
2
7
7
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
4
4
10-19
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
3
3
15-24
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
0
1
0
0
4
0
0
0
0
0
0
0
0
1
0
0
0
1
2
0
0
0
0
0
1
13
13
20-29
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
1
0
1
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
0
1
1
0
1
11
11
25-34
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
10
0
0
3
1
0
1
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
1
3
1
1
26
26
30-39
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
15
0
1
3
4
0
3
0
0
0
0
0
0
0
0
0
2
0
0
1
0
0
0
0
0
0
0
32
32
35-44
0
2
1
0
1
0
0
0
0
4
2
0
0
3
0
0
0
0
0
0
1
0
2
0
0
0
0
0
34
0
0
6
3
0
9
0
0
0
0
0
0
0
0
2
2
0
0
0
0
0
0
0
1
0
3
76
76
40-49
0
0
0
0
0
0
0
2
1
0
2
0
0
1
1
1
0
1
0
0
1
0
1
0
0
0
0
1
54
0
1
14
4
0
6
0
0
0
0
0
0
0
0
1
2
0
0
0
0
0
0
0
1
0
0
95
95
45-
-54
0
4
3
0
0
0
0
0
0
3
4
0
3
5
0
0
0
3
0
0
3
0
0
0
1
0
0
0
55
1
0
13
2
0
10
0
0
0
0
0
0
0
0
1
3
0
2
0
0
0
1
1
3
0
3
124
123
50-59
0
4
4
1
2
0
1
0
0
7
2
0
5
5
3
2
1
1
0
2
2
0
0
0
0
0
0
0
45
1
1
13
7
1
3
0
0
2
0
0
0
0
1
0
0
0
1
0
1
0
1
1
4
0
0
124
124
55-64
0
6
10
0
1
1
2
0
1
4
0
0
4
3
0
0
2
1
0
0
3
0
0
0
0
0
0
1
36
0
0
12
5
0
4
0
0
0
0
0
1
0
0
1
1
0
1
0
0
0
0
0
1
0
0
101
101
60-69
0
1
10
0
0
1
1
0
0
4
6
0
4
3
0
2
0
0
0
0
3
0
0
0
1
0
0
1
14
0
2
7
2
0
4
0
0
0
0
0
0
0
0
1
0
0
0
0
5
0
0
0
0
0
6
78
77
65-
Appendix 24: Number of new cancer cases, Indian Female, Malaysia 2007
-74
0
1
10
0
0
0
1
1
0
3
3
0
2
2
0
0
2
1
2
2
1
0
0
0
0
0
0
0
15
0
0
5
2
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
1
56
56
70-
1
2
10
0
0
0
0
0
0
3
5
0
3
4
1
1
0
1
0
1
1
1
0
1
3
0
0
0
15
1
1
8
3
1
2
0
0
0
0
0
2
0
0
0
1
0
0
0
0
0
0
0
0
0
0
72
69
75+
0.10%
2.40%
5.90%
0.10%
0.50%
0.20%
0.70%
0.40%
0.20%
3.40%
3.20%
0.00%
2.70%
3.20%
0.60%
0.80%
0.60%
1.00%
0.40%
0.60%
1.80%
0.20%
0.50%
0.10%
0.60%
0.00%
0.00%
0.50%
36.00%
0.40%
0.70%
10.30%
4.10%
0.20%
5.80%
0.00%
0.00%
0.20%
0.00%
0.00%
0.50%
0.00%
0.10%
1.60%
1.30%
0.00%
0.50%
0.40%
1.20%
0.00%
0.20%
0.70%
2.10%
0.60%
2.20%
100.00%
99.40%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
107
108
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
0
15
21
3
9
12
9
8
2
17
30
1
30
34
1
15
2
6
3
16
46
1
10
2
7
0
0
0
1
4
31
5
0
5
0
0
21
0
0
22
7
0
2
1
24
0
0
9
16
4
10
462
455
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3.3
0
1.1
0
5
5
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
1.1
0
0
1.1
0
0
0
3
3
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2.2
0
0
3
3
10-19
0
0
0
0
0
0
0
1.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
3.4
0
0
1.1
0
0
1.1
10
10
15-24
0
1.2
0
0
0
0
0
0
0
0
0
1.2
1.2
0
0
0
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
2.3
0
0
0
0
0
0
0
1.2
0
0
0
0
1.2
0
0
1.2
2.3
0
0
13
13
20-29
0
0
0
0
0
0
1.3
0
0
0
0
0
1.3
0
0
1.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.3
0
0
0
0
0
0
0
1.3
1.3
0
0
0
1.3
0
0
0
1.3
0
1.3
11
11
25-34
0
0
0
0
0
0
1.4
0
0
0
1.4
0
0
1.4
0
0
0
0
0
0
0
0
0
0
1.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4.2
0
0
0
0
0
0
10
8
30-39
0
2.9
0
1.4
0
0
2.9
0
0
0
0
0
0
1.4
0
0
0
0
1.4
0
1.4
0
0
1.4
0
0
0
0
0
1.4
0
0
0
0
0
0
1.4
0
0
7.2
0
0
0
0
5.8
0
0
0
1.4
0
0
30
30
35-44
0
0
0
0
0
3.1
0
0
0
0
0
0
0
4.6
0
0
0
0
0
0
1.5
0
3.1
0
3.1
0
0
0
0
0
1.5
1.5
0
1.5
0
0
0
0
0
4.6
0
0
1.5
0
0
0
0
0
3.1
0
0
29
26
40-49
0
3.3
6.7
0
5
0
0
3.3
0
5
3.3
0
6.7
1.7
0
5
0
1.7
0
0
6.7
1.7
3.3
0
0
0
0
0
1.7
0
1.7
0
0
0
0
0
3.3
0
0
5
3.3
0
1.7
0
1.7
0
0
1.7
1.7
1.7
0
77
77
45-
-54
0
3.8
1.9
1.9
1.9
1.9
1.9
0
0
0
5.8
0
7.7
7.7
0
0
1.9
3.8
0
7.7
5.8
0
0
0
3.8
0
0
0
0
0
3.8
0
0
3.8
0
0
7.7
0
0
3.8
0
0
0
1.9
0
0
0
1.9
5.8
0
0
87
83
50-59
0
5.5
5.5
0
0
8.2
2.7
5.5
0
8.2
16.5
0
8.2
16.5
0
11
0
0
5.5
5.5
27.5
0
2.7
0
2.7
0
0
0
0
2.7
2.7
0
0
0
0
0
0
0
0
2.7
5.5
0
0
0
8.2
0
0
2.7
2.7
0
8.2
168
165
55-64
0
13.2
0
4.4
8.8
8.8
8.8
4.4
0
13.2
17.6
0
13.2
8.8
0
8.8
4.4
8.8
0
13.2
39.7
0
4.4
0
0
0
0
0
0
0
17.6
0
0
4.4
0
0
4.4
0
0
4.4
0
0
0
0
13.2
0
0
0
8.8
8.8
8.8
251
251
60-
-69
0
0
46.1
0
0
6.6
6.6
0
6.6
32.9
39.5
0
32.9
39.5
0
0
0
0
0
13.2
52.7
0
0
0
0
0
0
0
0
6.6
13.2
0
0
6.6
0
0
39.5
0
0
0
6.6
0
0
0
26.3
0
0
0
0
0
6.6
382
382
65-74
0
10.6
21.3
0
10.6
31.9
0
21.3
10.6
21.3
42.6
0
53.2
31.9
10.6
10.6
0
10.6
0
21.3
31.9
0
0
10.6
10.6
0
0
0
0
0
63.9
10.6
0
0
0
0
31.9
0
0
31.9
10.6
0
0
0
0
0
0
0
0
0
0
511
500
70-
0
20.8
52.1
0
20.8
0
0
0
0
10.4
41.7
0
41.7
73
0
31.3
0
0
0
31.3
73
0
0
0
0
0
0
0
0
10.4
145.9
0
0
0
0
0
41.7
0
0
0
0
0
0
0
0
0
0
0
10.4
0
20.8
625
625
75+
0
1.6
2.2
0.3
1
1.3
1
0.9
0.2
1.8
3.2
0.1
3.2
3.6
0.1
1.6
0.2
0.6
0.3
1.7
4.9
0.1
1.1
0.2
0.7
0
0
0
0.1
0.4
3.3
0.5
0
0.5
0
0
2.2
0
0
2.3
0.7
0
0.2
0.1
2.6
0
0
1
1.7
0.4
1.1
49.2
48.4
Total
% of
0
2
3.6
0.4
1.4
1.8
1.1
1.1
0.4
2.8
4.8
0.1
4.7
5.2
0.2
2.2
0.3
0.9
0.3
2.6
7.2
0.1
1.1
0.3
0.8
0
0
0
0.1
0.6
5.8
0.6
0
0.7
0
0
3.5
0
0
2.5
0.9
0
0.2
0.1
3
0
0
1
1.8
0.6
1.5
68.2
67.4
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Trachea, Bronchus, Lung
Other Thoracic organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Other Female Genital
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary organs
Eye
Brain, Nervous system
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Immunoproliferative dis.
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
1
20
49
1
4
2
6
3
2
28
26
0
22
26
5
7
5
8
3
5
15
2
4
1
5
0
0
4
297
3
6
85
34
2
48
0
0
2
0
0
4
0
1
13
11
0
4
3
10
0
2
6
17
5
18
825
820
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
0
0
0
0
0
2.3
0
3
3
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
0
0
0
2.2
1.1
1.1
2.2
8
8
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
0
0
0
0
0
1.2
0
0
0
1.2
0
0
5
5
10-19
0
0
0
0
0
0
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.2
1.2
0
4
4
15-24
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
0
1.2
0
0
1.2
0
0
4.8
0
0
0
0
0
0
0
0
1.2
0
0
0
1.2
2.4
0
0
0
0
0
1.2
16
16
20-29
0
0
0
0
0
0
0
0
0
0
1.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3.8
0
0
0
1.3
0
1.3
0
0
0
0
0
0
0
0
1.3
0
0
0
1.3
0
0
0
1.3
1.3
0
1.3
14
14
25-34
0
0
0
0
0
0
0
0
0
0
1.4
0
0
0
0
0
0
0
0
0
0
1.4
0
0
0
0
0
0
13.5
0
0
4.1
1.4
0
1.4
0
0
0
0
0
0
0
0
4.1
0
0
0
0
0
0
0
1.4
4.1
1.4
1.4
35
35
30-39
0
0
1.4
0
0
0
0
0
0
0
0
0
0
0
0
1.4
0
0
0
0
0
0
0
0
0
0
0
1.4
21.1
0
1.4
4.2
5.6
0
4.2
0
0
0
0
0
0
0
0
0
2.8
0
0
1.4
0
0
0
0
0
0
0
45
45
35-44
0
3
1.5
0
1.5
0
0
0
0
6
3
0
0
4.5
0
0
0
0
0
0
1.5
0
3
0
0
0
0
0
50.9
0
0
9
4.5
0
13.5
0
0
0
0
0
0
0
0
3
3
0
0
0
0
0
0
0
1.5
0
4.5
114
114
40-49
0
0
0
0
0
0
0
3.2
1.6
0
3.2
0
0
1.6
1.6
1.6
0
1.6
0
0
1.6
0
1.6
0
0
0
0
1.6
87.4
0
1.6
22.7
6.5
0
9.7
0
0
0
0
0
0
0
0
1.6
3.2
0
0
0
0
0
0
0
1.6
0
0
154
154
45-
-54
0
7.4
5.6
0
0
0
0
0
0
5.6
7.4
0
5.6
9.3
0
0
0
5.6
0
0
5.6
0
0
0
1.9
0
0
0
101.9
1.9
0
24.1
3.7
0
18.5
0
0
0
0
0
0
0
0
1.9
5.6
0
3.7
0
0
0
1.9
1.9
5.6
0
5.6
230
228
50-59
0
10.5
10.5
2.6
5.3
0
2.6
0
0
18.4
5.3
0
13.2
13.2
7.9
5.3
2.6
2.6
0
5.3
5.3
0
0
0
0
0
0
0
118.5
2.6
2.6
34.2
18.4
2.6
7.9
0
0
5.3
0
0
0
0
2.6
0
0
0
2.6
0
2.6
0
2.6
2.6
10.5
0
0
327
327
55-64
0
24.9
41.5
0
4.2
4.2
8.3
0
4.2
16.6
0
0
16.6
12.5
0
0
8.3
4.2
0
0
12.5
0
0
0
0
0
0
4.2
149.5
0
0
49.8
20.8
0
16.6
0
0
0
0
0
4.2
0
0
4.2
4.2
0
4.2
0
0
0
0
0
4.2
0
0
419
419
60-
-69
0
5.5
55.3
0
0
5.5
5.5
0
0
22.1
33.2
0
22.1
16.6
0
11.1
0
0
0
0
16.6
0
0
0
5.5
0
0
5.5
77.4
0
11.1
38.7
11.1
0
22.1
0
0
0
0
0
0
0
0
5.5
0
0
0
0
27.6
0
0
0
0
0
33.2
431
426
65-74
0
7.6
76.4
0
0
0
7.6
7.6
0
22.9
22.9
0
15.3
15.3
0
0
15.3
7.6
15.3
15.3
7.6
0
0
0
0
0
0
0
114.6
0
0
38.2
15.3
0
0
0
0
0
0
0
7.6
0
0
0
0
0
0
0
7.6
0
0
0
0
0
7.6
428
428
70-
8.3
16.5
82.7
0
0
0
0
0
0
24.8
41.4
0
24.8
33.1
8.3
8.3
0
8.3
0
8.3
8.3
8.3
0
8.3
24.8
0
0
0
124.1
8.3
8.3
66.2
24.8
8.3
16.5
0
0
0
0
0
16.5
0
0
0
8.3
0
0
0
0
0
0
0
0
0
0
595
571
75+
0.1
2.1
5.2
0.1
0.4
0.2
0.6
0.3
0.2
3
2.8
0
2.3
2.8
0.5
0.7
0.5
0.8
0.3
0.5
1.6
0.2
0.4
0.1
0.5
0
0
0.4
31.5
0.3
0.6
9
3.6
0.2
5.1
0
0
0.2
0
0
0.4
0
0.1
1.4
1.2
0
0.4
0.3
1.1
0
0.2
0.6
1.8
0.5
1.9
87.5
87
Total
% of
0.2
2.6
7.4
0.1
0.5
0.3
0.9
0.3
0.3
3.7
3.4
0
3
3.3
0.6
0.9
0.7
1
0.4
0.7
2
0.2
0.4
0.2
0.8
0
0
0.5
33.7
0.4
0.8
10.3
4.1
0.3
5.2
0
0
0.2
0
0
0.6
0
0.1
1.4
1.2
0
0.5
0.3
1.4
0
0.2
0.6
1.7
0.6
2.2
99.9
99.1
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
109
Appendix 27: Morphology of the cancer cases reported and registered at NCR, Malaysia 2007
ICD
Histology
No.
C00 LIP
8000
8070
8010
8020
8200
Neoplasm, malignant
Squamous cell carcinoma, NOS
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Adenoid cystic carcinoma
1
13
1
1
1
17
5.88
76.47
5.88
5.88
5.88
100.00
8020
8000
8001
8032
8051
8073
8075
8140
8560
8980
8810
8010
8070
8071
9
7
2
1
1
1
1
5
1
1
1
14
126
1
171
5.3
4.1
1.2
0.6
0.6
0.6
0.6
2.9
0.6
0.6
0.6
8.2
73.7
0.6
100.0
8000
8010
8020
8041
8070
8071
8072
8076
8200
8140
8430
8480
8720
8920
8550
Neoplasm, malignant
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Small cell carcinoma, NOS
Squamous cell carcinoma, NOS
Squamous cell carcinoma, keratinizing, NOS
Squamous cell carc.large cell,nonkeratinizing, NOS
Squamous cell carcinoma, microinvasive
Adenoid cystic carcinoma
Adenocarcinoma, NOS
Mucoepidermoid carcinoma
Mucinous adenocarcinoma
Malignant melanoma, NOS (except juvenile melanoma)
Oxyphilic adenocarcinoma
Acinar cell carcinoma
5
11
8
1
119
1
1
1
4
7
3
1
1
1
1
165
3.0
6.7
4.8
0.6
72.1
0.6
0.6
0.6
2.4
4.2
1.8
0.6
0.6
0.6
0.6
100.0
8000
8001
8010
8020
8021
8070
8082
8140
8200
8430
8480
8500
8550
8561
8562
8830
Neoplasm, malignant
Tumor cells, malignant
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Carcinoma, anaplastic, NOS
Squamous cell carcinoma, NOS
Lymphoepithelial carcinoma
Adenocarcinoma, NOS
Adenoid cystic carcinoma
Mucoepidermoid carcinoma
Mucinous adenocarcinoma
Infiltrating duct carcinoma, NOS
Acinar cell carcinoma
Adenolymphoma
Epithelial-myoepithelial carcinoma
Malignant fibrous histiocytoma
9
2
9
4
1
11
3
14
6
10
1
1
2
1
1
1
10.6
2.4
10.6
4.7
1.2
12.9
3.5
16.5
7.1
11.8
1.2
1.2
2.4
1.2
1.2
1.2
C01-C02 TONGUE
C03- 06 MOUTH
110
ICD
Histology
No.
8940
8941
8980
8982
2
5
1
1
85
2.4
5.9
1.2
1.2
100.0
8000
8010
8012
8020
8070
8200
Neoplasm, malignant
Carcinoma, NOS
Large cell carcinoma, NOS
Carcinoma, undifferentiated, NOS
Squamous cell carcinoma, NOS
Adenoid cystic carcinoma
1
8
1
5
22
1
38
2.63
21.05
2.63
13.16
57.89
2.63
100.00
8000
8001
8010
8041
8070
8076
8140
Neoplasm, malignant
Tumor cells, malignant
Carcinoma, NOS
Small cell carcinoma, NOS
Squamous cell carcinoma, NOS
Squamous cell carcinoma, microinvasive
Adenocarcinoma, NOS
4
1
5
1
14
1
2
28
14.3
3.6
17.9
3.6
50.0
3.6
7.1
100.0
8000
8001
8010
8020
8032
8050
8070
8071
8072
8073
8075
8082
8120
8121
8140
8200
8230
8260
8800
8851
8900
8980
Neoplasm, malignant
Tumor cells, malignant
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Spindle cell carcinoma, NOS
Papillary carcinoma, NOS
Squamous cell carcinoma, NOS
Squamous cell carcinoma, keratinizing, NOS
Squamous cell carc.large cell,nonkeratinizing, NOS
Squamous cell carc.small cell,nonkeratinizing
Squamous cell carcinoma, adenoid
Lymphoepithelial carcinoma
Transitional cell carcinoma, NOS
Schneiderian carcinoma
Adenocarcinoma, NOS
Adenoid cystic carcinoma
Solid carcinoma, NOS
Papillary adenocarcinoma, NOS
Sarcoma, NOS
Liposarcoma, well differentiated
Rhabdomyosarcoma, NOS
Carcinosarcoma, NOS
80
2
254
337
1
1
85
18
107
8
1
2
1
1
31
2
1
1
1
2
1
3
940
8.5
0.2
27.0
35.9
0.1
0.1
9.0
1.9
11.4
0.9
0.1
0.2
0.1
0.1
3.3
0.2
0.1
0.1
0.1
0.2
0.1
0.3
100.0
8000
8010
8020
8070
8071
8140
Neoplasm, malignant
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Squamous cell carcinoma, NOS
Squamous cell carcinoma, keratinizing, NOS
Adenocarcinoma, NOS
1
10
2
34
1
1
49
2.0
20.4
4.1
69.4
2.0
2.0
100.0
C09 TONSIL
C11 NASOPHARYNX
C12-C13 HYPOPHARYNX
111
ICD
Histology
No.
Neoplasm, malignant
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Squamous cell carcinoma, NOS
Adenocarcinoma, NOS
Fibrosarcoma, NOS
1
1
3
5
2
1
13
7.7
7.7
23.1
38.5
15.4
7.7
100.0
8490
8260
8144
8140
8070
8020
8010
8000
8001
8071
8072
1
2
1
50
86
10
31
19
2
1
3
206
0.5
1.0
0.5
24.3
41.7
4.9
15.0
9.2
1.0
0.5
1.5
100.0
8153
8890
8800
8440
8490
8480
8260
8145
8144
8140
8050
8020
8010
8000
8001
8002
8003
8012
8042
8500
8936
8941
8510
8070
Gastrinoma, malignant
Leiomyosarcoma, NOS
Sarcoma, NOS
Myxosarcoma
Signet ring cell carcinoma
Mucinous adenocarcinoma
Papillary adenocarcinoma, NOS
Carcinoma, diffuse type
Adenocarcinoma, intestinal type
Adenocarcinoma, NOS
Papillary carcinoma, NOS
Carcinoma, undifferentiated, NOS
Carcinoma, NOS
Neoplasm, malignant
Tumor cells, malignant
Malignant tumor, small cell type
Malignant tumor, giant cell type
Large cell carcinoma, NOS
Oat cell carcinoma
Infiltrating duct carcinoma, NOS
Gastrointestinal stromal sarcoma
Carcinoma in pleomorphic adenoma
Medullary carcinoma, NOS
Squamous cell carcinoma, NOS
2
1
1
1
30
5
1
9
19
364
1
20
75
68
6
2
1
1
1
1
6
1
1
13
630
0.3
0.2
0.2
0.2
4.8
0.8
0.2
1.4
3.0
57.8
0.2
3.2
11.9
10.8
1.0
0.3
0.2
0.2
0.2
0.2
1.0
0.2
0.2
2.1
100.0
8936
8890
8240
8140
8010
8000
8144
8800
6
1
3
27
3
1
1
1
43
14.0
2.3
7.0
62.8
7.0
2.3
2.3
2.3
100.0
C15 OESOPHAGUS
C16 STOMACH
112
ICD
Histology
No.
C18-C21 COLORECTAL
8890
8800
8490
8481
8480
8263
8262
8261
8260
8240
8210
8144
8140
8120
8070
8020
8010
8000
8001
8050
8071
8075
8076
8145
8084
8211
8221
8245
8440
8470
8500
8560
8574
8270
8851
8936
8941
8980
8123
Leiomyosarcoma, NOS
Sarcoma, NOS
Signet ring cell carcinoma
Mucin-producing adenocarcinoma
Mucinous adenocarcinoma
Adenocarcinoma in tubulovillous adenoma
Villous adenocarcinoma
Adenocarcinoma in villous adenoma
Papillary adenocarcinoma, NOS
Carcinoid tumor, NOS
Adenocarcinoma in adenomatous polyp
Adenocarcinoma, intestinal type
Adenocarcinoma, NOS
Transitional cell carcinoma, NOS
Squamous cell carcinoma, NOS
Carcinoma, undifferentiated, NOS
Carcinoma, NOS
Neoplasm, malignant
Tumor cells, malignant
Papillary carcinoma, NOS
Squamous cell carcinoma, keratinizing, NOS
Squamous cell carcinoma, adenoid
Squamous cell carcinoma, microinvasive
Carcinoma, diffuse type
Squamous cell carcinoma, clear cell type
Tubular adenocarcinoma
Adenocarcinoma in multiple adenomatous polyps
Adenocarcinoid tumor
Cystadenocarcinoma, NOS
Mucinous cystadenocarcinoma, NOS
Infiltrating duct carcinoma, NOS
Adenosquamous carcinoma
Adenocarcinoma,neuroendocrine differentiation
Chromophobe carcinoma
Liposarcoma, well differentiated
Gastrointestinal stromal sarcoma
Carcinoma in pleomorphic adenoma
Carcinosarcoma, NOS
Basaloid carcinoma
4
1
4
3
31
3
2
1
12
9
4
4
1627
1
36
80
196
183
7
1
1
1
1
1
2
7
1
1
3
1
1
1
1
4
2
1
1
6
1
2246
0.2
0.0
0.2
0.1
1.4
0.1
0.1
0.0
0.5
0.4
0.2
0.2
72.4
0.0
1.6
3.6
8.7
8.1
0.3
0.0
0.0
0.0
0.0
0.0
0.1
0.3
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.2
0.1
0.0
0.0
0.3
0.0
100.0
9170
8805
8936
8970
8171
8170
8162
8160
8140
8070
8010
8000
8001
8020
8033
8050
8082
8091
Lymphangiosarcoma
Undifferentiated sarcoma
Gastrointestinal stromal sarcoma
Hepatoblastoma
Hepatocellular carcinoma, fibrolamellar
Hepatocellular carcinoma, NOS
Klatskin tumor
Cholangiocarcinoma
Adenocarcinoma, NOS
Squamous cell carcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Tumor cells, malignant
Carcinoma, undifferentiated, NOS
Pseudosarcomatous carcinoma
Papillary carcinoma, NOS
Lymphoepithelial carcinoma
Multifocal superficial basal cell carcinoma
1
1
1
4
6
405
8
39
25
2
41
38
4
12
1
2
1
1
0.2
0.2
0.2
0.7
1.0
66.9
1.3
6.4
4.1
0.3
6.8
6.3
0.7
2.0
0.2
0.3
0.2
0.2
C22 LIVER
113
ICD
Histology
No.
8172
8180
8260
8500
8800
1
8
2
1
1
605
0.2
1.3
0.3
0.2
0.2
100.0
8000
8001
8010
8020
8140
8160
8260
8480
8500
8560
Neoplasm, malignant
Tumor cells, malignant
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Adenocarcinoma, NOS
Cholangiocarcinoma
Papillary adenocarcinoma, NOS
Mucinous adenocarcinoma
Infiltrating duct carcinoma, NOS
Adenosquamous carcinoma
14
1
10
15
36
18
3
2
1
1
101
13.9
1.0
9.9
14.9
35.6
17.8
3.0
2.0
1.0
1.0
100.0
8452
8500
8480
8440
8260
8140
8010
8000
8001
8020
8033
8070
8150
8152
8154
8200
8240
8246
8261
3
5
1
1
2
84
68
80
3
20
2
5
1
1
1
3
1
2
1
284
1.1
1.8
0.4
0.4
0.7
29.6
23.9
28.2
1.1
7.0
0.7
1.8
0.4
0.4
0.4
1.1
0.4
0.7
0.4
100.0
8246
8260
9371
8720
9473
8070
8200
8020
8000
8001
8010
8071
8072
8076
8121
8140
8147
9522
2
1
1
1
1
31
3
11
5
1
3
2
1
1
3
9
1
2
79
2.53
1.27
1.27
1.27
1.27
39.24
3.80
13.92
6.33
1.27
3.80
2.53
1.27
1.27
3.80
11.39
1.27
2.53
100.00
C25 PANCREAS
114
ICD
Histology
No.
Neoplsm, malignant
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Papillary carcinoma, NOS
Squamous cell carcinoma, NOS
Squamous cell carcinoma, keratinizing, NOS
Squamous cell carc.large cell,nonkeratinizing, NOS
Adenocarcinoma, NOS
Squamous cell carc.small cell,nonkeratinizing
Sarcoma, NOS
Seminoma, NOS
14
27
7
1
124
1
1
5
1
1
1
183
7.7
14.8
3.8
0.5
67.8
0.5
0.5
2.7
0.5
0.5
0.5
100.0
Pulmonary blastoma
Rhabdomyosarcoma, NOS
Leiomyosarcoma, NOS
Carcinosarcoma, NOS
Liposarcoma, well differentiated
Epithelioid hemangioendothelioma, malignant
Mucoepidermoid carcinoma
Papillary adenocarcinoma, NOS
Bronchiolo-alveolar adenocarcinoma, NOS
Neuroendocrine carcinoma, NOS
8A typical carcinoid tumor
Adenocarcinoma, NOS
Squamous cell carc.large cell,nonkeratinizing, NOS
Squamous cell carcinoma, keratinizing, NOS
Squamous cell carcinoma, NOS
Non-small cell carcinoma
Oat cell carcinoma
Small cell carcinoma, NOS
Carcinoma, undifferentiated, NOS
Large cell carcinoma, NOS
Carcinoma, NOS
Neoplsm, malignant
Tumor cells, malignant
Malignant tumor, small cell type
Malignant tumor, giant cell type
Large cell neuroendocrine carcinoma
Spindle cell carcinoma, NOS
Small cell carcinoma, fusiform cell
Combined small cell carcinoma
Papillary carcinoma, NOS
Squamous cell carc.small cell,nonkeratinizing
Scirrhous adenocarcinoma
Basal cell adenocarcinoma
Adenoid cystic carcinoma
Infiltrating duct carcinoma, NOS
Adenosquamous carcinoma
Adenocarcinoma, neuroendocrine differentiation
Sarcoma, NOS
Small cell sarcoma
Liposarcoma, NOS
Mucinous adenocarcinoma
1
2
2
4
1
2
3
4
23
3
1
541
8
5
298
85
3
126
83
18
318
293
11
1
2
1
1
1
3
4
3
1
1
1
2
1
1
2
1
1
3
1865
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.2
1.2
0.2
0.1
29.0
0.4
0.3
16.0
4.6
0.2
6.8
4.5
1.0
17.1
15.7
0.6
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
100.0
Germinoma
Teratoma, malignant, NOS
Thymoma, malignant, NOS
1
1
7
1.9
1.9
13.5
C32 LARYNX
8000
8010
8020
8050
8070
8071
8072
8140
8073
8800
9061
115
ICD
Histology
No.
8070
8000
8010
8013
8020
8041
8052
8140
8260
8560
5
5
2
1
1
1
1
24
2
1
52
9.6
9.6
3.8
1.9
1.9
1.9
1.9
46.2
3.8
1.9
100.0
9364
9310
9260
9250
9220
9181
9180
8003
8000
8001
8002
8004
8010
8021
8070
8140
8500
8800
8810
8812
8830
8852
8890
9040
9120
9185
9194
9200
9231
9243
9270
9380
9400
1
1
13
5
7
1
63
1
27
2
1
1
3
1
5
4
1
3
1
3
2
1
1
1
1
1
1
11
1
1
6
1
1
173
0.6
0.6
7.5
2.9
4.0
0.6
36.4
0.6
15.6
1.2
0.6
0.6
1.7
0.6
2.9
2.3
0.6
1.7
0.6
1.7
1.2
0.6
0.6
0.6
0.6
0.6
0.6
6.4
0.6
0.6
3.5
0.6
0.6
100.0
8772
8720
8744
8770
1
57
1
2
61
1.6
93.4
1.6
3.3
100.0
8832
8410
8830
8800
8140
Dermatofibrosarcoma, NOS
Sebaceous adenocarcinoma
Malignant fibrous histiocytoma
Sarcoma, NOS
Adenocarcinoma, NOS
17
5
2
1
7
4.2
1.2
0.5
0.2
1.7
C40-C41 BONE
116
ICD
Histology
No.
1
1
205
2
3
116
1
1
10
1
7
2
8
2
2
2
4
1
1
402
0.2
0.2
51.0
0.5
0.7
28.9
0.2
0.2
2.5
0.2
1.7
0.5
2.0
0.5
0.5
0.5
1.0
0.2
0.2
100.0
9050
5
5
100
100
9140
2
2
100
100
1
10
2
7
3
1
1
1
2
7
12
8
10
7
9
1
2
35
6
2
1
2
4
3
1
1
1
1
1
2
1
0.7
6.8
1.4
4.7
2.0
0.7
0.7
0.7
1.4
4.7
8.1
5.4
6.8
4.7
6.1
0.7
1.4
23.6
4.1
1.4
0.7
1.4
2.7
2.0
0.7
0.7
0.7
0.7
0.7
1.4
0.7
8102
8402
8090
8247
8071
8070
8430
8032
8010
8390
8000
8001
8020
8022
8050
8072
8081
8110
8560
Trichilemmocarcinoma
Nodular hidradenoma, malignant
Basal cell carcinoma, NOS
Merkel cell carcinoma
Squamous cell carcinoma, keratinizing, NOS
Squamous cell carcinoma, NOS
Mucoepidermoid carcinoma
Spindle cell carcinoma, NOS
Carcinoma, NOS
Skin appendage carcinoma
Neoplsm, malignant
Tumor cells, malignant
Carcinoma, undifferentiated, NOS
Pleomorphic carcinoma
Papillary carcinoma, NOS
Squamous cell carc.large cell,nonkeratinizing, NOS
Bowen disease
Pilomatrix carcinoma
Adenosquamous carcinoma
C45 MESOTHELIOMA
Neurilemoma, malignant
Malignant peripheral nerve sheath tumor
Hemangiopericytoma, malignant
Hemangiosarcoma
Synovial sarcoma, NOS
Primitive neuroectodermal tumor, NOS
Alveolar rhabdomysarcoma
Clear cell sarcoma, NOS (except of kidney)
pleomorphic rhabdomysarcoma, adult type
Rhabdomysarcoma, NOS
Leiomyosarcoma, NOS
Myxoid liposarcoma
Liposarcoma, NOS
Malignant fibrous histiocytoma
Fibrosarcoma, NOS
Giant cell sarcoma (except of bone)
Spindle cell sarcoma
Sarcoma, NOS
Neoplasm, malignant
Tumor cells, malignant
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Squamous cell carcinoma, NOS
Adenocarcinoma, NOS
Neuroendocrine carcinoma, NOS
Mucinous cystadenocarcinoma, NOS
Small cell sarcoma
Epithelioid sarcoma
Desmoplastic small round cell tumor
Fibromyxosarcoma
Infantile fibrosarcoma
117
ICD
Histology
No.
8821
8822
8851
Aggressive fibromatosis
Abdominal fibromatosis
Liposarcoma, well differentiated
1
1
1
148
0.7
0.7
0.7
100.0
9020
9010
8980
8540
8530
8522
8521
8520
8510
8501
8500
8480
8140
8070
8050
8935
8890
8010
8000
8001
8004
8020
8032
8034
8071
8200
8201
8211
8310
8315
8503
8513
8523
8541
8543
8573
8800
8810
8850
8851
8852
18
2
16
3
1
9
185
50
20
2
2457
40
69
20
9
2
1
232
77
6
1
40
1
1
1
1
1
3
1
1
6
1
2
3
1
1
2
2
1
2
1
3292
0.5
0.1
0.5
0.1
0.0
0.3
5.6
1.5
0.6
0.1
74.6
1.2
2.1
0.6
0.3
0.1
0.0
7.0
2.3
0.2
0.0
1.2
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.2
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.0
100.0
8070
8010
8140
8542
8000
8720
14
3
1
1
1
1
21
66.7
14.3
4.8
4.8
4.8
4.8
100.0
8072
8071
8070
1
2
13
3.2
6.5
41.9
C50 BREAST
C51 VULVA
C52 VAGINA
118
ICD
Histology
No.
8010
8000
8020
8140
8980
Carcinoma, NOS
Neoplasm, malignant
Carcinoma, undifferentiated, NOS
Adenocarcinoma, NOS
Carcinosarcoma, NOS
2
3
2
7
1
31
6.5
9.7
6.5
22.6
3.2
100.0
8560
8481
8310
8260
8140
8076
8072
8071
8070
8052
8980
8020
8010
8000
8003
8001
8012
8050
8041
8073
8077
8246
8262
8263
8380
8384
8460
8890
Adenocarcinoma, NOS
Mucin-producing adenocarcinoma
Clear cell adenocarcinoma, NOS
Papillary adenocarcinoma, NOS
Adenocarcinoma, NOS
Squamous cell carcinoma, microinvasive
Squamous cell carc. large cell, nonkeratinizing
Squamous cell carcinoma, keratinizing,NOS
Squamous cell carcinoma, NOS
Papillary adenocarcinoma, NOS
Carcinosarcoma, NOS
Carcinoma, undifferentiated, NOS
Carcinoma, NOS
Neoplasm, malignant
Malignant tumor, giant cell type
Tumor cells, malignant
Large cell carcinoma, NOS
Papillary carcinoma, NOS
Small cell carcinoma, NOS
Squamous cell carc.small cell,nonkeratinizing
Squamous intraepithelial neoplasia, grade III
Neuroendocrine carcinoma, NOS
Villous adenocarcinoma
Adenocarcinoma in tubulovillous adenoma
Endometrioid adenocarcinoma, NOS
Adenocarcinoma, endocervical type
Papillary serous cystadenocarcinoma
Carcinosarcoma, NOS
10
1
3
5
145
10
159
42
252
1
4
41
79
53
1
3
2
6
2
5
1
3
1
1
7
7
1
2
847
1.2
0.1
0.4
0.6
17.1
1.2
18.8
5.0
29.8
0.1
0.5
4.8
9.3
6.3
0.1
0.4
0.2
0.7
0.2
0.6
0.1
0.4
0.1
0.1
0.8
0.8
0.1
0.2
100.0
8950
8930
8890
8800
8931
8560
8310
8260
8810
8140
8070
8010
8000
8001
8020
8050
8052
8073
8380
8072
8381
8480
3
16
4
1
5
5
3
4
3
169
3
36
26
1
24
2
1
1
102
2
2
1
414
0.7
3.9
1.0
0.2
1.2
1.2
0.7
1.0
0.7
40.8
0.7
8.7
6.3
0.2
5.8
0.5
0.2
0.2
24.6
0.5
0.5
0.2
100.0
119
ICD
Histology
No.
Leiomyosarcoma, NOS
Adenocarcinoma, NOS
Squamous cell carcinoma, NOS
Neoplasm, malignant
Tumor cells, malignant
Malignant tumor, small cell type
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Neuroendocrine carcinoma, NOS
Papillary adenocarcinoma, NOS
Endometrioid adenocarcinoma, NOS
Endometrioid adenofibroma, malignant
Mucinous adenocarcinoma
Rhabdomyosarcoma, NOS
Mullerian mixed tumor
Choriocarcinoma, NOS
14
24
3
8
1
1
6
10
1
1
10
1
1
1
2
1
85
16.5
28.2
3.5
9.4
1.2
1.2
7.1
11.8
1.2
1.2
11.8
1.2
1.2
1.2
2.4
1.2
100.0
9085
9080
9071
9060
9100
9580
8620
8480
8471
8470
8461
8460
8450
8441
8440
8380
8310
8260
8140
8070
8020
8010
8000
8001
8003
8002
8011
8041
8050
8072
8076
8246
8320
8323
8381
8472
8481
8490
8621
8631
8640
2
20
4
3
1
1
10
9
5
35
2
33
10
33
17
43
30
10
162
11
30
73
60
13
1
1
2
2
4
1
1
1
1
1
1
1
1
1
1
1
1
0.3
3.0
0.6
0.5
0.2
0.2
1.5
1.4
0.8
5.3
0.3
5.0
1.5
5.0
2.6
6.6
4.6
1.5
24.7
1.7
4.6
11.1
9.1
2.0
0.2
0.2
0.3
0.3
0.6
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
10.2
0.2
0.2
0.2
C56 OVARY
120
ICD
Histology
No.
2
1
1
3
1
1
1
3
3
1
656
0.3
0.2
0.2
0.5
0.2
0.2
0.2
0.5
0.5
0.2
100.0
8890
8891
8950
8980
8990
9000
9014
9082
9084
9090
Leiomyosarcoma, NOS
Epithelioid leiomyosarcoma
Mullerian mixed tumor
Carcinosarcoma, NOS
Mesenchymoma, malignant
Brenner tumor, malignant
Serous adenocarcinofibroma
Malignant teratoma, undifferentiated
Teratoma with malignant transformation
Struma ovarii, malignant
8140
8010
8001
Adenocarcinoma, NOS
Carcinoma, NOS
Tumor cells, malignant
1
1
1
3
33.3
33.3
33.3
100.0
9100
8000
9104
8260
Choriocarcinoma
Neoplasm, malignant
Placental site trophoblastic tumor
Papillary adenocarcinoma, NOS
3
2
1
1
7
42.9
28.6
14.3
14.3
100.0
8090
8070
8000
8010
1
17
2
3
23
4.3
73.9
8.7
13.0
100.0
8980
8550
8500
8260
8140
8070
8000
8001
8010
8020
8120
Carcinosarcoma, NOS
Acinar cell carcinoma
Infiltrating duct carcinoma, NOS
Papillary adenocarcinoma, NOS
Adenocarcinoma, NOS
Squamous cell carcinoma, NOS
Neoplasm, malignant
Tumor cells, malignant
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Transitional cell carcinoma, NOS
1
7
4
1
380
3
27
2
53
21
3
502
0.2
1.4
0.8
0.2
75.7
0.6
5.4
0.4
10.6
4.2
0.6
100.0
9120
9085
9080
8070
8010
8000
8001
8020
8590
8640
8650
8890
8900
9064
Hemangiosarcoma
Mixed germ cell tumor
Teratoma, malignant, NOS
Squamous cell carcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Tumor cells, malignant
Carcinoma, undifferentiated, NOS
Sex cord-gonadal stromal tumor, NOS
Sertoli cell carcinoma
Leydig cell tumor, malignant
Leiomyosarcoma, NOS
Rhabdomyosarcoma, NOS
Germinoma
1
2
4
1
5
5
3
4
1
1
1
1
1
10
1.4
2.7
5.4
1.4
6.8
6.8
4.1
5.4
1.4
1.4
1.4
1.4
1.4
13.5
C58 PLACENTA
C60 PENIS
C61 PROSTATE
C62 TESTIS
121
ICD
Histology
No.
9070
9061
9071
1
26
7
74
1.4
35.1
9.5
100.0
8010
8070
8140
9081
Carcinoma, NOS
Squamous cell carcinoma, NOS
Adenocarcinoma, NOS
Teratocarcinoma
1
1
1
1
4
25
25
25
25
100
8960
9500
8959
8860
8312
8310
8140
8120
9364
8010
8000
8001
8012
8020
8050
8070
8260
8318
8800
8850
8851
Nephroblastoma, NOS
Neuroblastoma, NOS
Malignant cystic nephroma
Angiomyolipoma
Renal cell carcinoma, NOS
Clear cell adenocarcinoma, NOS
Adenocarcinoma, NOS
Transitional cell carcinoma, NOS
Peripheral neuroectodermal tumor
Carcinoma, NOS
Neoplasm, malignant
Tumor cells, malignant
Large cell carcinoma, NOS
Carcinoma, undifferentiated, NOS
Papillary carcinoma, NOS
Squamous cell carcinoma, NOS
Papillary adenocarcinoma, NOS
Renal cell carcinoma, sarcomatoid
Sarcoma, NOS
Liposarcoma, NOS
Liposarcoma, well differentiated
10
1
2
1
88
13
5
11
1
33
11
4
1
8
1
4
1
2
2
1
1
201
5.0
0.5
1.0
0.5
43.8
6.5
2.5
5.5
0.5
16.4
5.5
2.0
0.5
4.0
0.5
2.0
0.5
1.0
1.0
0.5
0.5
100.0
8120
8020
8070
8130
8810
4
4
1
1
1
11
36.4
36.4
9.1
9.1
9.1
100.0
8120
3
3
100
100
8140
8130
8120
8070
8020
8010
8000
8001
8011
8050
8052
8071
8260
Adenocarcinoma, NOS
Papillary transitional cell carcinoma
Transitional cell carcinoma, NOS
Squamous cell carcinoma, NOS
Carcinoma, undifferentiated, NOS
Carcinoma, NOS
Neoplasm, malignant
Tumor cells, malignant
Epithelioma, malignant
Papillary carcinoma, NOS
Papillary squamous cell carcinoma
Squamous cell carcinoma, keratinizing, NOS
Papillary adenocarcinoma, NOS
23
22
143
12
18
47
45
1
1
11
1
1
1
6.9
6.6
43.2
3.6
5.4
14.2
13.6
0.3
10.3
3.3
0.3
0.3
0.3
C64 KIDNEY
C66 URETER
C67 BLADDER
122
ICD
Histology
No.
8480
8490
8852
9580
Mucinous adenocarcinoma
Signet ring cell carcinoma
Myxoid liposarcoma
Granular cell tumor, malignant
2
1
1
1
331
0.6
0.3
0.3
0.3
100.0
8140
8010
8050
8130
Adenocarcinoma, NOS
Carcinoma, NOS
Papillary carcinoma, NOS
Papillary transitional cell carcinoma
8
2
1
1
12
66.7
16.7
8.3
8.3
100.0
9500
9510
8140
8070
8000
8010
8011
8020
8800
8900
9100
9120
9511
Neuroblastoma, NOS
Retinoblastoma, NOS
Adenocarcinoma, NOS
Squamous cell carcinoma, NOS
Neoplasm, malignant
Carcinoma, NOS
Epithelioma, malignant
Carcinoma, undifferentiated, NOS
Sarcoma, NOS
Rhabdomyosarcoma, NOS
Choriocarcinoma, NOS
Hemangiosarcoma
Retinoblastoma, differentiated
1
15
4
5
2
1
1
1
1
1
2
1
2
37
2.70
40.54
10.81
13.51
5.41
2.70
2.70
2.70
2.70
2.70
5.41
2.70
5.41
100.00
Meningioma, malignant
Primitive neuroetodermal tumor, NOS
Medulloblastoma, NOS
Oligodendroglioma, NOS
Glioblastoma, NOS
Pilocytic astrocytoma
Cerebellar sarcoma, NOS
Oligodendroblastoma
Ganglioglioma, anaplastic
Meningeal sarcomatosis
Atypical teratoid/rhabdoid tumor
Papillary meningioma
Medulloepithelioma, NOS
Neuroblastoma, NOS
Meningothelial meningioma
Transitional meningioma
Gliosarcoma
Oligodendroglioma, anaplastic
Giant cell glioblastoma
Neurilemoma, malignant
Astrocytoma, anaplastic
Astroblastoma
Astrocytoma, NOS
Myxopapillary ependymoma
Papillary ependymoma
Malignant peripheral nerve sheath tumor
Ependymoma, NOS
Choroid plexus carcinoma
Mixed glioma
Glioma, malignant
Malig.periph.nerve sheath tumor, rhabdomyoblas. difftn.
77
6
21
12
66
1
2
1
4
2
1
1
1
24
1
1
9
3
2
16
3
2
45
1
3
5
10
1
2
39
1
16.3
1.3
4.5
2.5
14.0
0.2
0.4
0.2
0.8
0.4
0.2
0.2
0.2
5.1
0.2
0.2
1.9
0.6
0.4
3.4
0.6
0.4
9.6
0.2
0.6
1.1
2.1
0.2
0.4
8.3
0.2
C69 EYE
123
ICD
Histology
No.
9364
9150
8003
8002
8000
8001
8010
8140
8260
8481
8500
8070
8800
8802
8806
9064
9080
9081
9085
9120
9170
1
1
1
1
54
23
1
5
1
1
1
1
3
1
1
4
3
1
1
2
1
471
0.2
0.2
0.2
0.2
11.5
4.9
0.2
1.1
0.2
0.2
0.2
0.2
0.6
0.2
0.2
0.8
0.6
0.2
0.2
0.4
0.2
100.0
8850
8340
8330
8290
8260
8070
8050
8021
8010
8000
8011
8020
8052
8076
8140
8331
8332
8350
8480
8503
8510
Liposarcoma, NOS
Papillary carcinoma, follicular variant
Follicular adenocarcinoma
Oxyphilic adenocarcinoma
Papillary adenocarcinoma, NOS
Squamous cell carcinoma, NOS
Papillary carcinoma, NOS
Carcinoma, anaplastic, NOS
Carcinoma, NOS
Neoplasm, malignant
Epithelioma, malignant
Carcinoma, undifferentiated, NOS
Papillary squamous cell carcinoma
Squamous cell carcinoma, microinvasive
Adenocarcinoma, NOS
Follicular adenocarcinoma, well differentiated
Follicular adenocarcinoma, trabecular
Nonencapsulated sclerosing carcinoma
Mucinous adenocarcinoma
Intraductal papillary adenocarcinoma with invasion
Medullary carcinoma, NOS
2
27
78
1
33
3
146
8
33
45
1
21
1
1
20
2
5
1
2
1
3
434
0.5
6.2
18.0
0.2
7.6
0.7
33.6
1.8
7.6
10.4
0.2
4.8
0.2
0.2
4.6
0.5
1.2
0.2
0.5
0.2
0.7
100.0
9500
8700
8370
8000
8010
8020
8070
8140
Neuroblastoma, NOS
Pheochromocytoma, malignant
Adrenal cortical carcinoma
Neoplasm, malignant
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Squamous cell carcinoma, NOS
Adenocarcinoma, NOS
9
1
2
3
2
2
1
1
21
42.9
4.8
9.5
14.3
9.5
9.5
4.8
4.8
100.0
9580
8140
8000
1
18
5
1.9
34.0
9.4
C73 THYROID
124
ICD
Histology
No.
8001
8010
8020
8070
8210
8272
8281
8334
8711
9064
9085
9362
9350
9380
1
1
2
1
3
8
1
1
1
4
1
3
1
1
53
1.9
1.9
3.8
1.9
5.7
15.1
1.9
1.9
1.9
7.5
1.9
5.7
1.9
1.9
100.0
9663
9659
9665
9652
9650
9651
9
1
1
1
53
2
67
13.4
1.5
1.5
1.5
79.1
3.0
100.0
1
1
2
14
2
24
9
95
1
8
407
101
15
1
2
1
1
3
2
3
10
1
3
2
709
0.1
0.1
0.3
2.0
0.3
3.4
1.3
13.4
0.1
1.1
57.4
14.2
2.1
0.1
0.3
0.1
0.1
0.4
0.3
0.4
1.4
0.1
0.4
0.3
100.0
1
1
100.0
100.0
143
18
5
14
30
64.7
8.1
2.3
6.3
13.6
125
ICD
Histology
No.
9836
9837
9940
5
4
2
221
2.3
1.8
0.9
100.0
9861
9863
9866
9867
9945
9860
9931
9930
9840
9872
9875
9876
9896
9910
222
88
16
8
1
33
3
8
13
1
1
4
2
1
401
55.4
21.9
4.0
2.0
0.2
8.2
0.7
2.0
3.2
0.2
0.2
1.0
0.5
0.2
100.0
9801
9800
9805
107
10
2
119
89.9
8.4
1.7
100.0
126